id	sid	tid	token	lemma	pos
ct-9661	1	1	introduction	introduction	NOUN
ct-9661	1	2	antibiotic	antibiotic	ADJ
ct-9661	1	3	use	use	NOUN
ct-9661	1	4	in	in	ADP
ct-9661	1	5	human	human	ADJ
ct-9661	1	6	and	and	CCONJ
ct-9661	1	7	animal	animal	NOUN
ct-9661	1	8	medicines	medicine	NOUN
ct-9661	1	9	has	have	AUX
ct-9661	1	10	rapidly	rapidly	ADV
ct-9661	1	11	accelerated	accelerate	VERB
ct-9661	1	12	since	since	SCONJ
ct-9661	1	13	the	the	DET
ct-9661	1	14	discovery	discovery	NOUN
ct-9661	1	15	of	of	ADP
ct-9661	1	16	penicillin	penicillin	NOUN
ct-9661	1	17	in	in	ADP
ct-9661	1	18	1928	1928	NUM
ct-9661	1	19	.	.	PUNCT
ct-9661	2	1	consequently	consequently	ADV
ct-9661	2	2	,	,	PUNCT
ct-9661	2	3	microorganisms	microorganism	NOUN
ct-9661	2	4	resistant	resistant	ADJ
ct-9661	2	5	to	to	ADP
ct-9661	2	6	particular	particular	ADJ
ct-9661	2	7	antimicrobials	antimicrobial	NOUN
ct-9661	2	8	or	or	CCONJ
ct-9661	2	9	classes	class	NOUN
ct-9661	2	10	of	of	ADP
ct-9661	2	11	antibiotics	antibiotic	NOUN
ct-9661	2	12	have	have	AUX
ct-9661	2	13	emerged	emerge	VERB
ct-9661	2	14	.	.	PUNCT
ct-9661	3	1	growing	grow	VERB
ct-9661	3	2	trends	trend	NOUN
ct-9661	3	3	in	in	ADP
ct-9661	3	4	antimicrobial	antimicrobial	ADJ
ct-9661	3	5	resistance	resistance	NOUN
ct-9661	3	6	underscore	underscore	VERB
ct-9661	3	7	the	the	DET
ct-9661	3	8	urgency	urgency	NOUN
ct-9661	3	9	of	of	ADP
ct-9661	3	10	directed	directed	ADJ
ct-9661	3	11	,	,	PUNCT
ct-9661	3	12	rational	rational	ADJ
ct-9661	3	13	,	,	PUNCT
ct-9661	3	14	and	and	CCONJ
ct-9661	3	15	prudent	prudent	ADJ
ct-9661	3	16	antibiotic	antibiotic	ADJ
ct-9661	3	17	usage	usage	NOUN
ct-9661	3	18	.	.	PUNCT
ct-9661	4	1	antibiotics	antibiotic	NOUN
ct-9661	4	2	are	be	AUX
ct-9661	4	3	indispensable	indispensable	ADJ
ct-9661	4	4	in	in	ADP
ct-9661	4	5	treating	treat	VERB
ct-9661	4	6	endometritis	endometritis	NOUN
ct-9661	4	7	.	.	PUNCT
ct-9661	5	1	however	however	ADV
ct-9661	5	2	,	,	PUNCT
ct-9661	5	3	not	not	PART
ct-9661	5	4	all	all	DET
ct-9661	5	5	causes	cause	NOUN
ct-9661	5	6	of	of	ADP
ct-9661	5	7	uterine	uterine	ADJ
ct-9661	5	8	inflammation	inflammation	NOUN
ct-9661	5	9	call	call	NOUN
ct-9661	5	10	for	for	ADP
ct-9661	5	11	antibiotics	antibiotic	NOUN
ct-9661	5	12	,	,	PUNCT
ct-9661	5	13	and	and	CCONJ
ct-9661	5	14	many	many	ADJ
ct-9661	5	15	other	other	ADJ
ct-9661	5	16	therapeutic	therapeutic	ADJ
ct-9661	5	17	approaches	approach	NOUN
ct-9661	5	18	can	can	AUX
ct-9661	5	19	be	be	AUX
ct-9661	5	20	used	use	VERB
ct-9661	5	21	to	to	PART
ct-9661	5	22	decrease	decrease	VERB
ct-9661	5	23	reliance	reliance	NOUN
ct-9661	5	24	only	only	ADV
ct-9661	5	25	on	on	ADP
ct-9661	5	26	antibiotics	antibiotic	NOUN
ct-9661	5	27	.	.	PUNCT
ct-9661	6	1	endometritis	endometritis	NOUN
ct-9661	6	2	is	be	AUX
ct-9661	6	3	not	not	PART
ct-9661	6	4	a	a	DET
ct-9661	6	5	foe	foe	NOUN
ct-9661	6	6	that	that	PRON
ct-9661	6	7	will	will	AUX
ct-9661	6	8	be	be	AUX
ct-9661	6	9	conquered	conquer	VERB
ct-9661	6	10	by	by	ADP
ct-9661	6	11	an	an	DET
ct-9661	6	12	ever	ever	ADV
ct-9661	6	13	-	-	PUNCT
ct-9661	6	14	escalating	escalate	VERB
ct-9661	6	15	arms	arm	NOUN
ct-9661	6	16	race	race	NOUN
ct-9661	6	17	of	of	ADP
ct-9661	6	18	antibiotics	antibiotic	NOUN
ct-9661	6	19	and	and	CCONJ
ct-9661	6	20	chemical	chemical	NOUN
ct-9661	6	21	infusions	infusion	NOUN
ct-9661	6	22	.	.	PUNCT
ct-9661	7	1	rather	rather	ADV
ct-9661	7	2	,	,	PUNCT
ct-9661	7	3	endometritis	endometritis	PROPN
ct-9661	7	4	should	should	AUX
ct-9661	7	5	be	be	AUX
ct-9661	7	6	respected	respect	VERB
ct-9661	7	7	as	as	ADP
ct-9661	7	8	a	a	DET
ct-9661	7	9	condition	condition	NOUN
ct-9661	7	10	with	with	ADP
ct-9661	7	11	which	which	PRON
ct-9661	7	12	every	every	DET
ct-9661	7	13	reproductive	reproductive	ADJ
ct-9661	7	14	clinician	clinician	NOUN
ct-9661	7	15	must	must	AUX
ct-9661	7	16	coexist	coexist	VERB
ct-9661	7	17	,	,	PUNCT
ct-9661	7	18	and	and	CCONJ
ct-9661	7	19	only	only	ADV
ct-9661	7	20	through	through	ADP
ct-9661	7	21	appreciating	appreciate	VERB
ct-9661	7	22	its	its	PRON
ct-9661	7	23	origins	origin	NOUN
ct-9661	7	24	and	and	CCONJ
ct-9661	7	25	accordingly	accordingly	ADV
ct-9661	7	26	modifying	modify	VERB
ct-9661	7	27	its	its	PRON
ct-9661	7	28	natural	natural	ADJ
ct-9661	7	29	course	course	NOUN
ct-9661	7	30	success	success	NOUN
ct-9661	7	31	(	(	PUNCT
ct-9661	7	32	pregnancy	pregnancy	NOUN
ct-9661	7	33	)	)	PUNCT
ct-9661	7	34	can	can	AUX
ct-9661	7	35	be	be	AUX
ct-9661	7	36	achieved	achieve	VERB
ct-9661	7	37	.	.	PUNCT
ct-9661	8	1	at	at	ADP
ct-9661	8	2	the	the	DET
ct-9661	8	3	forefront	forefront	NOUN
ct-9661	8	4	of	of	ADP
ct-9661	8	5	this	this	DET
ct-9661	8	6	approach	approach	NOUN
ct-9661	8	7	is	be	AUX
ct-9661	8	8	a	a	DET
ct-9661	8	9	focus	focus	NOUN
ct-9661	8	10	on	on	ADP
ct-9661	8	11	diagnostic	diagnostic	ADJ
ct-9661	8	12	precision	precision	NOUN
ct-9661	8	13	to	to	PART
ct-9661	8	14	ensure	ensure	VERB
ct-9661	8	15	that	that	SCONJ
ct-9661	8	16	all	all	DET
ct-9661	8	17	underlying	underlying	ADJ
ct-9661	8	18	and	and	CCONJ
ct-9661	8	19	contributing	contribute	VERB
ct-9661	8	20	causes	cause	NOUN
ct-9661	8	21	are	be	AUX
ct-9661	8	22	addressed	address	VERB
ct-9661	8	23	.	.	PUNCT
ct-9661	9	1	endometrial	endometrial	ADJ
ct-9661	9	2	resistance	resistance	NOUN
ct-9661	9	3	has	have	AUX
ct-9661	9	4	historically	historically	ADV
ct-9661	9	5	been	be	AUX
ct-9661	9	6	attributed	attribute	VERB
ct-9661	9	7	to	to	ADP
ct-9661	9	8	physical	physical	ADJ
ct-9661	9	9	clearance	clearance	NOUN
ct-9661	9	10	of	of	ADP
ct-9661	9	11	irritants	irritant	NOUN
ct-9661	9	12	in	in	ADP
ct-9661	9	13	response	response	NOUN
ct-9661	9	14	to	to	ADP
ct-9661	9	15	appropriate	appropriate	VERB
ct-9661	9	16	local	local	ADJ
ct-9661	9	17	inflammation	inflammation	NOUN
ct-9661	9	18	.	.	PUNCT
ct-9661	10	1	physical	physical	ADJ
ct-9661	10	2	clearance	clearance	NOUN
ct-9661	10	3	requires	require	VERB
ct-9661	10	4	an	an	DET
ct-9661	10	5	appropriate	appropriate	ADJ
ct-9661	10	6	disposition	disposition	NOUN
ct-9661	10	7	of	of	ADP
ct-9661	10	8	the	the	DET
ct-9661	10	9	genital	genital	ADJ
ct-9661	10	10	tract,1	tract,1	NOUN
ct-9661	10	11	competence	competence	NOUN
ct-9661	10	12	and	and	CCONJ
ct-9661	10	13	function	function	NOUN
ct-9661	10	14	of	of	ADP
ct-9661	10	15	anatomical	anatomical	ADJ
ct-9661	10	16	barriers,2,3	barriers,2,3	ADJ
ct-9661	10	17	myometrial	myometrial	ADJ
ct-9661	10	18	contractility,4,5,6	contractility,4,5,6	X
ct-9661	10	19	lymphatic	lymphatic	PROPN
ct-9661	10	20	drainage,7and	drainage,7and	PROPN
ct-9661	10	21	mucociliary	mucociliary	NOUN
ct-9661	10	22	clearance.8,9	clearance.8,9	PROPN
ct-9661	10	23	additionally	additionally	ADV
ct-9661	10	24	,	,	PUNCT
ct-9661	10	25	local	local	ADJ
ct-9661	10	26	cellular	cellular	ADJ
ct-9661	10	27	and	and	CCONJ
ct-9661	10	28	humoral	humoral	ADJ
ct-9661	10	29	aspects	aspect	NOUN
ct-9661	10	30	of	of	ADP
ct-9661	10	31	the	the	DET
ct-9661	10	32	immune	immune	ADJ
ct-9661	10	33	system	system	NOUN
ct-9661	10	34	are	be	AUX
ct-9661	10	35	important.5	important.5	NOUN
ct-9661	10	36	treatment	treatment	NOUN
ct-9661	10	37	of	of	ADP
ct-9661	10	38	persistent	persistent	ADJ
ct-9661	10	39	endometritis	endometritis	NOUN
ct-9661	10	40	includes	include	VERB
ct-9661	10	41	restoration	restoration	NOUN
ct-9661	10	42	of	of	ADP
ct-9661	10	43	appropriate	appropriate	ADJ
ct-9661	10	44	external	external	ADJ
ct-9661	10	45	genital	genital	ADJ
ct-9661	10	46	anatomy,2	anatomy,2	NOUN
ct-9661	10	47	augmentation	augmentation	NOUN
ct-9661	10	48	of	of	ADP
ct-9661	10	49	uterine	uterine	ADJ
ct-9661	10	50	clearance,4	clearance,4	NOUN
ct-9661	10	51	and	and	CCONJ
ct-9661	10	52	overcoming	overcome	VERB
ct-9661	10	53	deficiencies	deficiency	NOUN
ct-9661	10	54	in	in	ADP
ct-9661	10	55	function	function	NOUN
ct-9661	10	56	of	of	ADP
ct-9661	10	57	humoral	humoral	ADJ
ct-9661	10	58	and	and	CCONJ
ct-9661	10	59	cellular	cellular	ADJ
ct-9661	10	60	immune	immune	ADJ
ct-9661	10	61	response	response	NOUN
ct-9661	10	62	to	to	ADP
ct-9661	10	63	endometrial	endometrial	ADJ
ct-9661	10	64	contamination.10	contamination.10	NOUN
ct-9661	10	65	excellent	excellent	ADJ
ct-9661	10	66	reviews	review	NOUN
ct-9661	10	67	discussing	discuss	VERB
ct-9661	10	68	alternatives	alternative	NOUN
ct-9661	10	69	to	to	ADP
ct-9661	10	70	primary	primary	ADJ
ct-9661	10	71	antimicrobials	antimicrobial	NOUN
ct-9661	10	72	for	for	ADP
ct-9661	10	73	treatment	treatment	NOUN
ct-9661	10	74	of	of	ADP
ct-9661	10	75	endometritis	endometritis	NOUN
ct-9661	10	76	are	be	AUX
ct-9661	10	77	available.11,12	available.11,12	NOUN
ct-9661	10	78	nonantibiotic	nonantibiotic	ADJ
ct-9661	10	79	therapies	therapy	NOUN
ct-9661	10	80	for	for	ADP
ct-9661	10	81	endometritis	endometritis	NOUN
ct-9661	10	82	:	:	PUNCT
ct-9661	10	83	what	what	PRON
ct-9661	10	84	,	,	PUNCT
ct-9661	10	85	when	when	SCONJ
ct-9661	10	86	,	,	PUNCT
ct-9661	10	87	and	and	CCONJ
ct-9661	10	88	why	why	SCONJ
ct-9661	10	89	kristina	kristina	PROPN
ct-9661	10	90	lu	lu	PROPN
ct-9661	10	91	,	,	PUNCT
ct-9661	10	92	karen	karen	PROPN
ct-9661	10	93	von	von	PROPN
ct-9661	10	94	dollen	dollen	PROPN
ct-9661	10	95	hagyard	hagyard	PROPN
ct-9661	10	96	equine	equine	PROPN
ct-9661	10	97	medical	medical	PROPN
ct-9661	10	98	institute	institute	PROPN
ct-9661	10	99	,	,	PUNCT
ct-9661	10	100	lexington	lexington	PROPN
ct-9661	10	101	,	,	PUNCT
ct-9661	10	102	ky	ky	PROPN
ct-9661	10	103	abstract	abstract	PROPN
ct-9661	10	104	endometritis	endometritis	PROPN
ct-9661	10	105	,	,	PUNCT
ct-9661	10	106	inflammation	inflammation	NOUN
ct-9661	10	107	of	of	ADP
ct-9661	10	108	the	the	DET
ct-9661	10	109	inner	inner	ADJ
ct-9661	10	110	lining	lining	NOUN
ct-9661	10	111	of	of	ADP
ct-9661	10	112	uterus	uterus	NOUN
ct-9661	10	113	,	,	PUNCT
ct-9661	10	114	can	can	AUX
ct-9661	10	115	be	be	AUX
ct-9661	10	116	caused	cause	VERB
ct-9661	10	117	by	by	ADP
ct-9661	10	118	several	several	ADJ
ct-9661	10	119	insults	insult	NOUN
ct-9661	10	120	.	.	PUNCT
ct-9661	11	1	the	the	DET
ct-9661	11	2	simplicity	simplicity	NOUN
ct-9661	11	3	of	of	ADP
ct-9661	11	4	this	this	DET
ct-9661	11	5	definition	definition	NOUN
ct-9661	11	6	belies	belie	VERB
ct-9661	11	7	the	the	DET
ct-9661	11	8	havoc	havoc	NOUN
ct-9661	11	9	it	it	PRON
ct-9661	11	10	can	can	AUX
ct-9661	11	11	wreak	wreak	VERB
ct-9661	11	12	on	on	ADP
ct-9661	11	13	a	a	DET
ct-9661	11	14	mare	mare	NOUN
ct-9661	11	15	’s	’s	PART
ct-9661	11	16	reproductive	reproductive	ADJ
ct-9661	11	17	efficiency	efficiency	NOUN
ct-9661	11	18	.	.	PUNCT
ct-9661	12	1	potential	potential	ADJ
ct-9661	12	2	inciting	inciting	NOUN
ct-9661	12	3	causes	cause	NOUN
ct-9661	12	4	include	include	VERB
ct-9661	12	5	a	a	DET
ct-9661	12	6	physiologic	physiologic	ADJ
ct-9661	12	7	response	response	NOUN
ct-9661	12	8	to	to	ADP
ct-9661	12	9	foreign	foreign	ADJ
ct-9661	12	10	invasion	invasion	NOUN
ct-9661	12	11	(	(	PUNCT
ct-9661	12	12	breeding	breeding	NOUN
ct-9661	12	13	-	-	PUNCT
ct-9661	12	14	induced	induce	VERB
ct-9661	12	15	endometritis	endometritis	NOUN
ct-9661	12	16	)	)	PUNCT
ct-9661	12	17	,	,	PUNCT
ct-9661	12	18	bacterial	bacterial	ADJ
ct-9661	12	19	infection	infection	NOUN
ct-9661	12	20	,	,	PUNCT
ct-9661	12	21	fungal	fungal	ADJ
ct-9661	12	22	infection	infection	NOUN
ct-9661	12	23	,	,	PUNCT
ct-9661	12	24	and	and	CCONJ
ct-9661	12	25	an	an	DET
ct-9661	12	26	iatrogenic	iatrogenic	ADJ
ct-9661	12	27	interference	interference	NOUN
ct-9661	12	28	in	in	ADP
ct-9661	12	29	uterus	uterus	NOUN
ct-9661	12	30	.	.	PUNCT
ct-9661	13	1	regardless	regardless	ADV
ct-9661	13	2	of	of	ADP
ct-9661	13	3	its	its	PRON
ct-9661	13	4	source	source	NOUN
ct-9661	13	5	,	,	PUNCT
ct-9661	13	6	inflammation	inflammation	NOUN
ct-9661	13	7	creates	create	VERB
ct-9661	13	8	an	an	DET
ct-9661	13	9	inhospitable	inhospitable	ADJ
ct-9661	13	10	embryonic	embryonic	ADJ
ct-9661	13	11	environment	environment	NOUN
ct-9661	13	12	.	.	PUNCT
ct-9661	14	1	keywords	keyword	NOUN
ct-9661	14	2	:	:	PUNCT
ct-9661	14	3	equine	equine	PROPN
ct-9661	14	4	endometritis	endometritis	PROPN
ct-9661	14	5	,	,	PUNCT
ct-9661	14	6	mare	mare	NOUN
ct-9661	14	7	,	,	PUNCT
ct-9661	14	8	antibiotics	antibiotic	NOUN
ct-9661	14	9	since	since	SCONJ
ct-9661	14	10	reproductive	reproductive	ADJ
ct-9661	14	11	efficiency	efficiency	NOUN
ct-9661	14	12	declines	decline	VERB
ct-9661	14	13	in	in	ADP
ct-9661	14	14	the	the	DET
ct-9661	14	15	face	face	NOUN
ct-9661	14	16	of	of	ADP
ct-9661	14	17	poor	poor	ADJ
ct-9661	14	18	systemic	systemic	ADJ
ct-9661	14	19	health	health	NOUN
ct-9661	14	20	,	,	PUNCT
ct-9661	14	21	general	general	ADJ
ct-9661	14	22	physical	physical	ADJ
ct-9661	14	23	examination	examination	NOUN
ct-9661	14	24	and	and	CCONJ
ct-9661	14	25	establishing	establish	VERB
ct-9661	14	26	an	an	DET
ct-9661	14	27	overall	overall	ADJ
ct-9661	14	28	health	health	NOUN
ct-9661	14	29	are	be	AUX
ct-9661	14	30	important	important	ADJ
ct-9661	14	31	components	component	NOUN
ct-9661	14	32	of	of	ADP
ct-9661	14	33	initial	initial	ADJ
ct-9661	14	34	approaches	approach	NOUN
ct-9661	14	35	to	to	PART
ct-9661	14	36	treat	treat	VERB
ct-9661	14	37	endometritis	endometritis	NOUN
ct-9661	14	38	.	.	PUNCT
ct-9661	15	1	age	age	NOUN
ct-9661	15	2	and	and	CCONJ
ct-9661	15	3	immunosuppressive	immunosuppressive	ADJ
ct-9661	15	4	diseases	disease	NOUN
ct-9661	15	5	(	(	PUNCT
ct-9661	15	6	e.g.	e.g.	ADV
ct-9661	15	7	pituitary	pituitary	ADJ
ct-9661	15	8	pars	par	NOUN
ct-9661	15	9	intermedia	intermedia	NOUN
ct-9661	15	10	dysfunction	dysfunction	NOUN
ct-9661	15	11	)	)	PUNCT
ct-9661	15	12	have	have	VERB
ct-9661	15	13	potential	potential	ADJ
ct-9661	15	14	impacts	impact	NOUN
ct-9661	15	15	on	on	ADP
ct-9661	15	16	body	body	NOUN
ct-9661	15	17	’s	’s	PART
ct-9661	15	18	resistance	resistance	NOUN
ct-9661	15	19	to	to	ADP
ct-9661	15	20	infection	infection	NOUN
ct-9661	15	21	and	and	CCONJ
ct-9661	15	22	endometrial	endometrial	ADJ
ct-9661	15	23	resistance	resistance	NOUN
ct-9661	15	24	to	to	PART
ct-9661	15	25	disease.13,14	disease.13,14	NOUN
ct-9661	15	26	anatomic	anatomic	ADJ
ct-9661	15	27	considerations	consideration	NOUN
ct-9661	15	28	a	a	DET
ct-9661	15	29	mare	mare	NOUN
ct-9661	15	30	’s	’s	PART
ct-9661	15	31	uterus	uterus	NOUN
ct-9661	15	32	is	be	AUX
ct-9661	15	33	protected	protect	VERB
ct-9661	15	34	from	from	ADP
ct-9661	15	35	external	external	ADJ
ct-9661	15	36	environment	environment	NOUN
ct-9661	15	37	by	by	ADP
ct-9661	15	38	3	3	NUM
ct-9661	15	39	distinct	distinct	ADJ
ct-9661	15	40	caudal	caudal	NOUN
ct-9661	15	41	to	to	ADP
ct-9661	15	42	cranial	cranial	ADJ
ct-9661	15	43	anatomic	anatomic	ADJ
ct-9661	15	44	barriers	barrier	NOUN
ct-9661	15	45	:	:	PUNCT
ct-9661	15	46	vulva	vulva	ADJ
ct-9661	15	47	,	,	PUNCT
ct-9661	15	48	vestibulovaginal	vestibulovaginal	ADJ
ct-9661	15	49	fold	fold	NOUN
ct-9661	15	50	,	,	PUNCT
ct-9661	15	51	and	and	CCONJ
ct-9661	15	52	cervix	cervix	NOUN
ct-9661	15	53	.	.	PUNCT
ct-9661	16	1	a	a	DET
ct-9661	16	2	compromise	compromise	NOUN
ct-9661	16	3	of	of	ADP
ct-9661	16	4	1	1	NUM
ct-9661	16	5	or	or	CCONJ
ct-9661	16	6	more	more	ADJ
ct-9661	16	7	of	of	ADP
ct-9661	16	8	these	these	DET
ct-9661	16	9	barriers	barrier	NOUN
ct-9661	16	10	will	will	AUX
ct-9661	16	11	predispose	predispose	VERB
ct-9661	16	12	a	a	DET
ct-9661	16	13	mare	mare	NOUN
ct-9661	16	14	to	to	ADP
ct-9661	16	15	uterine	uterine	VERB
ct-9661	16	16	contamination	contamination	NOUN
ct-9661	16	17	and	and	CCONJ
ct-9661	16	18	to	to	ADP
ct-9661	16	19	subsequent	subsequent	ADJ
ct-9661	16	20	endometritis	endometritis	NOUN
ct-9661	16	21	.	.	PUNCT
ct-9661	17	1	any	any	DET
ct-9661	17	2	amount	amount	NOUN
ct-9661	17	3	or	or	CCONJ
ct-9661	17	4	type	type	NOUN
ct-9661	17	5	of	of	ADP
ct-9661	17	6	antibiotic	antibiotic	NOUN
ct-9661	17	7	can	can	AUX
ct-9661	17	8	not	not	PART
ct-9661	17	9	effectively	effectively	ADV
ct-9661	17	10	resolve	resolve	VERB
ct-9661	17	11	this	this	DET
ct-9661	17	12	type	type	NOUN
ct-9661	17	13	of	of	ADP
ct-9661	17	14	endometritis	endometritis	NOUN
ct-9661	17	15	unless	unless	SCONJ
ct-9661	17	16	the	the	DET
ct-9661	17	17	anatomical	anatomical	ADJ
ct-9661	17	18	cause	cause	NOUN
ct-9661	17	19	is	be	AUX
ct-9661	17	20	rectified	rectify	VERB
ct-9661	17	21	.	.	PUNCT
ct-9661	18	1	importance	importance	NOUN
ct-9661	18	2	of	of	ADP
ct-9661	18	3	mare	mare	PROPN
ct-9661	18	4	’s	’s	PART
ct-9661	18	5	vulva	vulva	NOUN
ct-9661	18	6	,	,	PUNCT
ct-9661	18	7	as	as	SCONJ
ct-9661	18	8	the	the	DET
ct-9661	18	9	frontline	frontline	NOUN
ct-9661	18	10	barricade	barricade	VERB
ct-9661	18	11	between	between	ADP
ct-9661	18	12	environmental	environmental	ADJ
ct-9661	18	13	contaminants	contaminant	NOUN
ct-9661	18	14	and	and	CCONJ
ct-9661	18	15	reproductive	reproductive	ADJ
ct-9661	18	16	tract	tract	NOUN
ct-9661	18	17	,	,	PUNCT
ct-9661	18	18	can	can	AUX
ct-9661	18	19	not	not	PART
ct-9661	18	20	be	be	AUX
ct-9661	18	21	overemphasized	overemphasize	VERB
ct-9661	18	22	.	.	PUNCT
ct-9661	19	1	functionality	functionality	NOUN
ct-9661	19	2	is	be	AUX
ct-9661	19	3	compromised	compromise	VERB
ct-9661	19	4	when	when	SCONJ
ct-9661	19	5	vulva	vulva	NOUN
ct-9661	19	6	deviates	deviate	VERB
ct-9661	19	7	from	from	ADP
ct-9661	19	8	its	its	PRON
ct-9661	19	9	ideal	ideal	ADJ
ct-9661	19	10	position	position	NOUN
ct-9661	19	11	of	of	ADP
ct-9661	19	12	being	be	AUX
ct-9661	19	13	vertically	vertically	ADV
ct-9661	19	14	oriented	orient	VERB
ct-9661	19	15	,	,	PUNCT
ct-9661	19	16	in	in	ADP
ct-9661	19	17	the	the	DET
ct-9661	19	18	same	same	ADJ
ct-9661	19	19	plane	plane	NOUN
ct-9661	19	20	as	as	ADP
ct-9661	19	21	anus	anus	NOUN
ct-9661	19	22	with	with	ADP
ct-9661	19	23	>	>	X
ct-9661	19	24	70	70	NUM
ct-9661	19	25	%	%	NOUN
ct-9661	19	26	positioned	position	VERB
ct-9661	19	27	below	below	ADP
ct-9661	19	28	the	the	DET
ct-9661	19	29	pelvic	pelvic	ADJ
ct-9661	19	30	brim	brim	NOUN
ct-9661	19	31	.	.	PUNCT
ct-9661	20	1	caslick	caslick	PROPN
ct-9661	20	2	’s	’s	PART
ct-9661	20	3	vulvoplasty	vulvoplasty	NOUN
ct-9661	20	4	is	be	AUX
ct-9661	20	5	commonly	commonly	ADV
ct-9661	20	6	performed	perform	VERB
ct-9661	20	7	to	to	PART
ct-9661	20	8	correct	correct	VERB
ct-9661	20	9	imperfect	imperfect	ADJ
ct-9661	20	10	vulvar	vulvar	NOUN
ct-9661	20	11	anatomy	anatomy	NOUN
ct-9661	20	12	.	.	PUNCT
ct-9661	21	1	mares	mare	NOUN
ct-9661	21	2	with	with	ADP
ct-9661	21	3	more	more	ADV
ct-9661	21	4	severe	severe	ADJ
ct-9661	21	5	anatomical	anatomical	ADJ
ct-9661	21	6	deficits	deficit	NOUN
ct-9661	21	7	may	may	AUX
ct-9661	21	8	be	be	AUX
ct-9661	21	9	good	good	ADJ
ct-9661	21	10	candidates	candidate	NOUN
ct-9661	21	11	for	for	ADP
ct-9661	21	12	perineal	perineal	ADJ
ct-9661	21	13	body	body	NOUN
ct-9661	21	14	reconstruction	reconstruction	NOUN
ct-9661	21	15	(	(	PUNCT
ct-9661	21	16	common	common	ADJ
ct-9661	21	17	approaches	approach	NOUN
ct-9661	21	18	include	include	VERB
ct-9661	21	19	the	the	DET
ct-9661	21	20	gadd	gadd	NOUN
ct-9661	21	21	and	and	CCONJ
ct-9661	21	22	pouret	pouret	ADJ
ct-9661	21	23	techniques	technique	NOUN
ct-9661	21	24	)	)	PUNCT
ct-9661	21	25	.	.	PUNCT
ct-9661	22	1	moving	move	VERB
ct-9661	22	2	inward	inward	ADV
ct-9661	22	3	,	,	PUNCT
ct-9661	22	4	the	the	DET
ct-9661	22	5	next	next	ADJ
ct-9661	22	6	anatomical	anatomical	ADJ
ct-9661	22	7	barrier	barrier	NOUN
ct-9661	22	8	is	be	AUX
ct-9661	22	9	the	the	DET
ct-9661	22	10	vestibulovaginal	vestibulovaginal	ADJ
ct-9661	22	11	fold	fold	NOUN
ct-9661	22	12	.	.	PUNCT
ct-9661	23	1	assessment	assessment	NOUN
ct-9661	23	2	of	of	ADP
ct-9661	23	3	vestibulovaginal	vestibulovaginal	ADJ
ct-9661	23	4	fold	fold	NOUN
ct-9661	23	5	can	can	AUX
ct-9661	23	6	be	be	AUX
ct-9661	23	7	made	make	VERB
ct-9661	23	8	by	by	ADP
ct-9661	23	9	parting	part	VERB
ct-9661	23	10	the	the	DET
ct-9661	23	11	vulvar	vulvar	NOUN
ct-9661	23	12	labia	labia	NOUN
ct-9661	23	13	.	.	PUNCT
ct-9661	24	1	mares	mare	NOUN
ct-9661	24	2	with	with	ADP
ct-9661	24	3	an	an	DET
ct-9661	24	4	incompetent	incompetent	ADJ
ct-9661	24	5	clinical	clinical	ADJ
ct-9661	24	6	theriogenology	theriogenology	NOUN
ct-9661	24	7	2021	2021	NUM
ct-9661	24	8	;	;	PUNCT
ct-9661	24	9	13	13	NUM
ct-9661	24	10	:	:	SYM
ct-9661	24	11	260	260	NUM
ct-9661	24	12	vestibulovaginal	vestibulovaginal	ADJ
ct-9661	24	13	fold	fold	NOUN
ct-9661	24	14	will	will	AUX
ct-9661	24	15	aspirate	aspirate	VERB
ct-9661	24	16	air	air	NOUN
ct-9661	24	17	that	that	PRON
ct-9661	24	18	causes	cause	VERB
ct-9661	24	19	audible	audible	ADJ
ct-9661	24	20	‘	'	PUNCT
ct-9661	24	21	windsucking	windsucke	VERB
ct-9661	24	22	’	'	PUNCT
ct-9661	24	23	and	and	CCONJ
ct-9661	24	24	pneumovagina	pneumovagina	NOUN
ct-9661	24	25	.	.	PUNCT
ct-9661	25	1	cervix	cervix	NOUN
ct-9661	25	2	is	be	AUX
ct-9661	25	3	the	the	DET
ct-9661	25	4	most	most	ADV
ct-9661	25	5	cranial	cranial	ADJ
ct-9661	25	6	anatomical	anatomical	ADJ
ct-9661	25	7	defense	defense	NOUN
ct-9661	25	8	for	for	ADP
ct-9661	25	9	the	the	DET
ct-9661	25	10	uterus	uterus	NOUN
ct-9661	25	11	.	.	PUNCT
ct-9661	26	1	longitudinal	longitudinal	ADJ
ct-9661	26	2	folds	fold	NOUN
ct-9661	26	3	of	of	ADP
ct-9661	26	4	cervix	cervix	NOUN
ct-9661	26	5	are	be	AUX
ct-9661	26	6	contiguous	contiguous	ADJ
ct-9661	26	7	with	with	ADP
ct-9661	26	8	endometrial	endometrial	ADJ
ct-9661	26	9	folds	fold	NOUN
ct-9661	26	10	,	,	PUNCT
ct-9661	26	11	thereby	thereby	ADV
ct-9661	26	12	providing	provide	VERB
ct-9661	26	13	direct	direct	ADJ
ct-9661	26	14	access	access	NOUN
ct-9661	26	15	from	from	ADP
ct-9661	26	16	vagina	vagina	ADJ
ct-9661	26	17	to	to	ADP
ct-9661	26	18	uterus	uterus	NOUN
ct-9661	26	19	.	.	PUNCT
ct-9661	27	1	cervix	cervix	NOUN
ct-9661	27	2	is	be	AUX
ct-9661	27	3	dynamic	dynamic	ADJ
ct-9661	27	4	throughout	throughout	ADP
ct-9661	27	5	a	a	DET
ct-9661	27	6	mare	mare	NOUN
ct-9661	27	7	’s	’s	PART
ct-9661	27	8	reproductive	reproductive	ADJ
ct-9661	27	9	career	career	NOUN
ct-9661	27	10	.	.	PUNCT
ct-9661	28	1	its	its	PRON
ct-9661	28	2	elasticity	elasticity	NOUN
ct-9661	28	3	is	be	AUX
ct-9661	28	4	illustrated	illustrate	VERB
ct-9661	28	5	by	by	ADP
ct-9661	28	6	its	its	PRON
ct-9661	28	7	ability	ability	NOUN
ct-9661	28	8	to	to	PART
ct-9661	28	9	stretch	stretch	VERB
ct-9661	28	10	to	to	PART
ct-9661	28	11	accommodate	accommodate	VERB
ct-9661	28	12	50	50	NUM
ct-9661	28	13	+	+	NUM
ct-9661	28	14	kg	kg	NOUN
ct-9661	28	15	of	of	ADP
ct-9661	28	16	foal	foal	NOUN
ct-9661	28	17	at	at	ADP
ct-9661	28	18	parturition	parturition	NOUN
ct-9661	28	19	and	and	CCONJ
ct-9661	28	20	constrict	constrict	VERB
ct-9661	28	21	to	to	ADP
ct-9661	28	22	a	a	DET
ct-9661	28	23	neck	neck	NOUN
ct-9661	28	24	that	that	PRON
ct-9661	28	25	can	can	AUX
ct-9661	28	26	sometimes	sometimes	ADV
ct-9661	28	27	be	be	AUX
ct-9661	28	28	difficult	difficult	ADJ
ct-9661	28	29	to	to	PART
ct-9661	28	30	navigate	navigate	VERB
ct-9661	28	31	even	even	ADV
ct-9661	28	32	a	a	DET
ct-9661	28	33	small	small	ADJ
ct-9661	28	34	diameter	diameter	NOUN
ct-9661	28	35	instrument	instrument	NOUN
ct-9661	28	36	during	during	ADP
ct-9661	28	37	diestrus	diestrus	NOUN
ct-9661	28	38	.	.	PUNCT
ct-9661	29	1	this	this	DET
ct-9661	29	2	plasticity	plasticity	NOUN
ct-9661	29	3	is	be	AUX
ct-9661	29	4	not	not	PART
ct-9661	29	5	to	to	PART
ct-9661	29	6	be	be	AUX
ct-9661	29	7	taken	take	VERB
ct-9661	29	8	for	for	ADP
ct-9661	29	9	granted	grant	VERB
ct-9661	29	10	,	,	PUNCT
ct-9661	29	11	as	as	SCONJ
ct-9661	29	12	each	each	DET
ct-9661	29	13	extreme	extreme	NOUN
ct-9661	29	14	can	can	AUX
ct-9661	29	15	pose	pose	VERB
ct-9661	29	16	challenges	challenge	NOUN
ct-9661	29	17	for	for	ADP
ct-9661	29	18	managing	manage	VERB
ct-9661	29	19	endometritis	endometritis	NOUN
ct-9661	29	20	.	.	PUNCT
ct-9661	30	1	cervix	cervix	NOUN
ct-9661	30	2	that	that	PRON
ct-9661	30	3	is	be	AUX
ct-9661	30	4	damaged	damage	VERB
ct-9661	30	5	during	during	ADP
ct-9661	30	6	foaling	foal	VERB
ct-9661	30	7	trauma	trauma	NOUN
ct-9661	30	8	is	be	AUX
ct-9661	30	9	vulnerable	vulnerable	ADJ
ct-9661	30	10	to	to	PART
ct-9661	30	11	lose	lose	VERB
ct-9661	30	12	its	its	PRON
ct-9661	30	13	function	function	NOUN
ct-9661	30	14	to	to	PART
ct-9661	30	15	serve	serve	VERB
ct-9661	30	16	as	as	ADP
ct-9661	30	17	a	a	DET
ct-9661	30	18	barrier	barrier	NOUN
ct-9661	30	19	to	to	ADP
ct-9661	30	20	opportunistic	opportunistic	ADJ
ct-9661	30	21	ascending	ascend	VERB
ct-9661	30	22	infections	infection	NOUN
ct-9661	30	23	.	.	PUNCT
ct-9661	31	1	in	in	ADP
ct-9661	31	2	contrast	contrast	NOUN
ct-9661	31	3	,	,	PUNCT
ct-9661	31	4	cervix	cervix	NOUN
ct-9661	31	5	that	that	PRON
ct-9661	31	6	fails	fail	VERB
ct-9661	31	7	to	to	PART
ct-9661	31	8	appropriately	appropriately	ADV
ct-9661	31	9	dilate	dilate	VERB
ct-9661	31	10	during	during	ADP
ct-9661	31	11	estrus	estrus	NOUN
ct-9661	31	12	promotes	promote	VERB
ct-9661	31	13	debris	debris	NOUN
ct-9661	31	14	accumulation	accumulation	NOUN
ct-9661	31	15	within	within	ADP
ct-9661	31	16	the	the	DET
ct-9661	31	17	uterus	uterus	NOUN
ct-9661	31	18	and	and	CCONJ
ct-9661	31	19	exacerbates	exacerbate	VERB
ct-9661	31	20	endometritis	endometritis	NOUN
ct-9661	31	21	.	.	PUNCT
ct-9661	32	1	beyond	beyond	ADP
ct-9661	32	2	these	these	DET
ct-9661	32	3	major	major	ADJ
ct-9661	32	4	anatomic	anatomic	ADJ
ct-9661	32	5	defenses	defense	NOUN
ct-9661	32	6	of	of	ADP
ct-9661	32	7	the	the	DET
ct-9661	32	8	uterus	uterus	NOUN
ct-9661	32	9	,	,	PUNCT
ct-9661	32	10	description	description	NOUN
ct-9661	32	11	of	of	ADP
ct-9661	32	12	endometritis	endometritis	NOUN
ct-9661	32	13	would	would	AUX
ct-9661	32	14	be	be	AUX
ct-9661	32	15	incomplete	incomplete	ADJ
ct-9661	32	16	if	if	SCONJ
ct-9661	32	17	additional	additional	ADJ
ct-9661	32	18	anatomic	anatomic	ADJ
ct-9661	32	19	concerns	concern	NOUN
ct-9661	32	20	were	be	AUX
ct-9661	32	21	not	not	PART
ct-9661	32	22	discussed	discuss	VERB
ct-9661	32	23	.	.	PUNCT
ct-9661	33	1	uterus	uterus	NOUN
ct-9661	33	2	that	that	PRON
ct-9661	33	3	is	be	AUX
ct-9661	33	4	substantially	substantially	ADV
ct-9661	33	5	pendulous	pendulous	ADJ
ct-9661	33	6	over	over	ADP
ct-9661	33	7	the	the	DET
ct-9661	33	8	pelvic	pelvic	ADJ
ct-9661	33	9	brim	brim	NOUN
ct-9661	33	10	is	be	AUX
ct-9661	33	11	prone	prone	ADJ
ct-9661	33	12	to	to	ADP
ct-9661	33	13	poor	poor	ADJ
ct-9661	33	14	uterine	uterine	ADJ
ct-9661	33	15	clearance	clearance	NOUN
ct-9661	33	16	and	and	CCONJ
ct-9661	33	17	subsequent	subsequent	ADJ
ct-9661	33	18	accumulation	accumulation	NOUN
ct-9661	33	19	of	of	ADP
ct-9661	33	20	fluid	fluid	NOUN
ct-9661	33	21	and	and	CCONJ
ct-9661	33	22	debris	debris	NOUN
ct-9661	33	23	that	that	PRON
ct-9661	33	24	will	will	AUX
ct-9661	33	25	hamper	hamper	VERB
ct-9661	33	26	efforts	effort	NOUN
ct-9661	33	27	to	to	PART
ct-9661	33	28	achieve	achieve	VERB
ct-9661	33	29	pregnancy	pregnancy	NOUN
ct-9661	33	30	.	.	PUNCT
ct-9661	34	1	mares	mare	NOUN
ct-9661	34	2	that	that	PRON
ct-9661	34	3	had	have	VERB
ct-9661	34	4	trauma	trauma	NOUN
ct-9661	34	5	to	to	ADP
ct-9661	34	6	the	the	DET
ct-9661	34	7	reproductive	reproductive	ADJ
ct-9661	34	8	tract	tract	NOUN
ct-9661	34	9	(	(	PUNCT
ct-9661	34	10	e.g.	e.g.	ADV
ct-9661	34	11	dystocia	dystocia	NOUN
ct-9661	34	12	)	)	PUNCT
ct-9661	34	13	,	,	PUNCT
ct-9661	34	14	surgery	surgery	NOUN
ct-9661	34	15	(	(	PUNCT
ct-9661	34	16	e.g.	e.g.	ADV
ct-9661	34	17	cesarean	cesarean	ADJ
ct-9661	34	18	section	section	NOUN
ct-9661	34	19	or	or	CCONJ
ct-9661	34	20	mass	mass	NOUN
ct-9661	34	21	removal	removal	NOUN
ct-9661	34	22	)	)	PUNCT
ct-9661	34	23	,	,	PUNCT
ct-9661	34	24	or	or	CCONJ
ct-9661	34	25	iatrogenic	iatrogenic	ADJ
ct-9661	34	26	exposure	exposure	NOUN
ct-9661	34	27	to	to	ADP
ct-9661	34	28	irritating	irritate	VERB
ct-9661	34	29	substances	substance	NOUN
ct-9661	34	30	may	may	AUX
ct-9661	34	31	be	be	AUX
ct-9661	34	32	affected	affect	VERB
ct-9661	34	33	by	by	ADP
ct-9661	34	34	adhesion	adhesion	NOUN
ct-9661	34	35	formation	formation	NOUN
ct-9661	34	36	or	or	CCONJ
ct-9661	34	37	other	other	ADJ
ct-9661	34	38	mechanical	mechanical	ADJ
ct-9661	34	39	disruption	disruption	NOUN
ct-9661	34	40	within	within	ADP
ct-9661	34	41	the	the	DET
ct-9661	34	42	uterus	uterus	NOUN
ct-9661	34	43	and/or	and/or	CCONJ
ct-9661	34	44	in	in	ADP
ct-9661	34	45	caudal	caudal	NOUN
ct-9661	34	46	reproductive	reproductive	ADJ
ct-9661	34	47	tract	tract	NOUN
ct-9661	34	48	.	.	PUNCT
ct-9661	35	1	vesicovaginal	vesicovaginal	ADJ
ct-9661	35	2	reflux	reflux	NOUN
ct-9661	35	3	(	(	PUNCT
ct-9661	35	4	‘	'	PUNCT
ct-9661	35	5	urine	urine	NOUN
ct-9661	35	6	pooling	pooling	NOUN
ct-9661	35	7	’	'	PUNCT
ct-9661	35	8	)	)	PUNCT
ct-9661	35	9	can	can	AUX
ct-9661	35	10	have	have	VERB
ct-9661	35	11	many	many	ADJ
ct-9661	35	12	contributing	contributing	NOUN
ct-9661	35	13	causes	cause	NOUN
ct-9661	35	14	,	,	PUNCT
ct-9661	35	15	including	include	VERB
ct-9661	35	16	anatomic	anatomic	ADJ
ct-9661	35	17	variables	variable	NOUN
ct-9661	35	18	.	.	PUNCT
ct-9661	36	1	downstream	downstream	ADJ
ct-9661	36	2	effects	effect	NOUN
ct-9661	36	3	of	of	ADP
ct-9661	36	4	urine	urine	NOUN
ct-9661	36	5	pooling	pooling	NOUN
ct-9661	36	6	include	include	VERB
ct-9661	36	7	the	the	DET
ct-9661	36	8	potential	potential	NOUN
ct-9661	36	9	for	for	ADP
ct-9661	36	10	direct	direct	ADJ
ct-9661	36	11	transport	transport	NOUN
ct-9661	36	12	of	of	ADP
ct-9661	36	13	pathogens	pathogen	NOUN
ct-9661	36	14	into	into	ADP
ct-9661	36	15	uterus	uterus	NOUN
ct-9661	36	16	,	,	PUNCT
ct-9661	36	17	and	and	CCONJ
ct-9661	36	18	for	for	ADP
ct-9661	36	19	generalized	generalized	ADJ
ct-9661	36	20	vaginitis	vaginitis	NOUN
ct-9661	36	21	and	and	CCONJ
ct-9661	36	22	endometritis	endometritis	PROPN
ct-9661	36	23	.	.	PUNCT
ct-9661	37	1	uterine	uterine	ADJ
ct-9661	37	2	lavage	lavage	PROPN
ct-9661	37	3	uterine	uterine	ADJ
ct-9661	37	4	lavage	lavage	NOUN
ct-9661	37	5	is	be	AUX
ct-9661	37	6	the	the	DET
ct-9661	37	7	keystone	keystone	NOUN
ct-9661	37	8	of	of	ADP
ct-9661	37	9	endometritis	endometritis	PROPN
ct-9661	37	10	treatment	treatment	PROPN
ct-9661	37	11	.	.	PUNCT
ct-9661	38	1	uterine	uterine	ADJ
ct-9661	38	2	lavage	lavage	NOUN
ct-9661	38	3	provides	provide	VERB
ct-9661	38	4	a	a	DET
ct-9661	38	5	method	method	NOUN
ct-9661	38	6	of	of	ADP
ct-9661	38	7	removing	remove	VERB
ct-9661	38	8	detritus	detritus	NOUN
ct-9661	38	9	and	and	CCONJ
ct-9661	38	10	inflammatory	inflammatory	ADJ
ct-9661	38	11	products	product	NOUN
ct-9661	38	12	from	from	ADP
ct-9661	38	13	the	the	DET
ct-9661	38	14	uterus	uterus	NOUN
ct-9661	38	15	and	and	CCONJ
ct-9661	38	16	rinsing	rinse	VERB
ct-9661	38	17	away	away	ADV
ct-9661	38	18	planktonic	planktonic	ADJ
ct-9661	38	19	bacteria	bacteria	NOUN
ct-9661	38	20	.	.	PUNCT
ct-9661	39	1	uterine	uterine	ADJ
ct-9661	39	2	irrigation	irrigation	NOUN
ct-9661	39	3	should	should	AUX
ct-9661	39	4	be	be	AUX
ct-9661	39	5	considered	consider	VERB
ct-9661	39	6	fundamental	fundamental	ADJ
ct-9661	39	7	in	in	ADP
ct-9661	39	8	treating	treat	VERB
ct-9661	39	9	endometritis	endometritis	NOUN
ct-9661	39	10	without	without	ADP
ct-9661	39	11	disregarding	disregard	VERB
ct-9661	39	12	its	its	PRON
ct-9661	39	13	inherent	inherent	ADJ
ct-9661	39	14	inflammatory	inflammatory	ADJ
ct-9661	39	15	effects	effect	NOUN
ct-9661	39	16	.	.	PUNCT
ct-9661	40	1	autologous	autologous	ADJ
ct-9661	40	2	plasma	plasma	NOUN
ct-9661	40	3	,	,	PUNCT
ct-9661	40	4	potassium	potassium	NOUN
ct-9661	40	5	penicillin	penicillin	NOUN
ct-9661	40	6	,	,	PUNCT
ct-9661	40	7	prostaglandin	prostaglandin	NOUN
ct-9661	40	8	f2α	f2α	PRON
ct-9661	40	9	treatments	treatment	NOUN
ct-9661	40	10	reduced	reduce	VERB
ct-9661	40	11	uterine	uterine	ADJ
ct-9661	40	12	neutrophils	neutrophil	NOUN
ct-9661	40	13	and	and	CCONJ
ct-9661	40	14	cleared	clear	VERB
ct-9661	40	15	streptococcus	streptococcus	NOUN
ct-9661	40	16	equi	equi	NOUN
ct-9661	40	17	subspecies	subspecie	NOUN
ct-9661	40	18	zooepidemicus	zooepidemicus	NOUN
ct-9661	40	19	;	;	PUNCT
ct-9661	40	20	however	however	ADV
ct-9661	40	21	,	,	PUNCT
ct-9661	40	22	large	large	ADJ
ct-9661	40	23	volume	volume	NOUN
ct-9661	40	24	lavage	lavage	NOUN
ct-9661	40	25	alone	alone	ADV
ct-9661	40	26	had	have	AUX
ct-9661	40	27	similar	similar	ADJ
ct-9661	40	28	effects.15	effects.15	NOUN
ct-9661	40	29	postbreeding	postbreede	VERB
ct-9661	40	30	uterine	uterine	ADJ
ct-9661	40	31	lavage	lavage	NOUN
ct-9661	40	32	4	4	NUM
ct-9661	40	33	6	6	NUM
ct-9661	40	34	hours	hour	NOUN
ct-9661	40	35	after	after	SCONJ
ct-9661	40	36	breeding	breeding	NOUN
ct-9661	40	37	can	can	AUX
ct-9661	40	38	be	be	AUX
ct-9661	40	39	useful	useful	ADJ
ct-9661	40	40	in	in	ADP
ct-9661	40	41	managing	manage	VERB
ct-9661	40	42	postbreeding	postbreeding	NOUN
ct-9661	40	43	inflammation	inflammation	NOUN
ct-9661	40	44	and	and	CCONJ
ct-9661	40	45	to	to	PART
ct-9661	40	46	increase	increase	VERB
ct-9661	40	47	pregnancy	pregnancy	NOUN
ct-9661	40	48	rates.16	rates.16	PROPN
ct-9661	40	49	-	-	PUNCT
ct-9661	40	50	18	18	NUM
ct-9661	40	51	effective	effective	ADJ
ct-9661	40	52	management	management	NOUN
ct-9661	40	53	of	of	ADP
ct-9661	40	54	postbreeding	postbreede	VERB
ct-9661	40	55	inflammation	inflammation	NOUN
ct-9661	40	56	may	may	AUX
ct-9661	40	57	mitigate	mitigate	VERB
ct-9661	40	58	progression	progression	NOUN
ct-9661	40	59	to	to	ADP
ct-9661	40	60	chronic	chronic	ADJ
ct-9661	40	61	endometritis.11	endometritis.11	X
ct-9661	40	62	ecbolic	ecbolic	ADJ
ct-9661	40	63	therapy	therapy	NOUN
ct-9661	40	64	endometritis	endometritis	NOUN
ct-9661	40	65	is	be	AUX
ct-9661	40	66	classically	classically	ADV
ct-9661	40	67	(	(	PUNCT
ct-9661	40	68	but	but	CCONJ
ct-9661	40	69	not	not	PART
ct-9661	40	70	necessarily	necessarily	ADV
ct-9661	40	71	)	)	PUNCT
ct-9661	40	72	accompanied	accompany	VERB
ct-9661	40	73	by	by	ADP
ct-9661	40	74	fluid	fluid	ADJ
ct-9661	40	75	accumulation	accumulation	NOUN
ct-9661	40	76	within	within	ADP
ct-9661	40	77	the	the	DET
ct-9661	40	78	uterine	uterine	ADJ
ct-9661	40	79	lumen	luman	NOUN
ct-9661	40	80	.	.	PUNCT
ct-9661	41	1	evacuation	evacuation	NOUN
ct-9661	41	2	of	of	ADP
ct-9661	41	3	this	this	DET
ct-9661	41	4	fluid	fluid	NOUN
ct-9661	41	5	is	be	AUX
ct-9661	41	6	the	the	DET
ct-9661	41	7	goal	goal	NOUN
ct-9661	41	8	in	in	ADP
ct-9661	41	9	therapeutic	therapeutic	ADJ
ct-9661	41	10	approaches	approach	NOUN
ct-9661	41	11	.	.	PUNCT
ct-9661	42	1	ecbolic	ecbolic	ADJ
ct-9661	42	2	therapy	therapy	NOUN
ct-9661	42	3	can	can	AUX
ct-9661	42	4	take	take	VERB
ct-9661	42	5	on	on	ADP
ct-9661	42	6	several	several	ADJ
ct-9661	42	7	forms	form	NOUN
ct-9661	42	8	that	that	PRON
ct-9661	42	9	may	may	AUX
ct-9661	42	10	be	be	AUX
ct-9661	42	11	also	also	ADV
ct-9661	42	12	used	use	VERB
ct-9661	42	13	in	in	ADP
ct-9661	42	14	combination	combination	NOUN
ct-9661	42	15	.	.	PUNCT
ct-9661	43	1	these	these	PRON
ct-9661	43	2	include	include	VERB
ct-9661	43	3	oxytocin	oxytocin	NOUN
ct-9661	43	4	,	,	PUNCT
ct-9661	43	5	carbetocin	carbetocin	PROPN
ct-9661	43	6	,	,	PUNCT
ct-9661	43	7	cloprostenol	cloprostenol	NOUN
ct-9661	43	8	,	,	PUNCT
ct-9661	43	9	acupuncture	acupuncture	NOUN
ct-9661	43	10	,	,	PUNCT
ct-9661	43	11	and	and	CCONJ
ct-9661	43	12	exercise	exercise	NOUN
ct-9661	43	13	.	.	PUNCT
ct-9661	44	1	small	small	ADJ
ct-9661	44	2	,	,	PUNCT
ct-9661	44	3	frequent	frequent	ADJ
ct-9661	44	4	doses	dose	NOUN
ct-9661	44	5	of	of	ADP
ct-9661	44	6	oxytocin	oxytocin	PROPN
ct-9661	44	7	have	have	VERB
ct-9661	44	8	substantial	substantial	ADJ
ct-9661	44	9	impact	impact	NOUN
ct-9661	44	10	whereas	whereas	SCONJ
ct-9661	44	11	larger	large	ADJ
ct-9661	44	12	doses	dose	NOUN
ct-9661	44	13	can	can	AUX
ct-9661	44	14	lead	lead	VERB
ct-9661	44	15	to	to	ADP
ct-9661	44	16	tetanic	tetanic	ADJ
ct-9661	44	17	uterine	uterine	ADJ
ct-9661	44	18	contractions	contraction	NOUN
ct-9661	44	19	that	that	PRON
ct-9661	44	20	are	be	AUX
ct-9661	44	21	ineffective	ineffective	ADJ
ct-9661	44	22	.	.	PUNCT
ct-9661	45	1	hormonal	hormonal	ADJ
ct-9661	45	2	status	status	NOUN
ct-9661	45	3	of	of	ADP
ct-9661	45	4	the	the	DET
ct-9661	45	5	mare	mare	NOUN
ct-9661	45	6	influences	influence	VERB
ct-9661	45	7	the	the	DET
ct-9661	45	8	recommended	recommend	VERB
ct-9661	45	9	dose	dose	NOUN
ct-9661	45	10	of	of	ADP
ct-9661	45	11	oxytocin	oxytocin	NOUN
ct-9661	45	12	required	require	VERB
ct-9661	45	13	to	to	PART
ct-9661	45	14	have	have	VERB
ct-9661	45	15	a	a	DET
ct-9661	45	16	desired	desire	VERB
ct-9661	45	17	effect	effect	NOUN
ct-9661	45	18	.	.	PUNCT
ct-9661	46	1	smaller	small	ADJ
ct-9661	46	2	doses	dose	NOUN
ct-9661	46	3	of	of	ADP
ct-9661	46	4	oxytocin	oxytocin	PROPN
ct-9661	46	5	(	(	PUNCT
ct-9661	46	6	10	10	NUM
ct-9661	46	7	iu	iu	NOUN
ct-9661	46	8	)	)	PUNCT
ct-9661	46	9	are	be	AUX
ct-9661	46	10	effective	effective	ADJ
ct-9661	46	11	prior	prior	ADV
ct-9661	46	12	to	to	ADP
ct-9661	46	13	ovulation	ovulation	NOUN
ct-9661	46	14	,	,	PUNCT
ct-9661	46	15	whereas	whereas	SCONJ
ct-9661	46	16	after	after	ADP
ct-9661	46	17	ovulation	ovulation	NOUN
ct-9661	46	18	,	,	PUNCT
ct-9661	46	19	larger	large	ADJ
ct-9661	46	20	doses	dose	NOUN
ct-9661	46	21	(	(	PUNCT
ct-9661	46	22	25	25	NUM
ct-9661	46	23	iu	iu	NOUN
ct-9661	46	24	)	)	PUNCT
ct-9661	46	25	may	may	AUX
ct-9661	46	26	be	be	AUX
ct-9661	46	27	necessary.19	necessary.19	PROPN
ct-9661	46	28	carbetocin	carbetocin	PROPN
ct-9661	46	29	,	,	PUNCT
ct-9661	46	30	a	a	DET
ct-9661	46	31	synthetic	synthetic	ADJ
ct-9661	46	32	analog	analog	NOUN
ct-9661	46	33	of	of	ADP
ct-9661	46	34	oxytocin	oxytocin	PROPN
ct-9661	46	35	,	,	PUNCT
ct-9661	46	36	has	have	AUX
ct-9661	46	37	prolonged	prolong	VERB
ct-9661	46	38	half	half	ADJ
ct-9661	46	39	-	-	PUNCT
ct-9661	46	40	life	life	NOUN
ct-9661	46	41	(	(	PUNCT
ct-9661	46	42	17.2	17.2	NUM
ct-9661	46	43	versus	versus	ADP
ct-9661	46	44	6.8	6.8	NUM
ct-9661	46	45	minutes	minute	NOUN
ct-9661	46	46	)	)	PUNCT
ct-9661	46	47	and	and	CCONJ
ct-9661	46	48	requires	require	VERB
ct-9661	46	49	a	a	DET
ct-9661	46	50	smaller	small	ADJ
ct-9661	46	51	dose	dose	NOUN
ct-9661	46	52	(	(	PUNCT
ct-9661	46	53	1	1	NUM
ct-9661	46	54	mg	mg	PROPN
ct-9661	46	55	carbetocin	carbetocin	PROPN
ct-9661	46	56	equivalent	equivalent	ADJ
ct-9661	46	57	to	to	ADP
ct-9661	46	58	50	50	NUM
ct-9661	46	59	iu	iu	ADP
ct-9661	46	60	oxytocin).20	oxytocin).20	PROPN
ct-9661	46	61	cloprostenol	cloprostenol	NOUN
ct-9661	46	62	,	,	PUNCT
ct-9661	46	63	a	a	DET
ct-9661	46	64	synthetic	synthetic	ADJ
ct-9661	46	65	analog	analog	NOUN
ct-9661	46	66	of	of	ADP
ct-9661	46	67	prostaglandin	prostaglandin	NOUN
ct-9661	46	68	f2α	f2α	PROPN
ct-9661	46	69	is	be	AUX
ct-9661	46	70	an	an	DET
ct-9661	46	71	effective	effective	ADJ
ct-9661	46	72	ecbolic	ecbolic	ADJ
ct-9661	46	73	agent	agent	NOUN
ct-9661	46	74	for	for	ADP
ct-9661	46	75	clearing	clear	VERB
ct-9661	46	76	intrauterine	intrauterine	ADJ
ct-9661	46	77	fluid.21	fluid.21	NOUN
ct-9661	46	78	concern	concern	NOUN
ct-9661	46	79	regarding	regard	VERB
ct-9661	46	80	its	its	PRON
ct-9661	46	81	postovulation	postovulation	NOUN
ct-9661	46	82	use	use	NOUN
ct-9661	46	83	is	be	AUX
ct-9661	46	84	warranted	warrant	VERB
ct-9661	46	85	;	;	PUNCT
ct-9661	46	86	however	however	ADV
ct-9661	46	87	,	,	PUNCT
ct-9661	46	88	cloprostenol	cloprostenol	NOUN
ct-9661	46	89	could	could	AUX
ct-9661	46	90	be	be	AUX
ct-9661	46	91	used	use	VERB
ct-9661	46	92	until	until	ADP
ct-9661	46	93	the	the	DET
ct-9661	46	94	second	second	ADJ
ct-9661	46	95	day	day	NOUN
ct-9661	46	96	after	after	ADP
ct-9661	46	97	ovulation	ovulation	NOUN
ct-9661	46	98	without	without	ADP
ct-9661	46	99	negatively	negatively	ADV
ct-9661	46	100	impacting	impact	VERB
ct-9661	46	101	pregnancy	pregnancy	NOUN
ct-9661	46	102	rates	rate	NOUN
ct-9661	46	103	,	,	PUNCT
ct-9661	46	104	despite	despite	SCONJ
ct-9661	46	105	having	have	VERB
ct-9661	46	106	lower	low	ADJ
ct-9661	46	107	serum	serum	NOUN
ct-9661	46	108	progesterone	progesterone	NOUN
ct-9661	46	109	concentrations	concentration	NOUN
ct-9661	46	110	in	in	ADP
ct-9661	46	111	mares	mare	NOUN
ct-9661	46	112	receiving	receive	VERB
ct-9661	46	113	cloprostenol	cloprostenol	NOUN
ct-9661	46	114	versus	versus	ADP
ct-9661	46	115	oxytocin.22	oxytocin.22	PROPN
ct-9661	46	116	acupuncture	acupuncture	NOUN
ct-9661	46	117	is	be	AUX
ct-9661	46	118	an	an	DET
ct-9661	46	119	attractive	attractive	ADJ
ct-9661	46	120	adjunct	adjunct	ADJ
ct-9661	46	121	therapy	therapy	NOUN
ct-9661	46	122	to	to	PART
ct-9661	46	123	increase	increase	VERB
ct-9661	46	124	uterine	uterine	ADJ
ct-9661	46	125	contractility	contractility	NOUN
ct-9661	46	126	and	and	CCONJ
ct-9661	46	127	fluid	fluid	ADJ
ct-9661	46	128	clearance	clearance	NOUN
ct-9661	46	129	in	in	ADP
ct-9661	46	130	mares.23,24	mares.23,24	NOUN
ct-9661	46	131	lastly	lastly	ADV
ct-9661	46	132	,	,	PUNCT
ct-9661	46	133	exercise	exercise	NOUN
ct-9661	46	134	represents	represent	VERB
ct-9661	46	135	extreme	extreme	ADJ
ct-9661	46	136	value	value	NOUN
ct-9661	46	137	in	in	ADP
ct-9661	46	138	promoting	promote	VERB
ct-9661	46	139	fluid	fluid	ADJ
ct-9661	46	140	clearance	clearance	NOUN
ct-9661	46	141	,	,	PUNCT
ct-9661	46	142	is	be	AUX
ct-9661	46	143	economical	economical	ADJ
ct-9661	46	144	,	,	PUNCT
ct-9661	46	145	effective,25	effective,25	NOUN
ct-9661	46	146	and	and	CCONJ
ct-9661	46	147	easy	easy	ADJ
ct-9661	46	148	to	to	PART
ct-9661	46	149	use	use	VERB
ct-9661	46	150	.	.	PUNCT
ct-9661	47	1	intrauterine	intrauterine	ADJ
ct-9661	47	2	treatments	treatment	NOUN
ct-9661	47	3	several	several	ADJ
ct-9661	47	4	nonantibiotic	nonantibiotic	ADJ
ct-9661	47	5	intrauterine	intrauterine	ADJ
ct-9661	47	6	therapies	therapy	NOUN
ct-9661	47	7	are	be	AUX
ct-9661	47	8	available	available	ADJ
ct-9661	47	9	and	and	CCONJ
ct-9661	47	10	considerable	considerable	ADJ
ct-9661	47	11	variation	variation	NOUN
ct-9661	47	12	exists	exist	VERB
ct-9661	47	13	among	among	ADP
ct-9661	47	14	clinicians	clinician	NOUN
ct-9661	47	15	regarding	regard	VERB
ct-9661	47	16	preferred	preferred	ADJ
ct-9661	47	17	treatment	treatment	NOUN
ct-9661	47	18	regimens	regimen	NOUN
ct-9661	47	19	.	.	PUNCT
ct-9661	48	1	commonly	commonly	ADV
ct-9661	48	2	employed	employ	VERB
ct-9661	48	3	nonantibiotic	nonantibiotic	ADJ
ct-9661	48	4	intrauterine	intrauterine	ADJ
ct-9661	48	5	products	product	NOUN
ct-9661	48	6	include	include	VERB
ct-9661	48	7	tris	tri	NOUN
ct-9661	48	8	-	-	PUNCT
ct-9661	48	9	edta	edta	NOUN
ct-9661	48	10	,	,	PUNCT
ct-9661	48	11	tricide	tricide	ADJ
ct-9661	48	12	™	™	ADJ
ct-9661	48	13	(	(	PUNCT
ct-9661	48	14	molecular	molecular	ADJ
ct-9661	48	15	therapies	therapy	NOUN
ct-9661	48	16	,	,	PUNCT
ct-9661	48	17	llc	llc	PROPN
ct-9661	48	18	,	,	PUNCT
ct-9661	48	19	athens	athens	PROPN
ct-9661	48	20	,	,	PUNCT
ct-9661	48	21	ga	ga	PROPN
ct-9661	48	22	)	)	PUNCT
ct-9661	48	23	,	,	PUNCT
ct-9661	48	24	dimethyl	dimethyl	NOUN
ct-9661	48	25	sulfoxide	sulfoxide	NOUN
ct-9661	48	26	(	(	PUNCT
ct-9661	48	27	dmso	dmso	NOUN
ct-9661	48	28	)	)	PUNCT
ct-9661	48	29	,	,	PUNCT
ct-9661	48	30	hydrogen	hydrogen	NOUN
ct-9661	48	31	peroxide	peroxide	NOUN
ct-9661	48	32	,	,	PUNCT
ct-9661	48	33	n	n	CCONJ
ct-9661	48	34	-	-	PUNCT
ct-9661	48	35	acetylcysteine	acetylcysteine	NOUN
ct-9661	48	36	,	,	PUNCT
ct-9661	48	37	kerosene	kerosene	NOUN
ct-9661	48	38	,	,	PUNCT
ct-9661	48	39	ceragyn	ceragyn	PROPN
ct-9661	48	40	®	®	NOUN
ct-9661	48	41	(	(	PUNCT
ct-9661	48	42	csa	csa	PROPN
ct-9661	48	43	biotech	biotech	NOUN
ct-9661	48	44	,	,	PUNCT
ct-9661	48	45	spanish	spanish	ADJ
ct-9661	48	46	fork	fork	NOUN
ct-9661	48	47	,	,	PUNCT
ct-9661	48	48	ut	ut	PROPN
ct-9661	48	49	)	)	PUNCT
ct-9661	48	50	,	,	PUNCT
ct-9661	48	51	and	and	CCONJ
ct-9661	48	52	bactivatetm	bactivatetm	PROPN
ct-9661	48	53	(	(	PUNCT
ct-9661	48	54	bojesen	bojesen	ADJ
ct-9661	48	55	and	and	CCONJ
ct-9661	48	56	petersen	petersen	PROPN
ct-9661	48	57	biotech	biotech	PROPN
ct-9661	48	58	aps	aps	PROPN
ct-9661	48	59	,	,	PUNCT
ct-9661	48	60	copenhagen	copenhagen	PROPN
ct-9661	48	61	,	,	PUNCT
ct-9661	48	62	denmark	denmark	PROPN
ct-9661	48	63	)	)	PUNCT
ct-9661	48	64	.	.	PUNCT
ct-9661	49	1	recent	recent	ADJ
ct-9661	49	2	and	and	CCONJ
ct-9661	49	3	ongoing	ongoing	ADJ
ct-9661	49	4	research	research	NOUN
ct-9661	49	5	has	have	AUX
ct-9661	49	6	suggested	suggest	VERB
ct-9661	49	7	amniotic	amniotic	ADJ
ct-9661	49	8	microvesicle	microvesicle	NOUN
ct-9661	49	9	infusion,26	infusion,26	NOUN
ct-9661	49	10	lactoferrin,27	lactoferrin,27	ADJ
ct-9661	49	11	and	and	CCONJ
ct-9661	49	12	stem	stem	NOUN
ct-9661	49	13	cells28	cells28	NOUN
ct-9661	49	14	as	as	ADP
ct-9661	49	15	potential	potential	ADJ
ct-9661	49	16	aids	aid	NOUN
ct-9661	49	17	in	in	ADP
ct-9661	49	18	combating	combat	VERB
ct-9661	49	19	endometritis	endometritis	NOUN
ct-9661	49	20	,	,	PUNCT
ct-9661	49	21	although	although	SCONJ
ct-9661	49	22	these	these	PRON
ct-9661	49	23	are	be	AUX
ct-9661	49	24	not	not	PART
ct-9661	49	25	yet	yet	ADV
ct-9661	49	26	as	as	ADV
ct-9661	49	27	widespread	widespread	ADJ
ct-9661	49	28	in	in	ADP
ct-9661	49	29	clinical	clinical	ADJ
ct-9661	49	30	use	use	NOUN
ct-9661	49	31	as	as	ADP
ct-9661	49	32	those	those	PRON
ct-9661	49	33	mentioned	mention	VERB
ct-9661	49	34	above	above	ADV
ct-9661	49	35	.	.	PUNCT
ct-9661	50	1	tris	tris	NOUN
ct-9661	50	2	-	-	PUNCT
ct-9661	50	3	edta	edta	NOUN
ct-9661	50	4	and	and	CCONJ
ct-9661	50	5	its	its	PRON
ct-9661	50	6	third	third	ADJ
ct-9661	50	7	-	-	PUNCT
ct-9661	50	8	generation	generation	NOUN
ct-9661	50	9	cousin	cousin	NOUN
ct-9661	50	10	tricide	tricide	ADJ
ct-9661	50	11	®	®	NOUN
ct-9661	50	12	are	be	AUX
ct-9661	50	13	chelators	chelator	NOUN
ct-9661	50	14	that	that	PRON
ct-9661	50	15	presumably	presumably	ADV
ct-9661	50	16	act	act	VERB
ct-9661	50	17	to	to	PART
ct-9661	50	18	destabilize	destabilize	VERB
ct-9661	50	19	bacterial	bacterial	ADJ
ct-9661	50	20	structural	structural	ADJ
ct-9661	50	21	integrity	integrity	NOUN
ct-9661	50	22	,	,	PUNCT
ct-9661	50	23	especially	especially	ADV
ct-9661	50	24	useful	useful	ADJ
ct-9661	50	25	for	for	ADP
ct-9661	50	26	those	those	DET
ct-9661	50	27	bacteria	bacteria	NOUN
ct-9661	50	28	existing	exist	VERB
ct-9661	50	29	in	in	ADP
ct-9661	50	30	a	a	DET
ct-9661	50	31	biofilm	biofilm	NOUN
ct-9661	50	32	mass.29	mass.29	NOUN
ct-9661	50	33	tris	tris	NOUN
ct-9661	50	34	-	-	PUNCT
ct-9661	50	35	edta	edta	NOUN
ct-9661	50	36	is	be	AUX
ct-9661	50	37	safe	safe	ADJ
ct-9661	50	38	in	in	ADP
ct-9661	50	39	an	an	DET
ct-9661	50	40	equine	equine	NOUN
ct-9661	50	41	uterus30	uterus30	NOUN
ct-9661	50	42	and	and	CCONJ
ct-9661	50	43	its	its	PRON
ct-9661	50	44	activity	activity	NOUN
ct-9661	50	45	against	against	ADP
ct-9661	50	46	bacterial	bacterial	ADJ
ct-9661	50	47	biofilms	biofilm	NOUN
ct-9661	50	48	has	have	AUX
ct-9661	50	49	been	be	AUX
ct-9661	50	50	demonstrated	demonstrate	VERB
ct-9661	50	51	in	in	ADP
ct-9661	50	52	vitro.31	vitro.31	ADJ
ct-9661	50	53	chelators	chelator	NOUN
ct-9661	50	54	are	be	AUX
ct-9661	50	55	often	often	ADV
ct-9661	50	56	instilled	instill	VERB
ct-9661	50	57	into	into	ADP
ct-9661	50	58	the	the	DET
ct-9661	50	59	uterus	uterus	NOUN
ct-9661	50	60	following	follow	VERB
ct-9661	50	61	lavage	lavage	NOUN
ct-9661	50	62	and	and	CCONJ
ct-9661	50	63	in	in	ADP
ct-9661	50	64	conjunction	conjunction	NOUN
ct-9661	50	65	with	with	ADP
ct-9661	50	66	antimicrobials	antimicrobial	NOUN
ct-9661	50	67	to	to	PART
ct-9661	50	68	potentiate	potentiate	VERB
ct-9661	50	69	their	their	PRON
ct-9661	50	70	action.32	action.32	NOUN
ct-9661	50	71	despite	despite	SCONJ
ct-9661	50	72	a	a	DET
ct-9661	50	73	dearth	dearth	NOUN
ct-9661	50	74	of	of	ADP
ct-9661	50	75	peer	peer	NOUN
ct-9661	50	76	-	-	PUNCT
ct-9661	50	77	reviewed	review	VERB
ct-9661	50	78	resources	resource	NOUN
ct-9661	50	79	to	to	PART
ct-9661	50	80	support	support	VERB
ct-9661	50	81	its	its	PRON
ct-9661	50	82	use	use	NOUN
ct-9661	50	83	in	in	ADP
ct-9661	50	84	treating	treat	VERB
ct-9661	50	85	endometritis	endometritis	NOUN
ct-9661	50	86	in	in	ADP
ct-9661	50	87	mares	mare	NOUN
ct-9661	50	88	,	,	PUNCT
ct-9661	50	89	dmso	dmso	NOUN
ct-9661	50	90	is	be	AUX
ct-9661	50	91	utilized	utilize	VERB
ct-9661	50	92	widely	widely	ADV
ct-9661	50	93	for	for	ADP
ct-9661	50	94	this	this	DET
ct-9661	50	95	purpose	purpose	NOUN
ct-9661	50	96	.	.	PUNCT
ct-9661	51	1	at	at	ADP
ct-9661	51	2	increasing	increase	VERB
ct-9661	51	3	concentrations	concentration	NOUN
ct-9661	51	4	,	,	PUNCT
ct-9661	51	5	dmso	dmso	NOUN
ct-9661	51	6	induces	induce	VERB
ct-9661	51	7	membrane	membrane	NOUN
ct-9661	51	8	thinning	thinning	NOUN
ct-9661	51	9	,	,	PUNCT
ct-9661	51	10	followed	follow	VERB
ct-9661	51	11	by	by	ADP
ct-9661	51	12	transient	transient	ADJ
ct-9661	51	13	membrane	membrane	NOUN
ct-9661	51	14	water	water	NOUN
ct-9661	51	15	pores	pore	NOUN
ct-9661	51	16	,	,	PUNCT
ct-9661	51	17	and	and	CCONJ
ct-9661	51	18	then	then	ADV
ct-9661	51	19	disintegration	disintegration	NOUN
ct-9661	51	20	of	of	ADP
ct-9661	51	21	membrane	membrane	NOUN
ct-9661	51	22	bilayer	bilayer	NOUN
ct-9661	51	23	structure.33	structure.33	NOUN
ct-9661	51	24	it	it	PRON
ct-9661	51	25	is	be	AUX
ct-9661	51	26	recognized	recognize	VERB
ct-9661	51	27	as	as	ADP
ct-9661	51	28	an	an	DET
ct-9661	51	29	antiinflammatory	antiinflammatory	NOUN
ct-9661	51	30	agent	agent	NOUN
ct-9661	51	31	and	and	CCONJ
ct-9661	51	32	has	have	VERB
ct-9661	51	33	the	the	DET
ct-9661	51	34	ability	ability	NOUN
ct-9661	51	35	to	to	PART
ct-9661	51	36	reduce	reduce	VERB
ct-9661	51	37	biofilm	biofilm	NOUN
ct-9661	51	38	biomass	biomass	NOUN
ct-9661	51	39	in	in	ADP
ct-9661	51	40	vitro.34	vitro.34	NOUN
ct-9661	51	41	intrauterine	intrauterine	ADJ
ct-9661	51	42	use	use	NOUN
ct-9661	51	43	of	of	ADP
ct-9661	51	44	solutions	solution	NOUN
ct-9661	51	45	containing	contain	VERB
ct-9661	51	46	up	up	ADP
ct-9661	51	47	to	to	PART
ct-9661	51	48	30	30	NUM
ct-9661	51	49	%	%	NOUN
ct-9661	51	50	dmso	dmso	NOUN
ct-9661	51	51	was	be	AUX
ct-9661	51	52	safe.35	safe.35	VERB
ct-9661	51	53	its	its	PRON
ct-9661	51	54	economy	economy	NOUN
ct-9661	51	55	,	,	PUNCT
ct-9661	51	56	accessibility	accessibility	NOUN
ct-9661	51	57	,	,	PUNCT
ct-9661	51	58	and	and	CCONJ
ct-9661	51	59	versatility	versatility	NOUN
ct-9661	51	60	of	of	ADP
ct-9661	51	61	use	use	NOUN
ct-9661	51	62	make	make	VERB
ct-9661	51	63	it	it	PRON
ct-9661	51	64	an	an	DET
ct-9661	51	65	clinical	clinical	ADJ
ct-9661	51	66	theriogenology	theriogenology	NOUN
ct-9661	51	67	2021	2021	NUM
ct-9661	51	68	;	;	PUNCT
ct-9661	51	69	13	13	NUM
ct-9661	51	70	:	:	SYM
ct-9661	51	71	261	261	NUM
ct-9661	51	72	attractive	attractive	ADJ
ct-9661	51	73	option	option	NOUN
ct-9661	51	74	for	for	ADP
ct-9661	51	75	approaching	approach	VERB
ct-9661	51	76	endometritis	endometritis	NOUN
ct-9661	51	77	.	.	PUNCT
ct-9661	52	1	hydrogen	hydrogen	NOUN
ct-9661	52	2	peroxide	peroxide	NOUN
ct-9661	52	3	,	,	PUNCT
ct-9661	52	4	the	the	DET
ct-9661	52	5	household	household	NOUN
ct-9661	52	6	and	and	CCONJ
ct-9661	52	7	medicine	medicine	NOUN
ct-9661	52	8	cabinet	cabinet	NOUN
ct-9661	52	9	staple	staple	NOUN
ct-9661	52	10	,	,	PUNCT
ct-9661	52	11	exerts	exert	VERB
ct-9661	52	12	its	its	PRON
ct-9661	52	13	antibacterial	antibacterial	ADJ
ct-9661	52	14	effects	effect	NOUN
ct-9661	52	15	through	through	ADP
ct-9661	52	16	free	free	ADJ
ct-9661	52	17	radical	radical	ADJ
ct-9661	52	18	generation	generation	NOUN
ct-9661	52	19	and	and	CCONJ
ct-9661	52	20	subsequent	subsequent	ADJ
ct-9661	52	21	oxidation	oxidation	NOUN
ct-9661	52	22	.	.	PUNCT
ct-9661	53	1	as	as	ADP
ct-9661	53	2	with	with	ADP
ct-9661	53	3	dmso	dmso	NOUN
ct-9661	53	4	,	,	PUNCT
ct-9661	53	5	controlled	control	VERB
ct-9661	53	6	studies	study	NOUN
ct-9661	53	7	evaluating	evaluate	VERB
ct-9661	53	8	its	its	PRON
ct-9661	53	9	use	use	NOUN
ct-9661	53	10	in	in	ADP
ct-9661	53	11	the	the	DET
ct-9661	53	12	equine	equine	NOUN
ct-9661	53	13	uterus	uterus	NOUN
ct-9661	53	14	are	be	AUX
ct-9661	53	15	lacking	lack	VERB
ct-9661	53	16	;	;	PUNCT
ct-9661	53	17	however	however	ADV
ct-9661	53	18	,	,	PUNCT
ct-9661	53	19	in	in	ADP
ct-9661	53	20	vitro	vitro	X
ct-9661	53	21	work	work	NOUN
ct-9661	53	22	suggests	suggest	VERB
ct-9661	53	23	that	that	SCONJ
ct-9661	53	24	it	it	PRON
ct-9661	53	25	is	be	AUX
ct-9661	53	26	an	an	DET
ct-9661	53	27	effective	effective	ADJ
ct-9661	53	28	antibiofilm	antibiofilm	NOUN
ct-9661	53	29	disrupting	disrupt	VERB
ct-9661	53	30	agent.31	agent.31	NOUN
ct-9661	53	31	anecdotally	anecdotally	ADV
ct-9661	53	32	,	,	PUNCT
ct-9661	53	33	3	3	NUM
ct-9661	53	34	5	5	NUM
ct-9661	53	35	%	%	NOUN
ct-9661	53	36	hydrogen	hydrogen	NOUN
ct-9661	53	37	peroxide	peroxide	NOUN
ct-9661	53	38	infusion	infusion	NOUN
ct-9661	53	39	can	can	AUX
ct-9661	53	40	induce	induce	VERB
ct-9661	53	41	palpable	palpable	ADJ
ct-9661	53	42	adhesions	adhesion	NOUN
ct-9661	53	43	and	and	CCONJ
ct-9661	53	44	serosanguineous	serosanguineous	ADJ
ct-9661	53	45	discharge	discharge	NOUN
ct-9661	53	46	in	in	ADP
ct-9661	53	47	some	some	DET
ct-9661	53	48	mares	mare	NOUN
ct-9661	53	49	.	.	PUNCT
ct-9661	54	1	povidone	povidone	NOUN
ct-9661	54	2	iodine	iodine	NOUN
ct-9661	54	3	is	be	AUX
ct-9661	54	4	an	an	DET
ct-9661	54	5	antimicrobial	antimicrobial	ADJ
ct-9661	54	6	commonly	commonly	ADV
ct-9661	54	7	added	add	VERB
ct-9661	54	8	to	to	ADP
ct-9661	54	9	lavage	lavage	NOUN
ct-9661	54	10	fluids	fluid	NOUN
ct-9661	54	11	.	.	PUNCT
ct-9661	55	1	after	after	ADP
ct-9661	55	2	disassociation	disassociation	NOUN
ct-9661	55	3	,	,	PUNCT
ct-9661	55	4	iodine	iodine	NOUN
ct-9661	55	5	penetrates	penetrate	VERB
ct-9661	55	6	microbial	microbial	ADJ
ct-9661	55	7	cell	cell	NOUN
ct-9661	55	8	membranes	membrane	NOUN
ct-9661	55	9	to	to	PART
ct-9661	55	10	oxidize	oxidize	VERB
ct-9661	55	11	proteins	protein	NOUN
ct-9661	55	12	,	,	PUNCT
ct-9661	55	13	nucleotides	nucleotide	NOUN
ct-9661	55	14	and	and	CCONJ
ct-9661	55	15	fatty	fatty	NOUN
ct-9661	55	16	acids	acid	NOUN
ct-9661	55	17	.	.	PUNCT
ct-9661	56	1	dilute	dilute	NOUN
ct-9661	56	2	preparations	preparation	NOUN
ct-9661	56	3	may	may	AUX
ct-9661	56	4	be	be	AUX
ct-9661	56	5	more	more	ADV
ct-9661	56	6	rapidly	rapidly	ADV
ct-9661	56	7	bactericidal	bactericidal	ADJ
ct-9661	56	8	than	than	ADP
ct-9661	56	9	full	full	ADJ
ct-9661	56	10	strength	strength	NOUN
ct-9661	56	11	solutions.36	solutions.36	VERB
ct-9661	56	12	uterine	uterine	ADJ
ct-9661	56	13	lavage	lavage	NOUN
ct-9661	56	14	with	with	ADP
ct-9661	56	15	0.05	0.05	NUM
ct-9661	56	16	%	%	NOUN
ct-9661	56	17	povidone	povidone	NOUN
ct-9661	56	18	iodine	iodine	NOUN
ct-9661	56	19	(	(	PUNCT
ct-9661	56	20	5	5	NUM
ct-9661	56	21	ml	ml	NOUN
ct-9661	56	22	of	of	ADP
ct-9661	56	23	10	10	NUM
ct-9661	56	24	%	%	NOUN
ct-9661	56	25	betadine	betadine	NOUN
ct-9661	56	26	solution	solution	NOUN
ct-9661	56	27	in	in	ADP
ct-9661	56	28	a	a	DET
ct-9661	56	29	liter	liter	NOUN
ct-9661	56	30	)	)	PUNCT
ct-9661	56	31	was	be	AUX
ct-9661	56	32	not	not	PART
ct-9661	56	33	associated	associate	VERB
ct-9661	56	34	with	with	ADP
ct-9661	56	35	deleterious	deleterious	ADJ
ct-9661	56	36	effects	effect	NOUN
ct-9661	56	37	;	;	PUNCT
ct-9661	56	38	however	however	ADV
ct-9661	56	39	,	,	PUNCT
ct-9661	56	40	infusion	infusion	NOUN
ct-9661	56	41	of	of	ADP
ct-9661	56	42	1	1	NUM
ct-9661	56	43	%	%	NOUN
ct-9661	56	44	povidone	povidone	NOUN
ct-9661	56	45	iodine	iodine	NOUN
ct-9661	56	46	caused	cause	VERB
ct-9661	56	47	chronic	chronic	ADJ
ct-9661	56	48	endometrial	endometrial	ADJ
ct-9661	56	49	inflammatory	inflammatory	NOUN
ct-9661	56	50	changes.16,37	changes.16,37	NOUN
ct-9661	56	51	the	the	DET
ct-9661	56	52	mucolytic	mucolytic	ADJ
ct-9661	56	53	n	n	CCONJ
ct-9661	56	54	-	-	PUNCT
ct-9661	56	55	acetylcysteine	acetylcysteine	NOUN
ct-9661	56	56	improved	improve	VERB
ct-9661	56	57	reproductive	reproductive	ADJ
ct-9661	56	58	performance	performance	NOUN
ct-9661	56	59	in	in	ADP
ct-9661	56	60	mares	mare	NOUN
ct-9661	56	61	and	and	CCONJ
ct-9661	56	62	resulted	result	VERB
ct-9661	56	63	in	in	ADP
ct-9661	56	64	decreased	decrease	VERB
ct-9661	56	65	cox-2	cox-2	ADJ
ct-9661	56	66	presence	presence	NOUN
ct-9661	56	67	in	in	ADP
ct-9661	56	68	endometrial	endometrial	ADJ
ct-9661	56	69	biopsy	biopsy	NOUN
ct-9661	56	70	samples.38,39	samples.38,39	NOUN
ct-9661	56	71	we	we	PRON
ct-9661	56	72	have	have	AUX
ct-9661	56	73	observed	observe	VERB
ct-9661	56	74	enhanced	enhanced	ADJ
ct-9661	56	75	sensitivity	sensitivity	NOUN
ct-9661	56	76	in	in	ADP
ct-9661	56	77	diagnosis	diagnosis	NOUN
ct-9661	56	78	of	of	ADP
ct-9661	56	79	bacterial	bacterial	ADJ
ct-9661	56	80	endometritis	endometritis	NOUN
ct-9661	56	81	when	when	SCONJ
ct-9661	56	82	performing	perform	VERB
ct-9661	56	83	uterine	uterine	ADJ
ct-9661	56	84	lavage	lavage	NOUN
ct-9661	56	85	for	for	ADP
ct-9661	56	86	culture	culture	NOUN
ct-9661	56	87	and	and	CCONJ
ct-9661	56	88	cytology	cytology	NOUN
ct-9661	56	89	following	follow	VERB
ct-9661	56	90	n	n	CCONJ
ct-9661	56	91	-	-	PUNCT
ct-9661	56	92	acetylcysteine	acetylcysteine	NOUN
ct-9661	56	93	infusion	infusion	NOUN
ct-9661	56	94	(	(	PUNCT
ct-9661	56	95	lu	lu	INTJ
ct-9661	56	96	et	et	NOUN
ct-9661	56	97	al	al	PROPN
ct-9661	56	98	:	:	PUNCT
ct-9661	56	99	unpublished	unpublished	ADJ
ct-9661	56	100	data	datum	NOUN
ct-9661	56	101	)	)	PUNCT
ct-9661	56	102	.	.	PUNCT
ct-9661	57	1	the	the	DET
ct-9661	57	2	proprietary	proprietary	ADJ
ct-9661	57	3	commercial	commercial	ADJ
ct-9661	57	4	products	product	NOUN
ct-9661	57	5	ceragyn	ceragyn	NOUN
ct-9661	57	6	®	®	NOUN
ct-9661	57	7	and	and	CCONJ
ct-9661	57	8	bactivatetm	bactivatetm	PROPN
ct-9661	57	9	are	be	AUX
ct-9661	57	10	labeled	label	VERB
ct-9661	57	11	for	for	ADP
ct-9661	57	12	use	use	NOUN
ct-9661	57	13	in	in	ADP
ct-9661	57	14	managing	manage	VERB
ct-9661	57	15	subfertility	subfertility	NOUN
ct-9661	57	16	in	in	ADP
ct-9661	57	17	mares	mare	NOUN
ct-9661	57	18	.	.	PUNCT
ct-9661	58	1	ceragyn	ceragyn	PROPN
ct-9661	58	2	®	®	NOUN
ct-9661	58	3	mimics	mimic	VERB
ct-9661	58	4	antimicrobial	antimicrobial	ADJ
ct-9661	58	5	peptide	peptide	NOUN
ct-9661	58	6	,	,	PUNCT
ct-9661	58	7	is	be	AUX
ct-9661	58	8	intended	intend	VERB
ct-9661	58	9	to	to	PART
ct-9661	58	10	penetrate	penetrate	VERB
ct-9661	58	11	and	and	CCONJ
ct-9661	58	12	destroy	destroy	VERB
ct-9661	58	13	biofilms	biofilm	NOUN
ct-9661	58	14	,	,	PUNCT
ct-9661	58	15	and	and	CCONJ
ct-9661	58	16	is	be	AUX
ct-9661	58	17	available	available	ADJ
ct-9661	58	18	in	in	ADP
ct-9661	58	19	both	both	CCONJ
ct-9661	58	20	lavage	lavage	NOUN
ct-9661	58	21	and	and	CCONJ
ct-9661	58	22	as	as	ADP
ct-9661	58	23	infusion	infusion	NOUN
ct-9661	58	24	formulations	formulation	NOUN
ct-9661	58	25	for	for	ADP
ct-9661	58	26	use	use	NOUN
ct-9661	58	27	within	within	ADP
ct-9661	58	28	the	the	DET
ct-9661	58	29	equine	equine	NOUN
ct-9661	58	30	uterus	uterus	NOUN
ct-9661	58	31	.	.	PUNCT
ct-9661	59	1	bactivatetm	bactivatetm	PROPN
ct-9661	59	2	is	be	AUX
ct-9661	59	3	not	not	PART
ct-9661	59	4	a	a	DET
ct-9661	59	5	treatment	treatment	NOUN
ct-9661	59	6	for	for	ADP
ct-9661	59	7	endometritis	endometritis	PROPN
ct-9661	59	8	per	per	ADP
ct-9661	59	9	se	se	ADV
ct-9661	59	10	,	,	PUNCT
ct-9661	59	11	but	but	CCONJ
ct-9661	59	12	rather	rather	ADV
ct-9661	59	13	a	a	DET
ct-9661	59	14	method	method	NOUN
ct-9661	59	15	to	to	PART
ct-9661	59	16	complement	complement	VERB
ct-9661	59	17	diagnosis	diagnosis	NOUN
ct-9661	59	18	of	of	ADP
ct-9661	59	19	subclinical	subclinical	ADJ
ct-9661	59	20	endometritis	endometritis	NOUN
ct-9661	59	21	due	due	ADP
ct-9661	59	22	to	to	PART
ct-9661	59	23	dormant	dormant	VERB
ct-9661	59	24	beta	beta	ADJ
ct-9661	59	25	streptococcus	streptococcus	NOUN
ct-9661	59	26	sp.40	sp.40	NOUN
ct-9661	59	27	intrauterine	intrauterine	ADJ
ct-9661	59	28	infusion	infusion	NOUN
ct-9661	59	29	of	of	ADP
ct-9661	59	30	kerosene	kerosene	NOUN
ct-9661	59	31	is	be	AUX
ct-9661	59	32	intended	intend	VERB
ct-9661	59	33	as	as	ADP
ct-9661	59	34	a	a	DET
ct-9661	59	35	chemical	chemical	NOUN
ct-9661	59	36	curettage	curettage	NOUN
ct-9661	59	37	of	of	ADP
ct-9661	59	38	the	the	DET
ct-9661	59	39	endometrium	endometrium	NOUN
ct-9661	59	40	.	.	PUNCT
ct-9661	60	1	anecdotes	anecdote	NOUN
ct-9661	60	2	attributed	attribute	VERB
ct-9661	60	3	to	to	ADP
ct-9661	60	4	success	success	NOUN
ct-9661	60	5	of	of	ADP
ct-9661	60	6	kerosene	kerosene	NOUN
ct-9661	60	7	are	be	AUX
ct-9661	60	8	abundant	abundant	ADJ
ct-9661	60	9	;	;	PUNCT
ct-9661	60	10	however	however	ADV
ct-9661	60	11	,	,	PUNCT
ct-9661	60	12	practitioners	practitioner	NOUN
ct-9661	60	13	are	be	AUX
ct-9661	60	14	cautioned	caution	VERB
ct-9661	60	15	that	that	SCONJ
ct-9661	60	16	kerosene	kerosene	NOUN
ct-9661	60	17	is	be	AUX
ct-9661	60	18	not	not	PART
ct-9661	60	19	a	a	DET
ct-9661	60	20	panacea	panacea	NOUN
ct-9661	60	21	it	it	PRON
ct-9661	60	22	may	may	AUX
ct-9661	60	23	seem	seem	VERB
ct-9661	60	24	to	to	PART
ct-9661	60	25	be	be	AUX
ct-9661	60	26	,	,	PUNCT
ct-9661	60	27	and	and	CCONJ
ct-9661	60	28	that	that	SCONJ
ct-9661	60	29	inherent	inherent	ADJ
ct-9661	60	30	risks	risk	NOUN
ct-9661	60	31	to	to	ADP
ct-9661	60	32	mare	mare	NOUN
ct-9661	60	33	and	and	CCONJ
ct-9661	60	34	personnel	personnel	NOUN
ct-9661	60	35	exist	exist	VERB
ct-9661	60	36	with	with	ADP
ct-9661	60	37	its	its	PRON
ct-9661	60	38	use.41	use.41	ADJ
ct-9661	60	39	case	case	NOUN
ct-9661	60	40	selection	selection	NOUN
ct-9661	60	41	and	and	CCONJ
ct-9661	60	42	client	client	NOUN
ct-9661	60	43	communication	communication	NOUN
ct-9661	60	44	are	be	AUX
ct-9661	60	45	important	important	ADJ
ct-9661	60	46	when	when	SCONJ
ct-9661	60	47	using	use	VERB
ct-9661	60	48	kerosene	kerosene	NOUN
ct-9661	60	49	and	and	CCONJ
ct-9661	60	50	for	for	ADP
ct-9661	60	51	treatments	treatment	NOUN
ct-9661	60	52	that	that	PRON
ct-9661	60	53	have	have	VERB
ct-9661	60	54	no	no	DET
ct-9661	60	55	peer	peer	NOUN
ct-9661	60	56	-	-	PUNCT
ct-9661	60	57	reviewed	review	VERB
ct-9661	60	58	clinical	clinical	ADJ
ct-9661	60	59	trials	trial	NOUN
ct-9661	60	60	.	.	PUNCT
ct-9661	61	1	the	the	DET
ct-9661	61	2	idea	idea	NOUN
ct-9661	61	3	that	that	SCONJ
ct-9661	61	4	the	the	DET
ct-9661	61	5	equine	equine	NOUN
ct-9661	61	6	endometrium	endometrium	NOUN
ct-9661	61	7	has	have	AUX
ct-9661	61	8	the	the	DET
ct-9661	61	9	ability	ability	NOUN
ct-9661	61	10	to	to	PART
ct-9661	61	11	support	support	VERB
ct-9661	61	12	a	a	DET
ct-9661	61	13	robust	robust	ADJ
ct-9661	61	14	mucus	mucus	NOUN
ct-9661	61	15	layer	layer	NOUN
ct-9661	61	16	that	that	PRON
ct-9661	61	17	can	can	AUX
ct-9661	61	18	aid	aid	VERB
ct-9661	61	19	and	and	CCONJ
ct-9661	61	20	abet	abet	ADJ
ct-9661	61	21	nefarious	nefarious	ADJ
ct-9661	61	22	microorganisms	microorganism	NOUN
ct-9661	61	23	is	be	AUX
ct-9661	61	24	not	not	PART
ct-9661	61	25	new	new	ADJ
ct-9661	61	26	.	.	PUNCT
ct-9661	62	1	however	however	ADV
ct-9661	62	2	,	,	PUNCT
ct-9661	62	3	the	the	DET
ct-9661	62	4	past	past	ADJ
ct-9661	62	5	decade	decade	NOUN
ct-9661	62	6	’s	’s	PART
ct-9661	62	7	work42	work42	NOUN
ct-9661	62	8	has	have	AUX
ct-9661	62	9	promoted	promote	VERB
ct-9661	62	10	a	a	DET
ct-9661	62	11	resurgence	resurgence	NOUN
ct-9661	62	12	of	of	ADP
ct-9661	62	13	discussion	discussion	NOUN
ct-9661	62	14	regarding	regard	VERB
ct-9661	62	15	the	the	DET
ct-9661	62	16	potential	potential	NOUN
ct-9661	62	17	for	for	ADP
ct-9661	62	18	bacterial	bacterial	ADJ
ct-9661	62	19	biofilm	biofilm	NOUN
ct-9661	62	20	formation	formation	NOUN
ct-9661	62	21	in	in	ADP
ct-9661	62	22	the	the	DET
ct-9661	62	23	equine	equine	NOUN
ct-9661	62	24	uterus	uterus	NOUN
ct-9661	62	25	and	and	CCONJ
ct-9661	62	26	what	what	PRON
ct-9661	62	27	can	can	AUX
ct-9661	62	28	be	be	AUX
ct-9661	62	29	done	do	VERB
ct-9661	62	30	to	to	PART
ct-9661	62	31	diagnose	diagnose	VERB
ct-9661	62	32	and	and	CCONJ
ct-9661	62	33	address	address	VERB
ct-9661	62	34	this	this	DET
ct-9661	62	35	condition	condition	NOUN
ct-9661	62	36	.	.	PUNCT
ct-9661	63	1	it	it	PRON
ct-9661	63	2	is	be	AUX
ct-9661	63	3	challenging	challenge	VERB
ct-9661	63	4	to	to	PART
ct-9661	63	5	definitively	definitively	ADV
ct-9661	63	6	diagnose	diagnose	VERB
ct-9661	63	7	and	and	CCONJ
ct-9661	63	8	characterize	characterize	VERB
ct-9661	63	9	bacterial	bacterial	ADJ
ct-9661	63	10	biofilm	biofilm	NOUN
ct-9661	63	11	in	in	ADP
ct-9661	63	12	vivo	vivo	NOUN
ct-9661	63	13	,	,	PUNCT
ct-9661	63	14	leaving	leave	VERB
ct-9661	63	15	extrapolation	extrapolation	NOUN
ct-9661	63	16	from	from	ADP
ct-9661	63	17	in	in	ADP
ct-9661	63	18	vitro	vitro	X
ct-9661	63	19	work	work	NOUN
ct-9661	63	20	as	as	ADP
ct-9661	63	21	our	our	PRON
ct-9661	63	22	current	current	ADJ
ct-9661	63	23	best	good	ADJ
ct-9661	63	24	resource	resource	NOUN
ct-9661	63	25	for	for	ADP
ct-9661	63	26	combating	combat	VERB
ct-9661	63	27	tenacious	tenacious	ADJ
ct-9661	63	28	bacterial	bacterial	ADJ
ct-9661	63	29	endometritis	endometritis	NOUN
ct-9661	63	30	due	due	ADP
ct-9661	63	31	to	to	ADP
ct-9661	63	32	suspected	suspect	VERB
ct-9661	63	33	biofilm	biofilm	NOUN
ct-9661	63	34	presence	presence	NOUN
ct-9661	63	35	.	.	PUNCT
ct-9661	64	1	a	a	DET
ct-9661	64	2	project	project	NOUN
ct-9661	64	3	has	have	AUX
ct-9661	64	4	evaluated	evaluate	VERB
ct-9661	64	5	3.3	3.3	NUM
ct-9661	64	6	%	%	NOUN
ct-9661	64	7	n	n	CCONJ
ct-9661	64	8	-	-	PUNCT
ct-9661	64	9	acetylcysteine	acetylcysteine	NOUN
ct-9661	64	10	,	,	PUNCT
ct-9661	64	11	edta	edta	NOUN
ct-9661	64	12	,	,	PUNCT
ct-9661	64	13	and	and	CCONJ
ct-9661	64	14	hydrogen	hydrogen	NOUN
ct-9661	64	15	peroxide	peroxide	NOUN
ct-9661	64	16	as	as	ADP
ct-9661	64	17	antibiofilm	antibiofilm	NOUN
ct-9661	64	18	treatments	treatment	NOUN
ct-9661	64	19	against	against	ADP
ct-9661	64	20	isolates	isolate	NOUN
ct-9661	64	21	of	of	ADP
ct-9661	64	22	escherichia	escherichia	NOUN
ct-9661	64	23	coli	coli	NOUN
ct-9661	64	24	,	,	PUNCT
ct-9661	64	25	klebsiella	klebsiella	NOUN
ct-9661	64	26	pneumoniae	pneumoniae	ADJ
ct-9661	64	27	,	,	PUNCT
ct-9661	64	28	and	and	CCONJ
ct-9661	64	29	pseudomonas	pseudomona	NOUN
ct-9661	64	30	aeruginosa	aeruginosa	NOUN
ct-9661	64	31	.	.	PUNCT
ct-9661	65	1	of	of	ADP
ct-9661	65	2	treatments	treatment	NOUN
ct-9661	65	3	evaluated	evaluate	VERB
ct-9661	65	4	,	,	PUNCT
ct-9661	65	5	no	no	DET
ct-9661	65	6	single	single	ADJ
ct-9661	65	7	treatment	treatment	NOUN
ct-9661	65	8	was	be	AUX
ct-9661	65	9	active	active	ADJ
ct-9661	65	10	against	against	ADP
ct-9661	65	11	all	all	DET
ct-9661	65	12	bacterial	bacterial	ADJ
ct-9661	65	13	isolates	isolate	NOUN
ct-9661	65	14	,	,	PUNCT
ct-9661	65	15	highlighting	highlight	VERB
ct-9661	65	16	an	an	DET
ct-9661	65	17	important	important	ADJ
ct-9661	65	18	point	point	NOUN
ct-9661	65	19	about	about	ADP
ct-9661	65	20	the	the	DET
ct-9661	65	21	individuality	individuality	NOUN
ct-9661	65	22	of	of	ADP
ct-9661	65	23	bacterial	bacterial	ADJ
ct-9661	65	24	isolates.31	isolates.31	NOUN
ct-9661	65	25	this	this	DET
ct-9661	65	26	challenge	challenge	NOUN
ct-9661	65	27	has	have	AUX
ct-9661	65	28	been	be	AUX
ct-9661	65	29	addressed	address	VERB
ct-9661	65	30	by	by	ADP
ct-9661	65	31	the	the	DET
ct-9661	65	32	development	development	NOUN
ct-9661	65	33	of	of	ADP
ct-9661	65	34	an	an	DET
ct-9661	65	35	in	in	ADP
ct-9661	65	36	vitro	vitro	X
ct-9661	65	37	biofilm	biofilm	NOUN
ct-9661	65	38	assay	assay	NOUN
ct-9661	65	39	that	that	PRON
ct-9661	65	40	is	be	AUX
ct-9661	65	41	currently	currently	ADV
ct-9661	65	42	available	available	ADJ
ct-9661	65	43	in	in	ADP
ct-9661	65	44	clinical	clinical	ADJ
ct-9661	65	45	practice	practice	NOUN
ct-9661	65	46	to	to	PART
ct-9661	65	47	target	target	VERB
ct-9661	65	48	bacteria	bacteria	NOUN
ct-9661	65	49	in	in	ADP
ct-9661	65	50	a	a	DET
ct-9661	65	51	more	more	ADV
ct-9661	65	52	bespoke	bespoke	NOUN
ct-9661	65	53	fashion	fashion	NOUN
ct-9661	65	54	than	than	ADP
ct-9661	65	55	empiric	empiric	ADJ
ct-9661	65	56	treatment	treatment	NOUN
ct-9661	65	57	selection	selection	NOUN
ct-9661	65	58	.	.	PUNCT
ct-9661	66	1	immune	immune	ADJ
ct-9661	66	2	modulation	modulation	NOUN
ct-9661	66	3	and	and	CCONJ
ct-9661	66	4	antiinflammatories	antiinflammatorie	NOUN
ct-9661	66	5	use	use	NOUN
ct-9661	66	6	of	of	ADP
ct-9661	66	7	glucocorticoids	glucocorticoid	NOUN
ct-9661	66	8	prednisolone	prednisolone	PROPN
ct-9661	66	9	acetate	acetate	NOUN
ct-9661	66	10	and	and	CCONJ
ct-9661	66	11	dexamethasone	dexamethasone	NOUN
ct-9661	66	12	around	around	ADP
ct-9661	66	13	breeding	breed	VERB
ct-9661	66	14	in	in	ADP
ct-9661	66	15	mares	mare	NOUN
ct-9661	66	16	have	have	AUX
ct-9661	66	17	been	be	AUX
ct-9661	66	18	described	describe	VERB
ct-9661	66	19	to	to	PART
ct-9661	66	20	control	control	VERB
ct-9661	66	21	inflammation	inflammation	NOUN
ct-9661	66	22	.	.	PUNCT
ct-9661	67	1	oral	oral	ADJ
ct-9661	67	2	prednisolone	prednisolone	PROPN
ct-9661	67	3	acetate	acetate	NOUN
ct-9661	67	4	(	(	PUNCT
ct-9661	67	5	0.1	0.1	NUM
ct-9661	67	6	mg	mg	PROPN
ct-9661	67	7	/	/	SYM
ct-9661	67	8	kg	kg	PROPN
ct-9661	67	9	,	,	PUNCT
ct-9661	67	10	every	every	DET
ct-9661	67	11	12	12	NUM
ct-9661	67	12	hours	hour	NOUN
ct-9661	67	13	)	)	PUNCT
ct-9661	67	14	improved	improve	VERB
ct-9661	67	15	pregnancy	pregnancy	NOUN
ct-9661	67	16	rates	rate	NOUN
ct-9661	67	17	in	in	ADP
ct-9661	67	18	a	a	DET
ct-9661	67	19	limited	limited	ADJ
ct-9661	67	20	group	group	NOUN
ct-9661	67	21	of	of	ADP
ct-9661	67	22	mares	mare	NOUN
ct-9661	67	23	bred	breed	VERB
ct-9661	67	24	with	with	ADP
ct-9661	67	25	frozen	frozen	ADJ
ct-9661	67	26	semen.43	semen.43	NOUN
ct-9661	67	27	similarly	similarly	ADV
ct-9661	67	28	,	,	PUNCT
ct-9661	67	29	intravenous	intravenous	ADJ
ct-9661	67	30	dexamethasone	dexamethasone	NOUN
ct-9661	67	31	(	(	PUNCT
ct-9661	67	32	0.1	0.1	NUM
ct-9661	67	33	mg	mg	PROPN
ct-9661	67	34	/	/	SYM
ct-9661	67	35	kg	kg	NOUN
ct-9661	67	36	)	)	PUNCT
ct-9661	67	37	at	at	ADP
ct-9661	67	38	breeding	breed	VERB
ct-9661	67	39	improved	improve	VERB
ct-9661	67	40	pregnancy	pregnancy	NOUN
ct-9661	67	41	rates	rate	NOUN
ct-9661	67	42	in	in	ADP
ct-9661	67	43	mares	mare	NOUN
ct-9661	67	44	classified	classify	VERB
ct-9661	67	45	as	as	ADP
ct-9661	67	46	at	at	ADP
ct-9661	67	47	-	-	PUNCT
ct-9661	67	48	risk	risk	NOUN
ct-9661	67	49	for	for	ADP
ct-9661	67	50	susceptibility	susceptibility	NOUN
ct-9661	67	51	to	to	ADP
ct-9661	67	52	persistent	persistent	ADJ
ct-9661	67	53	mating	mating	NOUN
ct-9661	67	54	induced	induce	VERB
ct-9661	67	55	endometritis.44	endometritis.44	NOUN
ct-9661	67	56	furthermore	furthermore	ADV
ct-9661	67	57	,	,	PUNCT
ct-9661	67	58	in	in	ADP
ct-9661	67	59	mares	mare	NOUN
ct-9661	67	60	challenged	challenge	VERB
ct-9661	67	61	by	by	ADP
ct-9661	67	62	intrauterine	intrauterine	ADJ
ct-9661	67	63	inoculation	inoculation	NOUN
ct-9661	67	64	of	of	ADP
ct-9661	67	65	a	a	DET
ct-9661	67	66	known	know	VERB
ct-9661	67	67	quantity	quantity	NOUN
ct-9661	67	68	of	of	ADP
ct-9661	67	69	escherichia	escherichia	NOUN
ct-9661	67	70	coli	coli	NOUN
ct-9661	67	71	,	,	PUNCT
ct-9661	67	72	intravenous	intravenous	ADJ
ct-9661	67	73	dexamethasone	dexamethasone	NOUN
ct-9661	67	74	(	(	PUNCT
ct-9661	67	75	0.1	0.1	NUM
ct-9661	67	76	mg	mg	PROPN
ct-9661	67	77	/	/	SYM
ct-9661	67	78	kg	kg	PROPN
ct-9661	67	79	)	)	PUNCT
ct-9661	67	80	resulted	result	VERB
ct-9661	67	81	in	in	ADP
ct-9661	67	82	modulation	modulation	NOUN
ct-9661	67	83	of	of	ADP
ct-9661	67	84	the	the	DET
ct-9661	67	85	innate	innate	ADJ
ct-9661	67	86	uterine	uterine	ADJ
ct-9661	67	87	immune	immune	ADJ
ct-9661	67	88	response.45	response.45	NOUN
ct-9661	67	89	potential	potential	ADJ
ct-9661	67	90	interactions	interaction	NOUN
ct-9661	67	91	between	between	ADP
ct-9661	67	92	systemic	systemic	ADJ
ct-9661	67	93	corticosteroid	corticosteroid	ADJ
ct-9661	67	94	treatment	treatment	NOUN
ct-9661	67	95	and	and	CCONJ
ct-9661	67	96	pituitary	pituitary	ADJ
ct-9661	67	97	/	/	SYM
ct-9661	67	98	ovarian	ovarian	ADJ
ct-9661	67	99	function	function	NOUN
ct-9661	67	100	should	should	AUX
ct-9661	67	101	not	not	PART
ct-9661	67	102	be	be	AUX
ct-9661	67	103	overlooked	overlook	VERB
ct-9661	67	104	.	.	PUNCT
ct-9661	68	1	quarter	quarter	NOUN
ct-9661	68	2	horse	horse	NOUN
ct-9661	68	3	mares	mare	NOUN
ct-9661	68	4	(	(	PUNCT
ct-9661	68	5	n	n	NOUN
ct-9661	68	6	=	=	SYM
ct-9661	68	7	18	18	NUM
ct-9661	68	8	)	)	PUNCT
ct-9661	68	9	received	receive	VERB
ct-9661	68	10	either	either	DET
ct-9661	68	11	placebo	placebo	NOUN
ct-9661	68	12	,	,	PUNCT
ct-9661	68	13	intravenous	intravenous	ADJ
ct-9661	68	14	dexamethasone	dexamethasone	NOUN
ct-9661	68	15	(	(	PUNCT
ct-9661	68	16	0.05	0.05	NUM
ct-9661	68	17	mg	mg	PROPN
ct-9661	68	18	/	/	SYM
ct-9661	68	19	kg	kg	PROPN
ct-9661	68	20	,	,	PUNCT
ct-9661	68	21	twice	twice	DET
ct-9661	68	22	a	a	DET
ct-9661	68	23	day	day	NOUN
ct-9661	68	24	)	)	PUNCT
ct-9661	68	25	or	or	CCONJ
ct-9661	68	26	oral	oral	ADJ
ct-9661	68	27	prednisolone	prednisolone	PROPN
ct-9661	68	28	(	(	PUNCT
ct-9661	68	29	0.5	0.5	NUM
ct-9661	68	30	mg	mg	PROPN
ct-9661	68	31	/	/	SYM
ct-9661	68	32	kg	kg	PROPN
ct-9661	68	33	,	,	PUNCT
ct-9661	68	34	twice	twice	DET
ct-9661	68	35	a	a	DET
ct-9661	68	36	day	day	NOUN
ct-9661	68	37	)	)	PUNCT
ct-9661	68	38	for	for	ADP
ct-9661	68	39	5	5	NUM
ct-9661	68	40	days	day	NOUN
ct-9661	68	41	in	in	ADP
ct-9661	68	42	early	early	ADJ
ct-9661	68	43	estrus	estrus	NOUN
ct-9661	68	44	.	.	PUNCT
ct-9661	69	1	mares	mare	NOUN
ct-9661	69	2	treated	treat	VERB
ct-9661	69	3	with	with	ADP
ct-9661	69	4	dexamethasone	dexamethasone	NOUN
ct-9661	69	5	had	have	VERB
ct-9661	69	6	a	a	DET
ct-9661	69	7	40	40	NUM
ct-9661	69	8	%	%	NOUN
ct-9661	69	9	ovulation	ovulation	NOUN
ct-9661	69	10	rate	rate	NOUN
ct-9661	69	11	(	(	PUNCT
ct-9661	69	12	2/5	2/5	NUM
ct-9661	69	13	mares	mare	NOUN
ct-9661	69	14	)	)	PUNCT
ct-9661	69	15	,	,	PUNCT
ct-9661	69	16	those	those	PRON
ct-9661	69	17	treated	treat	VERB
ct-9661	69	18	with	with	ADP
ct-9661	69	19	prednisolone	prednisolone	PROPN
ct-9661	69	20	had	have	VERB
ct-9661	69	21	83	83	NUM
ct-9661	69	22	%	%	NOUN
ct-9661	69	23	ovulation	ovulation	NOUN
ct-9661	69	24	rate	rate	NOUN
ct-9661	69	25	(	(	PUNCT
ct-9661	69	26	5/6	5/6	NUM
ct-9661	69	27	mares	mare	NOUN
ct-9661	69	28	)	)	PUNCT
ct-9661	69	29	and	and	CCONJ
ct-9661	69	30	those	those	PRON
ct-9661	69	31	receiving	receive	VERB
ct-9661	69	32	placebo	placebo	NOUN
ct-9661	69	33	had	have	VERB
ct-9661	69	34	100	100	NUM
ct-9661	69	35	%	%	NOUN
ct-9661	69	36	ovulation	ovulation	NOUN
ct-9661	69	37	rate	rate	NOUN
ct-9661	69	38	(	(	PUNCT
ct-9661	69	39	6/6	6/6	NUM
ct-9661	69	40	mares).46	mares).46	NOUN
ct-9661	69	41	these	these	DET
ct-9661	69	42	results	result	NOUN
ct-9661	69	43	suggest	suggest	VERB
ct-9661	69	44	case	case	NOUN
ct-9661	69	45	selection	selection	NOUN
ct-9661	69	46	for	for	ADP
ct-9661	69	47	using	use	VERB
ct-9661	69	48	glucocorticoids	glucocorticoid	NOUN
ct-9661	69	49	should	should	AUX
ct-9661	69	50	carefully	carefully	ADV
ct-9661	69	51	weigh	weigh	VERB
ct-9661	69	52	risks	risk	NOUN
ct-9661	69	53	and	and	CCONJ
ct-9661	69	54	benefits	benefit	NOUN
ct-9661	69	55	,	,	PUNCT
ct-9661	69	56	and	and	CCONJ
ct-9661	69	57	the	the	DET
ct-9661	69	58	lowest	low	ADJ
ct-9661	69	59	doses	dose	NOUN
ct-9661	69	60	and	and	CCONJ
ct-9661	69	61	length	length	NOUN
ct-9661	69	62	of	of	ADP
ct-9661	69	63	therapy	therapy	NOUN
ct-9661	69	64	should	should	AUX
ct-9661	69	65	be	be	AUX
ct-9661	69	66	prescribed	prescribe	VERB
ct-9661	69	67	.	.	PUNCT
ct-9661	70	1	nonsteroidal	nonsteroidal	NOUN
ct-9661	70	2	antiinflammatories	antiinflammatorie	NOUN
ct-9661	70	3	can	can	AUX
ct-9661	70	4	also	also	ADV
ct-9661	70	5	be	be	AUX
ct-9661	70	6	harnessed	harness	VERB
ct-9661	70	7	to	to	PART
ct-9661	70	8	control	control	VERB
ct-9661	70	9	endometrial	endometrial	ADJ
ct-9661	70	10	inflammation	inflammation	NOUN
ct-9661	70	11	.	.	PUNCT
ct-9661	71	1	caution	caution	NOUN
ct-9661	71	2	is	be	AUX
ct-9661	71	3	necessary	necessary	ADJ
ct-9661	71	4	since	since	SCONJ
ct-9661	71	5	a	a	DET
ct-9661	71	6	substantial	substantial	ADJ
ct-9661	71	7	increase	increase	NOUN
ct-9661	71	8	in	in	ADP
ct-9661	71	9	anovulatory	anovulatory	NOUN
ct-9661	71	10	follicle	follicle	NOUN
ct-9661	71	11	development	development	NOUN
ct-9661	71	12	was	be	AUX
ct-9661	71	13	observed	observe	VERB
ct-9661	71	14	in	in	ADP
ct-9661	71	15	mares	mare	NOUN
ct-9661	71	16	treated	treat	VERB
ct-9661	71	17	with	with	ADP
ct-9661	71	18	flunixin	flunixin	PROPN
ct-9661	71	19	meglumine	meglumine	NOUN
ct-9661	71	20	(	(	PUNCT
ct-9661	71	21	2	2	NUM
ct-9661	71	22	mg	mg	PROPN
ct-9661	71	23	/	/	SYM
ct-9661	71	24	kg	kg	PROPN
ct-9661	71	25	,	,	PUNCT
ct-9661	71	26	twice	twice	DET
ct-9661	71	27	a	a	DET
ct-9661	71	28	day	day	NOUN
ct-9661	71	29	,	,	PUNCT
ct-9661	71	30	a	a	DET
ct-9661	71	31	supratherapeutic	supratherapeutic	ADJ
ct-9661	71	32	dose	dose	NOUN
ct-9661	71	33	for	for	ADP
ct-9661	71	34	standard	standard	ADJ
ct-9661	71	35	antiinflammatory	antiinflammatory	NOUN
ct-9661	71	36	purposes),47	purposes),47	NOUN
ct-9661	71	37	and	and	CCONJ
ct-9661	71	38	at	at	ADP
ct-9661	71	39	therapeutic	therapeutic	ADJ
ct-9661	71	40	doses	dose	NOUN
ct-9661	71	41	of	of	ADP
ct-9661	71	42	meloxicam	meloxicam	NOUN
ct-9661	71	43	(	(	PUNCT
ct-9661	71	44	0.6	0.6	NUM
ct-9661	71	45	mg	mg	PROPN
ct-9661	71	46	/	/	SYM
ct-9661	71	47	kg	kg	PROPN
ct-9661	71	48	,	,	PUNCT
ct-9661	71	49	once	once	ADV
ct-9661	71	50	a	a	DET
ct-9661	71	51	day	day	NOUN
ct-9661	71	52	)	)	PUNCT
ct-9661	71	53	and	and	CCONJ
ct-9661	71	54	phenylbutazone	phenylbutazone	NOUN
ct-9661	71	55	(	(	PUNCT
ct-9661	71	56	4.4	4.4	NUM
ct-9661	71	57	mg	mg	PROPN
ct-9661	71	58	/	/	SYM
ct-9661	71	59	kg	kg	PROPN
ct-9661	71	60	,	,	PUNCT
ct-9661	71	61	once	once	ADV
ct-9661	71	62	a	a	DET
ct-9661	71	63	day).48	day).48	NOUN
ct-9661	71	64	in	in	ADP
ct-9661	71	65	contrast	contrast	NOUN
ct-9661	71	66	,	,	PUNCT
ct-9661	71	67	other	other	ADJ
ct-9661	71	68	projects	project	NOUN
ct-9661	71	69	involving	involve	VERB
ct-9661	71	70	flunixin	flunixin	NOUN
ct-9661	71	71	meglumine	meglumine	NOUN
ct-9661	71	72	at	at	ADP
ct-9661	71	73	therapeutic	therapeutic	ADJ
ct-9661	71	74	doses	dose	NOUN
ct-9661	71	75	(	(	PUNCT
ct-9661	71	76	1.1	1.1	NUM
ct-9661	71	77	mg	mg	NUM
ct-9661	71	78	/	/	SYM
ct-9661	71	79	kg	kg	PROPN
ct-9661	71	80	,	,	PUNCT
ct-9661	71	81	once	once	ADV
ct-9661	71	82	a	a	DET
ct-9661	71	83	day)49	day)49	NOUN
ct-9661	71	84	and	and	CCONJ
ct-9661	71	85	phenylbutazone	phenylbutazone	NOUN
ct-9661	71	86	(	(	PUNCT
ct-9661	71	87	4.4	4.4	NUM
ct-9661	71	88	mg	mg	PROPN
ct-9661	71	89	/	/	SYM
ct-9661	71	90	kg	kg	PROPN
ct-9661	71	91	,	,	PUNCT
ct-9661	71	92	once	once	ADV
ct-9661	71	93	a	a	DET
ct-9661	71	94	day)50	day)50	PROPN
ct-9661	71	95	observed	observe	VERB
ct-9661	71	96	substantial	substantial	ADJ
ct-9661	71	97	differences	difference	NOUN
ct-9661	71	98	in	in	ADP
ct-9661	71	99	ovulation	ovulation	NOUN
ct-9661	71	100	rates	rate	NOUN
ct-9661	71	101	compared	compare	VERB
ct-9661	71	102	to	to	ADP
ct-9661	71	103	placebo	placebo	NOUN
ct-9661	71	104	treated	treat	VERB
ct-9661	71	105	mares	mare	NOUN
ct-9661	71	106	.	.	PUNCT
ct-9661	72	1	the	the	DET
ct-9661	72	2	cyclooxygenase-2	cyclooxygenase-2	NUM
ct-9661	72	3	(	(	PUNCT
ct-9661	72	4	cox-2	cox-2	NOUN
ct-9661	72	5	)	)	PUNCT
ct-9661	72	6	inhibitor	inhibitor	NOUN
ct-9661	72	7	firocoxib	firocoxib	NOUN
ct-9661	72	8	is	be	AUX
ct-9661	72	9	an	an	DET
ct-9661	72	10	attractive	attractive	ADJ
ct-9661	72	11	choice	choice	NOUN
ct-9661	72	12	given	give	VERB
ct-9661	72	13	its	its	PRON
ct-9661	72	14	more	more	ADV
ct-9661	72	15	selective	selective	ADJ
ct-9661	72	16	systemic	systemic	ADJ
ct-9661	72	17	effects	effect	NOUN
ct-9661	72	18	and	and	CCONJ
ct-9661	72	19	reduced	reduced	ADJ
ct-9661	72	20	postbreeding	postbreede	VERB
ct-9661	72	21	uterine	uterine	ADJ
ct-9661	72	22	inflammation	inflammation	NOUN
ct-9661	72	23	(	(	PUNCT
ct-9661	72	24	as	as	SCONJ
ct-9661	72	25	assessed	assess	VERB
ct-9661	72	26	by	by	ADP
ct-9661	72	27	polymorphonuclear	polymorphonuclear	NOUN
ct-9661	72	28	cell	cell	NOUN
ct-9661	72	29	presence	presence	NOUN
ct-9661	72	30	on	on	ADP
ct-9661	72	31	cytology	cytology	NOUN
ct-9661	72	32	and	and	CCONJ
ct-9661	72	33	biopsy	biopsy	NOUN
ct-9661	72	34	as	as	ADV
ct-9661	72	35	well	well	ADV
ct-9661	72	36	as	as	ADP
ct-9661	72	37	endometrial	endometrial	ADJ
ct-9661	72	38	cox-2	cox-2	NOUN
ct-9661	72	39	expression	expression	NOUN
ct-9661	72	40	)	)	PUNCT
ct-9661	72	41	while	while	SCONJ
ct-9661	72	42	not	not	PART
ct-9661	72	43	negatively	negatively	ADV
ct-9661	72	44	impacting	impact	VERB
ct-9661	72	45	ovulation.51	ovulation.51	PRON
ct-9661	72	46	similar	similar	ADJ
ct-9661	72	47	promising	promising	ADJ
ct-9661	72	48	work	work	NOUN
ct-9661	72	49	from	from	ADP
ct-9661	72	50	europe	europe	PROPN
ct-9661	72	51	has	have	AUX
ct-9661	72	52	provided	provide	VERB
ct-9661	72	53	support	support	NOUN
ct-9661	72	54	for	for	ADP
ct-9661	72	55	the	the	DET
ct-9661	72	56	use	use	NOUN
ct-9661	72	57	of	of	ADP
ct-9661	72	58	the	the	DET
ct-9661	72	59	cox-2	cox-2	ADJ
ct-9661	72	60	inhibitor	inhibitor	NOUN
ct-9661	72	61	vedaprofen	vedaprofen	NOUN
ct-9661	72	62	to	to	PART
ct-9661	72	63	improve	improve	VERB
ct-9661	72	64	pregnancy	pregnancy	NOUN
ct-9661	72	65	rates	rate	NOUN
ct-9661	72	66	in	in	ADP
ct-9661	72	67	mares.52	mares.52	NOUN
ct-9661	72	68	although	although	SCONJ
ct-9661	72	69	platelet	platelet	NOUN
ct-9661	72	70	rich	rich	ADJ
ct-9661	72	71	plasma	plasma	NOUN
ct-9661	72	72	(	(	PUNCT
ct-9661	72	73	prp	prp	PROPN
ct-9661	72	74	)	)	PUNCT
ct-9661	72	75	has	have	AUX
ct-9661	72	76	been	be	AUX
ct-9661	72	77	considered	consider	VERB
ct-9661	72	78	as	as	ADP
ct-9661	72	79	a	a	DET
ct-9661	72	80	more	more	ADV
ct-9661	72	81	recent	recent	ADJ
ct-9661	72	82	therapy	therapy	NOUN
ct-9661	72	83	in	in	ADP
ct-9661	72	84	equine	equine	NOUN
ct-9661	72	85	reproductive	reproductive	ADJ
ct-9661	72	86	medicine	medicine	NOUN
ct-9661	72	87	,	,	PUNCT
ct-9661	72	88	the	the	DET
ct-9661	72	89	clinical	clinical	ADJ
ct-9661	72	90	theriogenology	theriogenology	NOUN
ct-9661	72	91	2021	2021	NUM
ct-9661	72	92	;	;	PUNCT
ct-9661	72	93	13	13	NUM
ct-9661	72	94	:	:	SYM
ct-9661	72	95	262	262	NUM
ct-9661	72	96	concept	concept	NOUN
ct-9661	72	97	originated	originate	VERB
ct-9661	72	98	from	from	ADP
ct-9661	72	99	a	a	DET
ct-9661	72	100	1940	1940	NUM
ct-9661	72	101	study	study	NOUN
ct-9661	72	102	with	with	ADP
ct-9661	72	103	frog	frog	ADJ
ct-9661	72	104	legs	leg	NOUN
ct-9661	72	105	and	and	CCONJ
ct-9661	72	106	it	it	PRON
ct-9661	72	107	was	be	AUX
ct-9661	72	108	observed	observe	VERB
ct-9661	72	109	that	that	SCONJ
ct-9661	72	110	some	some	DET
ct-9661	72	111	unknown	unknown	ADJ
ct-9661	72	112	property	property	NOUN
ct-9661	72	113	of	of	ADP
ct-9661	72	114	platelets	platelet	NOUN
ct-9661	72	115	controlled	control	VERB
ct-9661	72	116	the	the	DET
ct-9661	72	117	formation	formation	NOUN
ct-9661	72	118	of	of	ADP
ct-9661	72	119	edema.53	edema.53	NOUN
ct-9661	72	120	from	from	ADP
ct-9661	72	121	these	these	DET
ct-9661	72	122	beginnings	beginning	NOUN
ct-9661	72	123	,	,	PUNCT
ct-9661	72	124	prp	prp	PROPN
ct-9661	72	125	has	have	AUX
ct-9661	72	126	evolved	evolve	VERB
ct-9661	72	127	,	,	PUNCT
ct-9661	72	128	and	and	CCONJ
ct-9661	72	129	used	use	VERB
ct-9661	72	130	widely	widely	ADV
ct-9661	72	131	in	in	ADP
ct-9661	72	132	human	human	ADJ
ct-9661	72	133	and	and	CCONJ
ct-9661	72	134	veterinary	veterinary	ADJ
ct-9661	72	135	medicine	medicine	NOUN
ct-9661	72	136	for	for	ADP
ct-9661	72	137	a	a	DET
ct-9661	72	138	wide	wide	ADJ
ct-9661	72	139	range	range	NOUN
ct-9661	72	140	of	of	ADP
ct-9661	72	141	purposes	purpose	NOUN
ct-9661	72	142	,	,	PUNCT
ct-9661	72	143	from	from	ADP
ct-9661	72	144	musculoskeletal	musculoskeletal	ADJ
ct-9661	72	145	and	and	CCONJ
ct-9661	72	146	wound	wound	ADJ
ct-9661	72	147	healing	healing	NOUN
ct-9661	72	148	to	to	ADP
ct-9661	72	149	dentistry	dentistry	NOUN
ct-9661	72	150	and	and	CCONJ
ct-9661	72	151	reproduction	reproduction	NOUN
ct-9661	72	152	.	.	PUNCT
ct-9661	73	1	intrauterine	intrauterine	ADJ
ct-9661	73	2	infusion	infusion	NOUN
ct-9661	73	3	of	of	ADP
ct-9661	73	4	prp	prp	PROPN
ct-9661	73	5	has	have	AUX
ct-9661	73	6	modulated	modulate	VERB
ct-9661	73	7	the	the	DET
ct-9661	73	8	immune	immune	ADJ
ct-9661	73	9	response	response	NOUN
ct-9661	73	10	in	in	ADP
ct-9661	73	11	mares	mare	NOUN
ct-9661	73	12	previously	previously	ADV
ct-9661	73	13	diagnosed	diagnose	VERB
ct-9661	73	14	with	with	ADP
ct-9661	73	15	chronic	chronic	ADJ
ct-9661	73	16	degenerative	degenerative	ADJ
ct-9661	73	17	endometritis54	endometritis54	NOUN
ct-9661	73	18	and	and	CCONJ
ct-9661	73	19	improved	improve	VERB
ct-9661	73	20	pregnancy	pregnancy	NOUN
ct-9661	73	21	rates	rate	NOUN
ct-9661	73	22	in	in	ADP
ct-9661	73	23	mares	mare	NOUN
ct-9661	73	24	classified	classify	VERB
ct-9661	73	25	as	as	ADP
ct-9661	73	26	susceptible	susceptible	ADJ
ct-9661	73	27	to	to	ADP
ct-9661	73	28	persistent	persistent	ADJ
ct-9661	73	29	mating	mating	NOUN
ct-9661	73	30	induced	induce	VERB
ct-9661	73	31	endometritis.55	endometritis.55	NOUN
ct-9661	73	32	measured	measure	VERB
ct-9661	73	33	exposure	exposure	NOUN
ct-9661	73	34	to	to	ADP
ct-9661	73	35	emasculated	emasculated	ADJ
ct-9661	73	36	bacterial	bacterial	ADJ
ct-9661	73	37	products	product	NOUN
ct-9661	73	38	has	have	AUX
ct-9661	73	39	been	be	AUX
ct-9661	73	40	demonstrated	demonstrate	VERB
ct-9661	73	41	to	to	PART
ct-9661	73	42	have	have	VERB
ct-9661	73	43	positive	positive	ADJ
ct-9661	73	44	immune	immune	ADJ
ct-9661	73	45	effects	effect	NOUN
ct-9661	73	46	.	.	PUNCT
ct-9661	74	1	immune	immune	ADJ
ct-9661	74	2	stimulation	stimulation	NOUN
ct-9661	74	3	through	through	ADP
ct-9661	74	4	systemic	systemic	ADJ
ct-9661	74	5	treatment	treatment	NOUN
ct-9661	74	6	of	of	ADP
ct-9661	74	7	propionibacterium	propionibacterium	NOUN
ct-9661	74	8	acnes	acne	NOUN
ct-9661	74	9	(	(	PUNCT
ct-9661	74	10	eqstim	eqstim	PROPN
ct-9661	74	11	®	®	NOUN
ct-9661	74	12	,	,	PUNCT
ct-9661	74	13	immunovet	immunovet	PROPN
ct-9661	74	14	,	,	PUNCT
ct-9661	74	15	inc	inc	PROPN
ct-9661	74	16	.	.	PROPN
ct-9661	74	17	,	,	PUNCT
ct-9661	74	18	tampa	tampa	PROPN
ct-9661	74	19	,	,	PUNCT
ct-9661	74	20	fl	fl	PROPN
ct-9661	74	21	)	)	PUNCT
ct-9661	74	22	improved	improve	VERB
ct-9661	74	23	endometrial	endometrial	ADJ
ct-9661	74	24	cytology	cytology	NOUN
ct-9661	74	25	scores	score	NOUN
ct-9661	74	26	and	and	CCONJ
ct-9661	74	27	pregnancy	pregnancy	NOUN
ct-9661	74	28	rates	rate	NOUN
ct-9661	74	29	in	in	ADP
ct-9661	74	30	barren	barren	ADJ
ct-9661	74	31	mares.56,57	mares.56,57	NOUN
ct-9661	74	32	recently	recently	ADV
ct-9661	74	33	,	,	PUNCT
ct-9661	74	34	mares	mare	NOUN
ct-9661	74	35	were	be	AUX
ct-9661	74	36	inseminated	inseminate	VERB
ct-9661	74	37	and	and	CCONJ
ct-9661	74	38	treated	treat	VERB
ct-9661	74	39	intravenously	intravenously	ADV
ct-9661	74	40	with	with	ADP
ct-9661	74	41	either	either	CCONJ
ct-9661	74	42	dexamethasone	dexamethasone	NOUN
ct-9661	74	43	(	(	PUNCT
ct-9661	74	44	50	50	NUM
ct-9661	74	45	mg	mg	NOUN
ct-9661	74	46	at	at	ADP
ct-9661	74	47	insemination	insemination	NOUN
ct-9661	74	48	)	)	PUNCT
ct-9661	74	49	or	or	CCONJ
ct-9661	74	50	mycobacterial	mycobacterial	ADJ
ct-9661	74	51	cell	cell	NOUN
ct-9661	74	52	wall	wall	NOUN
ct-9661	74	53	extract	extract	NOUN
ct-9661	74	54	(	(	PUNCT
ct-9661	74	55	mcwe	mcwe	NOUN
ct-9661	74	56	,	,	PUNCT
ct-9661	74	57	settle	settle	NOUN
ct-9661	74	58	®	®	NOUN
ct-9661	74	59	,	,	PUNCT
ct-9661	74	60	novavive	novavive	PROPN
ct-9661	74	61	,	,	PUNCT
ct-9661	74	62	ontario	ontario	PROPN
ct-9661	74	63	,	,	PUNCT
ct-9661	74	64	canada	canada	PROPN
ct-9661	74	65	,	,	PUNCT
ct-9661	74	66	1.5	1.5	NUM
ct-9661	74	67	mg	mg	NOUN
ct-9661	74	68	,	,	PUNCT
ct-9661	74	69	at	at	ADP
ct-9661	74	70	24	24	NUM
ct-9661	74	71	hours	hour	NOUN
ct-9661	74	72	prior	prior	ADV
ct-9661	74	73	to	to	ADP
ct-9661	74	74	insemination	insemination	NOUN
ct-9661	74	75	)	)	PUNCT
ct-9661	74	76	.	.	PUNCT
ct-9661	75	1	nitric	nitric	ADJ
ct-9661	75	2	oxide	oxide	NOUN
ct-9661	75	3	concentrations	concentration	NOUN
ct-9661	75	4	in	in	ADP
ct-9661	75	5	uterine	uterine	ADJ
ct-9661	75	6	secretions	secretion	NOUN
ct-9661	75	7	and	and	CCONJ
ct-9661	75	8	inflammatory	inflammatory	ADJ
ct-9661	75	9	cytokine	cytokine	ADJ
ct-9661	75	10	presence	presence	NOUN
ct-9661	75	11	in	in	ADP
ct-9661	75	12	uterine	uterine	ADJ
ct-9661	75	13	biopsy	biopsy	NOUN
ct-9661	75	14	samples	sample	NOUN
ct-9661	75	15	(	(	PUNCT
ct-9661	75	16	collected	collect	VERB
ct-9661	75	17	6	6	NUM
ct-9661	75	18	hours	hour	NOUN
ct-9661	75	19	after	after	ADP
ct-9661	75	20	insemination	insemination	NOUN
ct-9661	75	21	)	)	PUNCT
ct-9661	75	22	were	be	AUX
ct-9661	75	23	used	use	VERB
ct-9661	75	24	as	as	ADP
ct-9661	75	25	end	end	NOUN
ct-9661	75	26	points	point	NOUN
ct-9661	75	27	for	for	ADP
ct-9661	75	28	assessing	assess	VERB
ct-9661	75	29	uterine	uterine	ADJ
ct-9661	75	30	inflammatory	inflammatory	ADJ
ct-9661	75	31	response	response	NOUN
ct-9661	75	32	.	.	PUNCT
ct-9661	76	1	mares	mare	NOUN
ct-9661	76	2	treated	treat	VERB
ct-9661	76	3	with	with	ADP
ct-9661	76	4	mcwe	mcwe	NOUN
ct-9661	76	5	had	have	VERB
ct-9661	76	6	lower	low	ADJ
ct-9661	76	7	nitric	nitric	ADJ
ct-9661	76	8	oxide	oxide	NOUN
ct-9661	76	9	concentrations	concentration	NOUN
ct-9661	76	10	in	in	ADP
ct-9661	76	11	uterine	uterine	ADJ
ct-9661	76	12	secretions	secretion	NOUN
ct-9661	76	13	than	than	ADP
ct-9661	76	14	untreated	untreated	ADJ
ct-9661	76	15	mares	mare	NOUN
ct-9661	76	16	or	or	CCONJ
ct-9661	76	17	mares	mare	NOUN
ct-9661	76	18	treated	treat	VERB
ct-9661	76	19	with	with	ADP
ct-9661	76	20	dexamethasone.58	dexamethasone.58	ADJ
ct-9661	76	21	conclusion	conclusion	NOUN
ct-9661	76	22	historical	historical	ADJ
ct-9661	76	23	and	and	CCONJ
ct-9661	76	24	ongoing	ongoing	ADJ
ct-9661	76	25	research	research	NOUN
ct-9661	76	26	have	have	AUX
ct-9661	76	27	identified	identify	VERB
ct-9661	76	28	several	several	ADJ
ct-9661	76	29	products	product	NOUN
ct-9661	76	30	and	and	CCONJ
ct-9661	76	31	techniques	technique	NOUN
ct-9661	76	32	that	that	PRON
ct-9661	76	33	have	have	VERB
ct-9661	76	34	the	the	DET
ct-9661	76	35	potential	potential	NOUN
ct-9661	76	36	to	to	PART
ct-9661	76	37	aid	aid	VERB
ct-9661	76	38	in	in	ADP
ct-9661	76	39	the	the	DET
ct-9661	76	40	resolution	resolution	NOUN
ct-9661	76	41	of	of	ADP
ct-9661	76	42	endometritis	endometritis	NOUN
ct-9661	76	43	.	.	PUNCT
ct-9661	77	1	when	when	SCONJ
ct-9661	77	2	approaching	approach	VERB
ct-9661	77	3	this	this	DET
ct-9661	77	4	ever	ever	ADV
ct-9661	77	5	-	-	PUNCT
ct-9661	77	6	expanding	expand	VERB
ct-9661	77	7	‘	'	PUNCT
ct-9661	77	8	pantry	pantry	NOUN
ct-9661	77	9	of	of	ADP
ct-9661	77	10	options	option	NOUN
ct-9661	77	11	’	'	PUNCT
ct-9661	77	12	,	,	PUNCT
ct-9661	77	13	a	a	DET
ct-9661	77	14	strategic	strategic	ADJ
ct-9661	77	15	approach	approach	NOUN
ct-9661	77	16	rooted	root	VERB
ct-9661	77	17	in	in	ADP
ct-9661	77	18	fundamentals	fundamental	NOUN
ct-9661	77	19	is	be	AUX
ct-9661	77	20	advised	advise	VERB
ct-9661	77	21	.	.	PUNCT
ct-9661	78	1	critical	critical	ADJ
ct-9661	78	2	consideration	consideration	NOUN
ct-9661	78	3	of	of	ADP
ct-9661	78	4	why	why	SCONJ
ct-9661	78	5	a	a	DET
ct-9661	78	6	mare	mare	NOUN
ct-9661	78	7	is	be	AUX
ct-9661	78	8	‘	'	PUNCT
ct-9661	78	9	dirty	dirty	ADJ
ct-9661	78	10	’	'	PUNCT
ct-9661	78	11	or	or	CCONJ
ct-9661	78	12	‘	'	PUNCT
ct-9661	78	13	problematic	problematic	ADJ
ct-9661	78	14	’	'	PUNCT
ct-9661	78	15	will	will	AUX
ct-9661	78	16	provide	provide	VERB
ct-9661	78	17	a	a	DET
ct-9661	78	18	blueprint	blueprint	NOUN
ct-9661	78	19	for	for	ADP
ct-9661	78	20	addressing	address	VERB
ct-9661	78	21	underlying	underlying	ADJ
ct-9661	78	22	factors	factor	NOUN
ct-9661	78	23	and	and	CCONJ
ct-9661	78	24	primary	primary	ADJ
ct-9661	78	25	endometritis	endometritis	NOUN
ct-9661	78	26	.	.	PUNCT
ct-9661	79	1	conflict	conflict	NOUN
ct-9661	79	2	of	of	ADP
ct-9661	79	3	interest	interest	NOUN
ct-9661	79	4	there	there	PRON
ct-9661	79	5	are	be	VERB
ct-9661	79	6	no	no	DET
ct-9661	79	7	conflicts	conflict	NOUN
ct-9661	79	8	of	of	ADP
ct-9661	79	9	interest	interest	NOUN
ct-9661	79	10	to	to	PART
ct-9661	79	11	declare	declare	VERB
ct-9661	79	12	.	.	PUNCT
ct-9661	80	1	references	reference	NOUN
ct-9661	80	2	1	1	NUM
ct-9661	80	3	.	.	PUNCT
ct-9661	81	1	leblanc	leblanc	PROPN
ct-9661	81	2	mm	mm	PROPN
ct-9661	81	3	,	,	PUNCT
ct-9661	81	4	neuwirth	neuwirth	PROPN
ct-9661	81	5	l	l	PROPN
ct-9661	81	6	,	,	PUNCT
ct-9661	81	7	jones	jones	PROPN
ct-9661	81	8	l	l	PROPN
ct-9661	81	9	,	,	PUNCT
ct-9661	81	10	et	et	PROPN
ct-9661	81	11	al	al	PROPN
ct-9661	81	12	:	:	PUNCT
ct-9661	81	13	differences	difference	NOUN
ct-9661	81	14	in	in	ADP
ct-9661	81	15	uterine	uterine	ADJ
ct-9661	81	16	position	position	NOUN
ct-9661	81	17	of	of	ADP
ct-9661	81	18	reproductively	reproductively	ADV
ct-9661	81	19	normal	normal	ADJ
ct-9661	81	20	mares	mare	NOUN
ct-9661	81	21	and	and	CCONJ
ct-9661	81	22	those	those	PRON
ct-9661	81	23	with	with	ADP
ct-9661	81	24	delayed	delay	VERB
ct-9661	81	25	uterine	uterine	ADJ
ct-9661	81	26	clearance	clearance	NOUN
ct-9661	81	27	detected	detect	VERB
ct-9661	81	28	by	by	ADP
ct-9661	81	29	scintigraphy	scintigraphy	NOUN
ct-9661	81	30	.	.	PUNCT
ct-9661	82	1	theriogenology	theriogenology	NOUN
ct-9661	82	2	1998;50:49	1998;50:49	NUM
ct-9661	82	3	-	-	SYM
ct-9661	82	4	54	54	NUM
ct-9661	82	5	.	.	PUNCT
ct-9661	83	1	2	2	X
ct-9661	83	2	.	.	X
ct-9661	83	3	caslick	caslick	PROPN
ct-9661	83	4	ea	ea	PROPN
ct-9661	83	5	:	:	PUNCT
ct-9661	83	6	the	the	DET
ct-9661	83	7	vulva	vulva	NOUN
ct-9661	83	8	and	and	CCONJ
ct-9661	83	9	the	the	DET
ct-9661	83	10	vulvo	vulvo	NOUN
ct-9661	83	11	-	-	PUNCT
ct-9661	83	12	vaginal	vaginal	ADJ
ct-9661	83	13	orifice	orifice	NOUN
ct-9661	83	14	and	and	CCONJ
ct-9661	83	15	its	its	PRON
ct-9661	83	16	relation	relation	NOUN
ct-9661	83	17	to	to	ADP
ct-9661	83	18	genital	genital	ADJ
ct-9661	83	19	health	health	NOUN
ct-9661	83	20	of	of	ADP
ct-9661	83	21	the	the	DET
ct-9661	83	22	thoroughbred	thoroughbred	ADJ
ct-9661	83	23	mare	mare	NOUN
ct-9661	83	24	.	.	PUNCT
ct-9661	84	1	cornell	cornell	PROPN
ct-9661	84	2	vet	vet	NOUN
ct-9661	84	3	1937;27:178	1937;27:178	NUM
ct-9661	84	4	-	-	NUM
ct-9661	84	5	187	187	NUM
ct-9661	84	6	.	.	PUNCT
ct-9661	85	1	3	3	X
ct-9661	85	2	.	.	X
ct-9661	85	3	watson	watson	PROPN
ct-9661	85	4	ed	ed	NOUN
ct-9661	85	5	:	:	PUNCT
ct-9661	85	6	post	post	ADJ
ct-9661	85	7	-	-	ADJ
ct-9661	85	8	breeding	breeding	ADJ
ct-9661	85	9	endometritis	endometritis	NOUN
ct-9661	85	10	in	in	ADP
ct-9661	85	11	the	the	DET
ct-9661	85	12	mare	mare	NOUN
ct-9661	85	13	:	:	PUNCT
ct-9661	85	14	anim	anim	NOUN
ct-9661	85	15	reprod	reprod	PROPN
ct-9661	85	16	sci	sci	PROPN
ct-9661	85	17	2000;60	2000;60	NUM
ct-9661	85	18	-	-	PUNCT
ct-9661	85	19	61:221	61:221	NUM
ct-9661	85	20	-	-	PUNCT
ct-9661	85	21	232	232	NUM
ct-9661	85	22	.	.	NOUN
ct-9661	86	1	4	4	NUM
ct-9661	86	2	.	.	PUNCT
ct-9661	86	3	leblanc	leblanc	PROPN
ct-9661	86	4	m	m	PROPN
ct-9661	86	5	,	,	PUNCT
ct-9661	86	6	neuwirth	neuwirth	PROPN
ct-9661	86	7	l	l	PROPN
ct-9661	86	8	,	,	PUNCT
ct-9661	86	9	mauragis	mauragis	PROPN
ct-9661	86	10	d	d	PROPN
ct-9661	86	11	,	,	PUNCT
ct-9661	86	12	et	et	PROPN
ct-9661	86	13	al	al	PROPN
ct-9661	86	14	:	:	PUNCT
ct-9661	86	15	oxytocin	oxytocin	NOUN
ct-9661	86	16	enhances	enhance	VERB
ct-9661	86	17	clearance	clearance	NOUN
ct-9661	86	18	of	of	ADP
ct-9661	86	19	radiocolloid	radiocolloid	NOUN
ct-9661	86	20	from	from	ADP
ct-9661	86	21	the	the	DET
ct-9661	86	22	uterine	uterine	ADJ
ct-9661	86	23	lumen	luman	NOUN
ct-9661	86	24	of	of	ADP
ct-9661	86	25	reproductively	reproductively	ADV
ct-9661	86	26	normal	normal	ADJ
ct-9661	86	27	mares	mare	NOUN
ct-9661	86	28	and	and	CCONJ
ct-9661	86	29	mares	mare	NOUN
ct-9661	86	30	susceptible	susceptible	ADJ
ct-9661	86	31	to	to	ADP
ct-9661	86	32	endometritis	endometritis	PROPN
ct-9661	86	33	.	.	PUNCT
ct-9661	87	1	equine	equine	PROPN
ct-9661	87	2	vet	vet	NOUN
ct-9661	87	3	j	j	PROPN
ct-9661	87	4	1994;26:279	1994;26:279	NUM
ct-9661	87	5	-	-	SYM
ct-9661	87	6	282	282	NUM
ct-9661	87	7	.	.	PUNCT
ct-9661	88	1	5	5	NUM
ct-9661	88	2	.	.	X
ct-9661	88	3	troedsson	troedsson	PROPN
ct-9661	88	4	mh	mh	PROPN
ct-9661	88	5	,	,	PUNCT
ct-9661	88	6	liu	liu	PROPN
ct-9661	88	7	ik	ik	PROPN
ct-9661	88	8	,	,	PUNCT
ct-9661	88	9	ing	ing	NOUN
ct-9661	88	10	m	m	PROPN
ct-9661	88	11	,	,	PUNCT
ct-9661	88	12	et	et	PROPN
ct-9661	88	13	al	al	PROPN
ct-9661	88	14	:	:	PUNCT
ct-9661	88	15	multiple	multiple	ADJ
ct-9661	88	16	site	site	NOUN
ct-9661	88	17	electromyography	electromyography	NOUN
ct-9661	88	18	recordings	recording	NOUN
ct-9661	88	19	of	of	ADP
ct-9661	88	20	uterine	uterine	ADJ
ct-9661	88	21	activity	activity	NOUN
ct-9661	88	22	following	follow	VERB
ct-9661	88	23	an	an	DET
ct-9661	88	24	intrauterine	intrauterine	ADJ
ct-9661	88	25	bacterial	bacterial	ADJ
ct-9661	88	26	challenge	challenge	NOUN
ct-9661	88	27	in	in	ADP
ct-9661	88	28	mares	mare	NOUN
ct-9661	88	29	susceptible	susceptible	ADJ
ct-9661	88	30	and	and	CCONJ
ct-9661	88	31	resistant	resistant	ADJ
ct-9661	88	32	to	to	ADP
ct-9661	88	33	chronic	chronic	VERB
ct-9661	88	34	uterine	uterine	ADJ
ct-9661	88	35	infection	infection	NOUN
ct-9661	88	36	.	.	PUNCT
ct-9661	89	1	j	j	PROPN
ct-9661	89	2	reprod	reprod	PROPN
ct-9661	89	3	fertil	fertil	VERB
ct-9661	89	4	1993;99:307	1993;99:307	NUM
ct-9661	89	5	-	-	SYM
ct-9661	89	6	313	313	NUM
ct-9661	89	7	.	.	NOUN
ct-9661	90	1	6	6	NUM
ct-9661	90	2	.	.	X
ct-9661	90	3	evans	evans	PROPN
ct-9661	90	4	mj	mj	PROPN
ct-9661	90	5	,	,	PUNCT
ct-9661	90	6	hamer	hamer	PROPN
ct-9661	90	7	jm	jm	PROPN
ct-9661	90	8	,	,	PUNCT
ct-9661	90	9	gason	gason	PROPN
ct-9661	90	10	lm	lm	PROPN
ct-9661	90	11	,	,	PUNCT
ct-9661	90	12	et	et	PROPN
ct-9661	90	13	al	al	PROPN
ct-9661	90	14	:	:	PUNCT
ct-9661	90	15	clearance	clearance	NOUN
ct-9661	90	16	of	of	ADP
ct-9661	90	17	bacteria	bacteria	NOUN
ct-9661	90	18	and	and	CCONJ
ct-9661	90	19	non	non	ADJ
ct-9661	90	20	-	-	ADJ
ct-9661	90	21	antigenic	antigenic	ADJ
ct-9661	90	22	markers	marker	NOUN
ct-9661	90	23	following	follow	VERB
ct-9661	90	24	intra	intra	ADJ
ct-9661	90	25	-	-	ADJ
ct-9661	90	26	uterine	uterine	ADJ
ct-9661	90	27	inoculation	inoculation	NOUN
ct-9661	90	28	into	into	ADP
ct-9661	90	29	maiden	maiden	ADJ
ct-9661	90	30	mares	mare	NOUN
ct-9661	90	31	:	:	PUNCT
ct-9661	90	32	effect	effect	NOUN
ct-9661	90	33	of	of	ADP
ct-9661	90	34	steroid	steroid	NOUN
ct-9661	90	35	hormone	hormone	NOUN
ct-9661	90	36	environment	environment	NOUN
ct-9661	90	37	.	.	PUNCT
ct-9661	91	1	theriogenology	theriogenology	NOUN
ct-9661	91	2	1986;26:37	1986;26:37	PROPN
ct-9661	91	3	-	-	SYM
ct-9661	91	4	50	50	NUM
ct-9661	91	5	.	.	PUNCT
ct-9661	91	6	7	7	X
ct-9661	91	7	.	.	PUNCT
ct-9661	91	8	leblanc	leblanc	PROPN
ct-9661	91	9	m	m	PROPN
ct-9661	91	10	,	,	PUNCT
ct-9661	91	11	johnson	johnson	PROPN
ct-9661	91	12	r	r	PROPN
ct-9661	91	13	,	,	PUNCT
ct-9661	91	14	calderwood	calderwood	PROPN
ct-9661	91	15	mays	mays	PROPN
ct-9661	91	16	m	m	PROPN
ct-9661	91	17	,	,	PUNCT
ct-9661	91	18	et	et	PROPN
ct-9661	91	19	al	al	PROPN
ct-9661	91	20	:	:	PUNCT
ct-9661	91	21	lymphatic	lymphatic	ADJ
ct-9661	91	22	clearance	clearance	NOUN
ct-9661	91	23	of	of	ADP
ct-9661	91	24	india	india	PROPN
ct-9661	91	25	ink	ink	NOUN
ct-9661	91	26	in	in	ADP
ct-9661	91	27	reproductively	reproductively	ADV
ct-9661	91	28	normal	normal	ADJ
ct-9661	91	29	mares	mare	NOUN
ct-9661	91	30	and	and	CCONJ
ct-9661	91	31	mares	mare	NOUN
ct-9661	91	32	susceptible	susceptible	ADJ
ct-9661	91	33	to	to	ADP
ct-9661	91	34	endometritis	endometritis	PROPN
ct-9661	91	35	.	.	PUNCT
ct-9661	92	1	biol	biol	PROPN
ct-9661	92	2	of	of	ADP
ct-9661	92	3	reprod	reprod	PROPN
ct-9661	92	4	monograph	monograph	PROPN
ct-9661	92	5	1995;1:501	1995;1:501	PROPN
ct-9661	92	6	-	-	SYM
ct-9661	92	7	506	506	NUM
ct-9661	92	8	.	.	NOUN
ct-9661	92	9	8	8	NUM
ct-9661	92	10	.	.	PUNCT
ct-9661	93	1	morresey	morresey	NOUN
ct-9661	93	2	p	p	X
ct-9661	93	3	,	,	PUNCT
ct-9661	93	4	causey	causey	PROPN
ct-9661	93	5	r	r	PROPN
ct-9661	93	6	,	,	PUNCT
ct-9661	93	7	leblanc	leblanc	PROPN
ct-9661	93	8	m	m	PRON
ct-9661	93	9	:	:	PUNCT
ct-9661	93	10	scanning	scan	VERB
ct-9661	93	11	electron	electron	NOUN
ct-9661	93	12	microscopy	microscopy	NOUN
ct-9661	93	13	of	of	ADP
ct-9661	93	14	ciliated	ciliated	ADJ
ct-9661	93	15	endometrial	endometrial	ADJ
ct-9661	93	16	cells	cell	NOUN
ct-9661	93	17	from	from	ADP
ct-9661	93	18	reproductively	reproductively	ADV
ct-9661	93	19	normal	normal	ADJ
ct-9661	93	20	mares	mare	NOUN
ct-9661	93	21	and	and	CCONJ
ct-9661	93	22	from	from	ADP
ct-9661	93	23	mares	mare	NOUN
ct-9661	93	24	with	with	ADP
ct-9661	93	25	delayed	delay	VERB
ct-9661	93	26	uterine	uterine	ADJ
ct-9661	93	27	clearance	clearance	NOUN
ct-9661	93	28	.	.	PUNCT
ct-9661	94	1	anim	anim	PROPN
ct-9661	94	2	reprod	reprod	PROPN
ct-9661	94	3	sci	sci	PROPN
ct-9661	94	4	2010;121(1	2010;121(1	PROPN
ct-9661	94	5	-	-	PUNCT
ct-9661	94	6	2	2	NUM
ct-9661	94	7	,	,	PUNCT
ct-9661	94	8	supplement):94	supplement):94	PROPN
ct-9661	94	9	-	-	PUNCT
ct-9661	94	10	95	95	NUM
ct-9661	94	11	.	.	PUNCT
ct-9661	95	1	9	9	NUM
ct-9661	95	2	.	.	X
ct-9661	95	3	causey	causey	PROPN
ct-9661	95	4	rc	rc	PROPN
ct-9661	95	5	:	:	PUNCT
ct-9661	95	6	mucus	mucus	NOUN
ct-9661	95	7	and	and	CCONJ
ct-9661	95	8	the	the	DET
ct-9661	95	9	mare	mare	NOUN
ct-9661	95	10	:	:	PUNCT
ct-9661	95	11	how	how	SCONJ
ct-9661	95	12	little	little	ADJ
ct-9661	95	13	we	we	PRON
ct-9661	95	14	know	know	VERB
ct-9661	95	15	.	.	PUNCT
ct-9661	96	1	theriogenology	theriogenology	NOUN
ct-9661	96	2	2007;68:386	2007;68:386	PROPN
ct-9661	96	3	-	-	SYM
ct-9661	96	4	394	394	NUM
ct-9661	96	5	.	.	NOUN
ct-9661	96	6	10	10	NUM
ct-9661	96	7	.	.	PUNCT
ct-9661	97	1	watson	watson	PROPN
ct-9661	97	2	ed	ed	PROPN
ct-9661	97	3	,	,	PUNCT
ct-9661	97	4	stokes	stokes	PROPN
ct-9661	97	5	cr	cr	PROPN
ct-9661	97	6	,	,	PUNCT
ct-9661	97	7	bourne	bourne	NOUN
ct-9661	97	8	fj	fj	PROPN
ct-9661	97	9	:	:	PUNCT
ct-9661	97	10	cellular	cellular	ADJ
ct-9661	97	11	and	and	CCONJ
ct-9661	97	12	humoral	humoral	ADJ
ct-9661	97	13	defence	defence	NOUN
ct-9661	97	14	mechanisms	mechanism	NOUN
ct-9661	97	15	in	in	ADP
ct-9661	97	16	mares	mare	NOUN
ct-9661	97	17	susceptible	susceptible	ADJ
ct-9661	97	18	and	and	CCONJ
ct-9661	97	19	resistant	resistant	ADJ
ct-9661	97	20	to	to	ADP
ct-9661	97	21	persistent	persistent	ADJ
ct-9661	97	22	endometritis	endometritis	NOUN
ct-9661	97	23	.	.	PUNCT
ct-9661	98	1	vet	vet	NOUN
ct-9661	98	2	immunol	immunol	NOUN
ct-9661	98	3	immunopathol	immunopathol	PROPN
ct-9661	98	4	1987;16:107	1987;16:107	PROPN
ct-9661	98	5	-	-	SYM
ct-9661	98	6	121	121	NUM
ct-9661	98	7	.	.	PUNCT
ct-9661	98	8	11	11	NUM
ct-9661	98	9	.	.	PUNCT
ct-9661	99	1	morris	morris	PROPN
ct-9661	99	2	lha	lha	PROPN
ct-9661	99	3	,	,	PUNCT
ct-9661	99	4	mccue	mccue	PROPN
ct-9661	99	5	pm	pm	PROPN
ct-9661	99	6	,	,	PUNCT
ct-9661	99	7	aurich	aurich	PROPN
ct-9661	99	8	c	c	AUX
ct-9661	99	9	:	:	PUNCT
ct-9661	99	10	equine	equine	PROPN
ct-9661	99	11	endometritis	endometritis	NOUN
ct-9661	99	12	:	:	PUNCT
ct-9661	99	13	a	a	DET
ct-9661	99	14	review	review	NOUN
ct-9661	99	15	of	of	ADP
ct-9661	99	16	challenges	challenge	NOUN
ct-9661	99	17	and	and	CCONJ
ct-9661	99	18	new	new	ADJ
ct-9661	99	19	approaches	approach	NOUN
ct-9661	99	20	.	.	PUNCT
ct-9661	100	1	reproduction	reproduction	NOUN
ct-9661	100	2	2020;160	2020;160	NOUN
ct-9661	100	3	:	:	PUNCT
ct-9661	100	4	r95	r95	VERB
ct-9661	100	5	-	-	PUNCT
ct-9661	100	6	110	110	NUM
ct-9661	100	7	.	.	PUNCT
ct-9661	101	1	12	12	NUM
ct-9661	101	2	.	.	PUNCT
ct-9661	102	1	troedsson	troedsson	PROPN
ct-9661	102	2	mht	mht	PROPN
ct-9661	102	3	,	,	PUNCT
ct-9661	102	4	nielsen	nielsen	PROPN
ct-9661	102	5	jm	jm	PROPN
ct-9661	102	6	:	:	PUNCT
ct-9661	102	7	non	non	ADJ
ct-9661	102	8	-	-	ADJ
ct-9661	102	9	antibiotic	antibiotic	ADJ
ct-9661	102	10	treatment	treatment	NOUN
ct-9661	102	11	of	of	ADP
ct-9661	102	12	equine	equine	NOUN
ct-9661	102	13	endometritis	endometritis	NOUN
ct-9661	102	14	.	.	PUNCT
ct-9661	103	1	pferdeheilkunde	pferdeheilkunde	PROPN
ct-9661	103	2	2018;34:17	2018;34:17	NUM
ct-9661	103	3	-	-	SYM
ct-9661	103	4	22	22	NUM
ct-9661	103	5	.	.	PUNCT
ct-9661	104	1	13	13	NUM
ct-9661	104	2	.	.	PUNCT
ct-9661	105	1	mcfarlane	mcfarlane	PROPN
ct-9661	105	2	d	d	PROPN
ct-9661	105	3	,	,	PUNCT
ct-9661	105	4	hill	hill	PROPN
ct-9661	105	5	k	k	PROPN
ct-9661	105	6	,	,	PUNCT
ct-9661	105	7	anton	anton	PROPN
ct-9661	105	8	j	j	PROPN
ct-9661	105	9	:	:	PUNCT
ct-9661	105	10	neutrophil	neutrophil	ADJ
ct-9661	105	11	function	function	NOUN
ct-9661	105	12	in	in	ADP
ct-9661	105	13	healthy	healthy	ADJ
ct-9661	105	14	aged	aged	ADJ
ct-9661	105	15	horses	horse	NOUN
ct-9661	105	16	and	and	CCONJ
ct-9661	105	17	horses	horse	NOUN
ct-9661	105	18	with	with	ADP
ct-9661	105	19	pituitary	pituitary	ADJ
ct-9661	105	20	dysfunction	dysfunction	NOUN
ct-9661	105	21	.	.	PUNCT
ct-9661	106	1	vet	vet	NOUN
ct-9661	106	2	immunol	immunol	NOUN
ct-9661	106	3	immunopathol	immunopathol	PROPN
ct-9661	106	4	2015;165:99	2015;165:99	NUM
ct-9661	106	5	-	-	SYM
ct-9661	106	6	106	106	NUM
ct-9661	106	7	.	.	PUNCT
ct-9661	106	8	14	14	NUM
ct-9661	106	9	.	.	PUNCT
ct-9661	107	1	schöniger	schöniger	PROPN
ct-9661	107	2	s	s	PROPN
ct-9661	107	3	,	,	PUNCT
ct-9661	107	4	schoon	schoon	PROPN
ct-9661	107	5	ha	ha	NOUN
ct-9661	107	6	:	:	PUNCT
ct-9661	107	7	the	the	DET
ct-9661	107	8	healthy	healthy	ADJ
ct-9661	107	9	and	and	CCONJ
ct-9661	107	10	diseased	diseased	ADJ
ct-9661	107	11	equine	equine	NOUN
ct-9661	107	12	endometrium	endometrium	NOUN
ct-9661	107	13	:	:	PUNCT
ct-9661	107	14	a	a	DET
ct-9661	107	15	review	review	NOUN
ct-9661	107	16	of	of	ADP
ct-9661	107	17	morphological	morphological	ADJ
ct-9661	107	18	features	feature	NOUN
ct-9661	107	19	and	and	CCONJ
ct-9661	107	20	molecular	molecular	ADJ
ct-9661	107	21	analyses	analysis	NOUN
ct-9661	107	22	.	.	PUNCT
ct-9661	108	1	animals	animal	NOUN
ct-9661	108	2	2020;10:1	2020;10:1	NUM
ct-9661	108	3	-	-	SYM
ct-9661	108	4	2	2	NUM
ct-9661	108	5	.	.	NOUN
ct-9661	108	6	15	15	NUM
ct-9661	108	7	.	.	PUNCT
ct-9661	109	1	troedsson	troedsson	PROPN
ct-9661	109	2	mh	mh	PROPN
ct-9661	109	3	,	,	PUNCT
ct-9661	109	4	scott	scott	PROPN
ct-9661	109	5	ma	ma	PROPN
ct-9661	109	6	,	,	PUNCT
ct-9661	109	7	liu	liu	PROPN
ct-9661	109	8	ik	ik	PROPN
ct-9661	109	9	:	:	PUNCT
ct-9661	109	10	comparative	comparative	ADJ
ct-9661	109	11	treatment	treatment	NOUN
ct-9661	109	12	of	of	ADP
ct-9661	109	13	mares	mare	NOUN
ct-9661	109	14	susceptible	susceptible	ADJ
ct-9661	109	15	to	to	ADP
ct-9661	109	16	chronic	chronic	ADJ
ct-9661	109	17	uterine	uterine	ADJ
ct-9661	109	18	infection	infection	NOUN
ct-9661	109	19	.	.	PUNCT
ct-9661	110	1	am	be	AUX
ct-9661	110	2	j	j	PROPN
ct-9661	110	3	vet	vet	NOUN
ct-9661	110	4	res	re	NOUN
ct-9661	110	5	1995;56:468	1995;56:468	NUM
ct-9661	110	6	-	-	SYM
ct-9661	110	7	472	472	NUM
ct-9661	110	8	.	.	PUNCT
ct-9661	111	1	16	16	NUM
ct-9661	111	2	.	.	X
ct-9661	111	3	brinsko	brinsko	PROPN
ct-9661	111	4	sp	sp	PROPN
ct-9661	111	5	,	,	PUNCT
ct-9661	111	6	varner	varner	PROPN
ct-9661	111	7	dd	dd	PROPN
ct-9661	111	8	,	,	PUNCT
ct-9661	111	9	blanchard	blanchard	PROPN
ct-9661	111	10	tl	tl	PROPN
ct-9661	111	11	,	,	PUNCT
ct-9661	111	12	et	et	PROPN
ct-9661	111	13	al	al	PROPN
ct-9661	111	14	:	:	PUNCT
ct-9661	111	15	the	the	DET
ct-9661	111	16	effect	effect	NOUN
ct-9661	111	17	of	of	ADP
ct-9661	111	18	postbreeding	postbreede	VERB
ct-9661	111	19	uterine	uterine	ADJ
ct-9661	111	20	lavage	lavage	NOUN
ct-9661	111	21	on	on	ADP
ct-9661	111	22	pregnancy	pregnancy	NOUN
ct-9661	111	23	rate	rate	NOUN
ct-9661	111	24	in	in	ADP
ct-9661	111	25	mares	mare	NOUN
ct-9661	111	26	.	.	PUNCT
ct-9661	112	1	theriogenology	theriogenology	NOUN
ct-9661	112	2	1990;33:465	1990;33:465	PROPN
ct-9661	112	3	-	-	SYM
ct-9661	112	4	475	475	NUM
ct-9661	112	5	17	17	NUM
ct-9661	112	6	.	.	PUNCT
ct-9661	112	7	brinsko	brinsko	PROPN
ct-9661	112	8	sp	sp	PROPN
ct-9661	112	9	,	,	PUNCT
ct-9661	112	10	varner	varner	PROPN
ct-9661	112	11	dd	dd	PROPN
ct-9661	112	12	,	,	PUNCT
ct-9661	112	13	blanchard	blanchard	PROPN
ct-9661	112	14	tl	tl	PROPN
ct-9661	112	15	:	:	PUNCT
ct-9661	112	16	the	the	DET
ct-9661	112	17	effect	effect	NOUN
ct-9661	112	18	of	of	ADP
ct-9661	112	19	uterine	uterine	ADJ
ct-9661	112	20	lavage	lavage	NOUN
ct-9661	112	21	performed	perform	VERB
ct-9661	112	22	four	four	NUM
ct-9661	112	23	hours	hour	NOUN
ct-9661	112	24	post	post	NOUN
ct-9661	112	25	insemination	insemination	NOUN
ct-9661	112	26	on	on	ADP
ct-9661	112	27	pregnancy	pregnancy	NOUN
ct-9661	112	28	rate	rate	NOUN
ct-9661	112	29	in	in	ADP
ct-9661	112	30	mares	mare	NOUN
ct-9661	112	31	.	.	PUNCT
ct-9661	113	1	theriogenology	theriogenology	NOUN
ct-9661	113	2	1991;35:1111	1991;35:1111	NUM
ct-9661	113	3	-	-	SYM
ct-9661	113	4	1119	1119	NUM
ct-9661	113	5	.	.	PUNCT
ct-9661	114	1	18	18	NUM
ct-9661	114	2	.	.	PUNCT
ct-9661	114	3	knutti	knutti	PROPN
ct-9661	114	4	b	b	PROPN
ct-9661	114	5	,	,	PUNCT
ct-9661	114	6	pycock	pycock	PROPN
ct-9661	114	7	jf	jf	PROPN
ct-9661	114	8	,	,	PUNCT
ct-9661	114	9	van	van	PROPN
ct-9661	114	10	der	der	PROPN
ct-9661	114	11	weijden	weijden	PROPN
ct-9661	114	12	gc	gc	PROPN
ct-9661	114	13	,	,	PUNCT
ct-9661	114	14	et	et	PROPN
ct-9661	114	15	al	al	PROPN
ct-9661	114	16	:	:	PUNCT
ct-9661	114	17	the	the	DET
ct-9661	114	18	influence	influence	NOUN
ct-9661	114	19	of	of	ADP
ct-9661	114	20	early	early	ADJ
ct-9661	114	21	postbreeding	postbreeding	NOUN
ct-9661	114	22	uterine	uterine	ADJ
ct-9661	114	23	lavage	lavage	NOUN
ct-9661	114	24	on	on	ADP
ct-9661	114	25	pregnancy	pregnancy	NOUN
ct-9661	114	26	rate	rate	NOUN
ct-9661	114	27	in	in	ADP
ct-9661	114	28	mares	mare	NOUN
ct-9661	114	29	with	with	ADP
ct-9661	114	30	intrauterine	intrauterine	ADJ
ct-9661	114	31	fluid	fluid	ADJ
ct-9661	114	32	accumulations	accumulation	NOUN
ct-9661	114	33	after	after	ADP
ct-9661	114	34	breeding	breed	VERB
ct-9661	114	35	.	.	PUNCT
ct-9661	115	1	equine	equine	NOUN
ct-9661	115	2	vet	vet	NOUN
ct-9661	115	3	educ	educ	VERB
ct-9661	115	4	2000;12:267	2000;12:267	PROPN
ct-9661	115	5	-	-	PUNCT
ct-9661	115	6	270	270	NUM
ct-9661	115	7	.	.	NOUN
ct-9661	116	1	19	19	NUM
ct-9661	116	2	.	.	PUNCT
ct-9661	117	1	gutjahr	gutjahr	PROPN
ct-9661	117	2	s	s	PROPN
ct-9661	117	3	,	,	PUNCT
ct-9661	117	4	paccamonti	paccamonti	PROPN
ct-9661	117	5	dl	dl	PROPN
ct-9661	117	6	,	,	PUNCT
ct-9661	117	7	pycock	pycock	PROPN
ct-9661	117	8	jf	jf	PROPN
ct-9661	117	9	,	,	PUNCT
ct-9661	117	10	et	et	PROPN
ct-9661	117	11	al	al	PROPN
ct-9661	117	12	:	:	PUNCT
ct-9661	117	13	effect	effect	NOUN
ct-9661	117	14	of	of	ADP
ct-9661	117	15	dose	dose	NOUN
ct-9661	117	16	and	and	CCONJ
ct-9661	117	17	day	day	NOUN
ct-9661	117	18	of	of	ADP
ct-9661	117	19	treatment	treatment	NOUN
ct-9661	117	20	on	on	ADP
ct-9661	117	21	uterine	uterine	ADJ
ct-9661	117	22	response	response	NOUN
ct-9661	117	23	to	to	ADP
ct-9661	117	24	oxytocin	oxytocin	PROPN
ct-9661	117	25	in	in	ADP
ct-9661	117	26	mares	mare	NOUN
ct-9661	117	27	.	.	PUNCT
ct-9661	118	1	theriogenology	theriogenology	NOUN
ct-9661	118	2	2000;54:447	2000;54:447	NOUN
ct-9661	118	3	-	-	NOUN
ct-9661	118	4	456	456	NUM
ct-9661	118	5	.	.	PUNCT
ct-9661	119	1	20	20	NUM
ct-9661	119	2	.	.	X
ct-9661	119	3	schramme	schramme	PROPN
ct-9661	119	4	ar	ar	PROPN
ct-9661	119	5	,	,	PUNCT
ct-9661	119	6	pinto	pinto	PROPN
ct-9661	119	7	crf	crf	PROPN
ct-9661	119	8	,	,	PUNCT
ct-9661	119	9	davis	davis	PROPN
ct-9661	119	10	j	j	PROPN
ct-9661	119	11	,	,	PUNCT
ct-9661	119	12	et	et	PROPN
ct-9661	119	13	al	al	PROPN
ct-9661	119	14	:	:	PUNCT
ct-9661	119	15	pharmacokinetics	pharmacokinetic	NOUN
ct-9661	119	16	of	of	ADP
ct-9661	119	17	carbetocin	carbetocin	PROPN
ct-9661	119	18	,	,	PUNCT
ct-9661	119	19	a	a	DET
ct-9661	119	20	long	long	ADV
ct-9661	119	21	-	-	PUNCT
ct-9661	119	22	acting	act	VERB
ct-9661	119	23	oxytocin	oxytocin	NOUN
ct-9661	119	24	analogue	analogue	NOUN
ct-9661	119	25	,	,	PUNCT
ct-9661	119	26	following	follow	VERB
ct-9661	119	27	intravenous	intravenous	ADJ
ct-9661	119	28	administration	administration	NOUN
ct-9661	119	29	in	in	ADP
ct-9661	119	30	horses	horse	NOUN
ct-9661	119	31	.	.	PUNCT
ct-9661	120	1	equine	equine	NOUN
ct-9661	120	2	vet	vet	PROPN
ct-9661	120	3	j	j	PROPN
ct-9661	120	4	2008;40:658	2008;40:658	X
ct-9661	120	5	-	-	PUNCT
ct-9661	120	6	661	661	NUM
ct-9661	120	7	21	21	NUM
ct-9661	120	8	.	.	PUNCT
ct-9661	121	1	combs	comb	NOUN
ct-9661	121	2	gb	gb	PROPN
ct-9661	121	3	,	,	PUNCT
ct-9661	121	4	leblanc	leblanc	PROPN
ct-9661	121	5	mm	mm	PROPN
ct-9661	121	6	,	,	PUNCT
ct-9661	121	7	neuwirth	neuwirth	PROPN
ct-9661	121	8	l	l	PROPN
ct-9661	121	9	,	,	PUNCT
ct-9661	121	10	et	et	PROPN
ct-9661	121	11	al	al	PROPN
ct-9661	121	12	:	:	PUNCT
ct-9661	121	13	effects	effect	NOUN
ct-9661	121	14	of	of	ADP
ct-9661	121	15	prostaglandin	prostaglandin	ADJ
ct-9661	121	16	f2α	f2α	PROPN
ct-9661	121	17	,	,	PUNCT
ct-9661	121	18	cloprostenol	cloprostenol	NOUN
ct-9661	121	19	and	and	CCONJ
ct-9661	121	20	fenprostalene	fenprostalene	NOUN
ct-9661	121	21	on	on	ADP
ct-9661	121	22	uterine	uterine	ADJ
ct-9661	121	23	clearance	clearance	NOUN
ct-9661	121	24	of	of	ADP
ct-9661	121	25	radiocolloid	radiocolloid	PROPN
ct-9661	121	26	in	in	ADP
ct-9661	121	27	the	the	DET
ct-9661	121	28	mare	mare	NOUN
ct-9661	121	29	.	.	PUNCT
ct-9661	122	1	theriogenology	theriogenology	NOUN
ct-9661	122	2	1996;45:1449	1996;45:1449	NUM
ct-9661	122	3	-	-	PUNCT
ct-9661	122	4	1455	1455	NUM
ct-9661	122	5	.	.	PUNCT
ct-9661	123	1	22	22	NUM
ct-9661	123	2	.	.	PUNCT
ct-9661	123	3	nie	nie	PROPN
ct-9661	123	4	gj	gj	PROPN
ct-9661	123	5	,	,	PUNCT
ct-9661	123	6	johnson	johnson	PROPN
ct-9661	123	7	ke	ke	PROPN
ct-9661	123	8	,	,	PUNCT
ct-9661	123	9	wenzel	wenzel	PROPN
ct-9661	123	10	jg	jg	PROPN
ct-9661	123	11	,	,	PUNCT
ct-9661	123	12	et	et	PROPN
ct-9661	123	13	al	al	PROPN
ct-9661	123	14	:	:	PUNCT
ct-9661	123	15	effect	effect	NOUN
ct-9661	123	16	of	of	ADP
ct-9661	123	17	administering	administer	VERB
ct-9661	123	18	oxytocin	oxytocin	NOUN
ct-9661	123	19	or	or	CCONJ
ct-9661	123	20	cloprostenol	cloprostenol	NOUN
ct-9661	123	21	in	in	ADP
ct-9661	123	22	the	the	DET
ct-9661	123	23	periovulatory	periovulatory	ADJ
ct-9661	123	24	period	period	NOUN
ct-9661	123	25	on	on	ADP
ct-9661	123	26	pregnancy	pregnancy	NOUN
ct-9661	123	27	outcome	outcome	NOUN
ct-9661	123	28	and	and	CCONJ
ct-9661	123	29	luteal	luteal	ADJ
ct-9661	123	30	function	function	NOUN
ct-9661	123	31	in	in	ADP
ct-9661	123	32	mares	mare	NOUN
ct-9661	123	33	.	.	PUNCT
ct-9661	124	1	theriogenology	theriogenology	NOUN
ct-9661	124	2	2003;60:1111	2003;60:1111	PROPN
ct-9661	124	3	-	-	SYM
ct-9661	124	4	1118	1118	NUM
ct-9661	124	5	.	.	PUNCT
ct-9661	125	1	23	23	NUM
ct-9661	125	2	.	.	PUNCT
ct-9661	126	1	rathegeber	rathegeber	ADJ
ct-9661	126	2	r	r	NOUN
ct-9661	126	3	:	:	PUNCT
ct-9661	126	4	acupuncture	acupuncture	NOUN
ct-9661	126	5	therapies	therapy	NOUN
ct-9661	126	6	for	for	ADP
ct-9661	126	7	equine	equine	NOUN
ct-9661	126	8	reproductive	reproductive	ADJ
ct-9661	126	9	disorders	disorder	NOUN
ct-9661	126	10	.	.	PUNCT
ct-9661	127	1	proc	proc	NOUN
ct-9661	127	2	bluegrass	bluegrass	NOUN
ct-9661	127	3	reproductive	reproductive	ADJ
ct-9661	127	4	symposium	symposium	NOUN
ct-9661	127	5	2000	2000	NUM
ct-9661	127	6	.	.	PUNCT
ct-9661	128	1	24	24	NUM
ct-9661	128	2	.	.	PUNCT
ct-9661	129	1	schofield	schofield	PROPN
ct-9661	129	2	wa	wa	PROPN
ct-9661	129	3	:	:	PUNCT
ct-9661	129	4	use	use	NOUN
ct-9661	129	5	of	of	ADP
ct-9661	129	6	acupuncture	acupuncture	NOUN
ct-9661	129	7	in	in	ADP
ct-9661	129	8	equine	equine	NOUN
ct-9661	129	9	reproduction	reproduction	NOUN
ct-9661	129	10	.	.	PUNCT
ct-9661	130	1	theriogenology	theriogenology	NOUN
ct-9661	130	2	2008;70:430	2008;70:430	PROPN
ct-9661	130	3	-	-	SYM
ct-9661	130	4	434	434	NUM
ct-9661	130	5	.	.	PUNCT
ct-9661	131	1	25	25	NUM
ct-9661	131	2	.	.	PUNCT
ct-9661	132	1	swift	swift	PROPN
ct-9661	132	2	la	la	PROPN
ct-9661	132	3	,	,	PUNCT
ct-9661	132	4	christensen	christensen	PROPN
ct-9661	132	5	bw	bw	PROPN
ct-9661	132	6	,	,	PUNCT
ct-9661	132	7	samocha	samocha	ADJ
ct-9661	132	8	mb	mb	ADP
ct-9661	132	9	,	,	PUNCT
ct-9661	132	10	et	et	PROPN
ct-9661	132	11	al	al	PROPN
ct-9661	132	12	:	:	PUNCT
ct-9661	132	13	randomized	randomize	VERB
ct-9661	132	14	comparative	comparative	ADJ
ct-9661	132	15	trial	trial	NOUN
ct-9661	132	16	of	of	ADP
ct-9661	132	17	acupuncture	acupuncture	NOUN
ct-9661	132	18	and	and	CCONJ
ct-9661	132	19	exercise	exercise	NOUN
ct-9661	132	20	versus	versus	ADP
ct-9661	132	21	uterine	uterine	ADJ
ct-9661	132	22	ecbolics	ecbolic	NOUN
ct-9661	132	23	in	in	ADP
ct-9661	132	24	the	the	DET
ct-9661	132	25	clinical	clinical	ADJ
ct-9661	132	26	theriogenology	theriogenology	NOUN
ct-9661	132	27	2021	2021	NUM
ct-9661	132	28	;	;	PUNCT
ct-9661	132	29	13	13	NUM
ct-9661	132	30	:	:	SYM
ct-9661	132	31	263	263	NUM
ct-9661	132	32	treatment	treatment	NOUN
ct-9661	132	33	of	of	ADP
ct-9661	132	34	persistent	persistent	ADJ
ct-9661	132	35	postbreeding	postbreeding	NOUN
ct-9661	132	36	endometritis	endometritis	NOUN
ct-9661	132	37	in	in	ADP
ct-9661	132	38	mares	mare	NOUN
ct-9661	132	39	.	.	PUNCT
ct-9661	133	1	j	j	PROPN
ct-9661	133	2	equine	equine	PROPN
ct-9661	133	3	vet	vet	NOUN
ct-9661	133	4	sci	sci	PROPN
ct-9661	133	5	2020;86:102821	2020;86:102821	PROPN
ct-9661	133	6	.	.	PROPN
ct-9661	133	7	26	26	NUM
ct-9661	133	8	.	.	PUNCT
ct-9661	134	1	lange	lange	NOUN
ct-9661	134	2	-	-	PUNCT
ct-9661	134	3	consiglio	consiglio	PROPN
ct-9661	134	4	a	a	X
ct-9661	134	5	,	,	PUNCT
ct-9661	134	6	funghi	funghi	PROPN
ct-9661	134	7	f	f	PROPN
ct-9661	134	8	,	,	PUNCT
ct-9661	134	9	cantile	cantile	ADJ
ct-9661	134	10	c	c	NOUN
ct-9661	134	11	,	,	PUNCT
ct-9661	134	12	et	et	PROPN
ct-9661	134	13	al	al	PROPN
ct-9661	134	14	:	:	PUNCT
ct-9661	134	15	case	case	NOUN
ct-9661	134	16	report	report	NOUN
ct-9661	134	17	:	:	PUNCT
ct-9661	134	18	use	use	NOUN
ct-9661	134	19	of	of	ADP
ct-9661	134	20	amniotic	amniotic	ADJ
ct-9661	134	21	microvesicles	microvesicle	NOUN
ct-9661	134	22	for	for	ADP
ct-9661	134	23	regenerative	regenerative	ADJ
ct-9661	134	24	medicine	medicine	NOUN
ct-9661	134	25	treatment	treatment	NOUN
ct-9661	134	26	of	of	ADP
ct-9661	134	27	a	a	DET
ct-9661	134	28	mare	mare	NOUN
ct-9661	134	29	with	with	ADP
ct-9661	134	30	chronic	chronic	ADJ
ct-9661	134	31	endometritis	endometritis	NOUN
ct-9661	134	32	.	.	PUNCT
ct-9661	135	1	front	front	ADJ
ct-9661	135	2	vet	vet	NOUN
ct-9661	135	3	sci	sci	PROPN
ct-9661	135	4	2020;7:1	2020;7:1	PROPN
ct-9661	135	5	-	-	PUNCT
ct-9661	135	6	6	6	NUM
ct-9661	135	7	.	.	NOUN
ct-9661	135	8	27	27	NUM
ct-9661	135	9	.	.	PUNCT
ct-9661	136	1	fedorka	fedorka	PROPN
ct-9661	136	2	ce	ce	PROPN
ct-9661	136	3	,	,	PUNCT
ct-9661	136	4	scoggin	scoggin	VERB
ct-9661	136	5	ke	ke	PROPN
ct-9661	136	6	,	,	PUNCT
ct-9661	136	7	boakari	boakari	NOUN
ct-9661	136	8	yl	yl	NOUN
ct-9661	136	9	,	,	PUNCT
ct-9661	136	10	et	et	PROPN
ct-9661	136	11	al	al	PROPN
ct-9661	136	12	:	:	PUNCT
ct-9661	136	13	the	the	DET
ct-9661	136	14	anti	anti	ADJ
ct-9661	136	15	-	-	ADJ
ct-9661	136	16	inflammatory	inflammatory	ADJ
ct-9661	136	17	effect	effect	NOUN
ct-9661	136	18	of	of	ADP
ct-9661	136	19	exogenous	exogenous	ADJ
ct-9661	136	20	lactoferrin	lactoferrin	NOUN
ct-9661	136	21	on	on	ADP
ct-9661	136	22	breeding	breed	VERB
ct-9661	136	23	-	-	PUNCT
ct-9661	136	24	induced	induce	VERB
ct-9661	136	25	endometritis	endometritis	NOUN
ct-9661	136	26	when	when	SCONJ
ct-9661	136	27	administered	administer	VERB
ct-9661	136	28	post	post	NOUN
ct-9661	136	29	-	-	ADJ
ct-9661	136	30	breeding	breeding	NOUN
ct-9661	136	31	in	in	ADP
ct-9661	136	32	susceptible	susceptible	ADJ
ct-9661	136	33	mares	mare	NOUN
ct-9661	136	34	.	.	PUNCT
ct-9661	137	1	theriogenology	theriogenology	NOUN
ct-9661	137	2	2018;114:63	2018;114:63	NUM
ct-9661	137	3	-	-	SYM
ct-9661	137	4	69	69	NUM
ct-9661	137	5	.	.	PUNCT
ct-9661	137	6	28	28	NUM
ct-9661	137	7	.	.	PUNCT
ct-9661	138	1	navarrete	navarrete	PROPN
ct-9661	138	2	f	f	PROPN
ct-9661	138	3	,	,	PUNCT
ct-9661	138	4	saravia	saravia	PROPN
ct-9661	138	5	f	f	PROPN
ct-9661	138	6	,	,	PUNCT
ct-9661	138	7	cisterna	cisterna	PROPN
ct-9661	138	8	g	g	PROPN
ct-9661	138	9	,	,	PUNCT
ct-9661	138	10	et	et	PROPN
ct-9661	138	11	al	al	PROPN
ct-9661	138	12	:	:	PUNCT
ct-9661	138	13	assessment	assessment	NOUN
ct-9661	138	14	of	of	ADP
ct-9661	138	15	the	the	DET
ct-9661	138	16	anti	anti	ADJ
ct-9661	138	17	-	-	ADJ
ct-9661	138	18	inflammatory	inflammatory	ADJ
ct-9661	138	19	and	and	CCONJ
ct-9661	138	20	engraftment	engraftment	ADJ
ct-9661	138	21	potential	potential	NOUN
ct-9661	138	22	of	of	ADP
ct-9661	138	23	horse	horse	NOUN
ct-9661	138	24	endometrial	endometrial	NOUN
ct-9661	138	25	and	and	CCONJ
ct-9661	138	26	adipose	adipose	ADJ
ct-9661	138	27	mesenchymal	mesenchymal	ADJ
ct-9661	138	28	stem	stem	NOUN
ct-9661	138	29	cells	cell	NOUN
ct-9661	138	30	in	in	ADP
ct-9661	138	31	an	an	DET
ct-9661	138	32	in	in	ADP
ct-9661	138	33	vivo	vivo	NOUN
ct-9661	138	34	model	model	NOUN
ct-9661	138	35	of	of	ADP
ct-9661	138	36	post	post	NOUN
ct-9661	138	37	breeding	breed	VERB
ct-9661	138	38	induced	induced	ADJ
ct-9661	138	39	endometritis	endometritis	NOUN
ct-9661	138	40	.	.	PUNCT
ct-9661	139	1	theriogenology	theriogenology	NOUN
ct-9661	139	2	2020;155:33	2020;155:33	NUM
ct-9661	139	3	-	-	SYM
ct-9661	139	4	42	42	NUM
ct-9661	139	5	.	.	PUNCT
ct-9661	139	6	29	29	NUM
ct-9661	139	7	.	.	PUNCT
ct-9661	140	1	vaara	vaara	PROPN
ct-9661	140	2	m	m	PROPN
ct-9661	140	3	:	:	PUNCT
ct-9661	140	4	agents	agent	NOUN
ct-9661	140	5	that	that	PRON
ct-9661	140	6	increase	increase	VERB
ct-9661	140	7	the	the	DET
ct-9661	140	8	permeability	permeability	NOUN
ct-9661	140	9	of	of	ADP
ct-9661	140	10	the	the	DET
ct-9661	140	11	outer	outer	ADJ
ct-9661	140	12	membrane	membrane	NOUN
ct-9661	140	13	.	.	PUNCT
ct-9661	141	1	microbiol	microbiol	PROPN
ct-9661	141	2	rev	rev	VERB
ct-9661	141	3	1992;56:395	1992;56:395	PROPN
ct-9661	141	4	-	-	PUNCT
ct-9661	141	5	411	411	NUM
ct-9661	141	6	.	.	PUNCT
ct-9661	141	7	30	30	NUM
ct-9661	141	8	.	.	PUNCT
ct-9661	142	1	youngquist	youngquist	NOUN
ct-9661	142	2	rs	rs	PROPN
ct-9661	142	3	,	,	PUNCT
ct-9661	142	4	blanchard	blanchard	PROPN
ct-9661	142	5	tl	tl	PROPN
ct-9661	142	6	,	,	PUNCT
ct-9661	142	7	lapin	lapin	PROPN
ct-9661	142	8	d	d	PROPN
ct-9661	142	9	,	,	PUNCT
ct-9661	142	10	et	et	PROPN
ct-9661	142	11	al	al	PROPN
ct-9661	142	12	:	:	PUNCT
ct-9661	142	13	the	the	DET
ct-9661	142	14	effects	effect	NOUN
ct-9661	142	15	of	of	ADP
ct-9661	142	16	edta	edta	NOUN
ct-9661	142	17	-	-	PUNCT
ct-9661	142	18	tris	tris	NOUN
ct-9661	142	19	infusion	infusion	NOUN
ct-9661	142	20	on	on	ADP
ct-9661	142	21	the	the	DET
ct-9661	142	22	equine	equine	NOUN
ct-9661	142	23	endometrium	endometrium	NOUN
ct-9661	142	24	.	.	PUNCT
ct-9661	143	1	theriogenology	theriogenology	NOUN
ct-9661	143	2	1984;22:593	1984;22:593	PROPN
ct-9661	143	3	-	-	SYM
ct-9661	143	4	599	599	NUM
ct-9661	143	5	.	.	PUNCT
ct-9661	143	6	31	31	NUM
ct-9661	143	7	.	.	PUNCT
ct-9661	144	1	ferris	ferris	PROPN
ct-9661	144	2	ra	ra	PROPN
ct-9661	144	3	,	,	PUNCT
ct-9661	144	4	mccue	mccue	PROPN
ct-9661	144	5	pm	pm	PROPN
ct-9661	144	6	,	,	PUNCT
ct-9661	144	7	borlee	borlee	PROPN
ct-9661	144	8	gi	gi	PROPN
ct-9661	144	9	,	,	PUNCT
ct-9661	144	10	et	et	PROPN
ct-9661	144	11	al	al	PROPN
ct-9661	144	12	:	:	PUNCT
ct-9661	144	13	in	in	ADP
ct-9661	144	14	vitro	vitro	X
ct-9661	144	15	efficacy	efficacy	NOUN
ct-9661	144	16	of	of	ADP
ct-9661	144	17	nonantibiotic	nonantibiotic	ADJ
ct-9661	144	18	treatments	treatment	NOUN
ct-9661	144	19	on	on	ADP
ct-9661	144	20	biofilm	biofilm	NOUN
ct-9661	144	21	disruption	disruption	NOUN
ct-9661	144	22	of	of	ADP
ct-9661	144	23	gram	gram	NOUN
ct-9661	144	24	-	-	PUNCT
ct-9661	144	25	negative	negative	ADJ
ct-9661	144	26	pathogens	pathogen	NOUN
ct-9661	144	27	and	and	CCONJ
ct-9661	144	28	an	an	DET
ct-9661	144	29	in	in	ADP
ct-9661	144	30	vivo	vivo	NOUN
ct-9661	144	31	model	model	NOUN
ct-9661	144	32	of	of	ADP
ct-9661	144	33	infectious	infectious	ADJ
ct-9661	144	34	endometritis	endometritis	NOUN
ct-9661	144	35	utilizing	utilize	VERB
ct-9661	144	36	isolates	isolate	NOUN
ct-9661	144	37	from	from	ADP
ct-9661	144	38	the	the	DET
ct-9661	144	39	equine	equine	NOUN
ct-9661	144	40	uterus	uterus	NOUN
ct-9661	144	41	.	.	PUNCT
ct-9661	145	1	j	j	PROPN
ct-9661	145	2	clin	clin	PROPN
ct-9661	145	3	microbiol	microbiol	PROPN
ct-9661	145	4	2016;54:631	2016;54:631	PROPN
ct-9661	145	5	-	-	PUNCT
ct-9661	145	6	639	639	NUM
ct-9661	145	7	.	.	PUNCT
ct-9661	146	1	32	32	NUM
ct-9661	146	2	.	.	PUNCT
ct-9661	147	1	lyle	lyle	PROPN
ct-9661	147	2	sk	sk	PROPN
ct-9661	147	3	,	,	PUNCT
ct-9661	147	4	leblanc	leblanc	PROPN
ct-9661	147	5	mm	mm	PROPN
ct-9661	147	6	,	,	PUNCT
ct-9661	147	7	staempfli	staempfli	PROPN
ct-9661	147	8	sa	sa	PROPN
ct-9661	147	9	,	,	PUNCT
ct-9661	147	10	et	et	PROPN
ct-9661	147	11	al	al	PROPN
ct-9661	147	12	:	:	PUNCT
ct-9661	147	13	how	how	SCONJ
ct-9661	147	14	to	to	PART
ct-9661	147	15	use	use	VERB
ct-9661	147	16	a	a	DET
ct-9661	147	17	buffered	buffer	VERB
ct-9661	147	18	chelator	chelator	NOUN
ct-9661	147	19	solution	solution	NOUN
ct-9661	147	20	for	for	ADP
ct-9661	147	21	mares	mare	NOUN
ct-9661	147	22	with	with	ADP
ct-9661	147	23	chronic	chronic	ADJ
ct-9661	147	24	endometritis	endometritis	NOUN
ct-9661	147	25	.	.	PUNCT
ct-9661	148	1	proc	proc	PROPN
ct-9661	148	2	am	be	AUX
ct-9661	148	3	assoc	assoc	PROPN
ct-9661	148	4	equine	equine	PROPN
ct-9661	148	5	pract	pract	PROPN
ct-9661	148	6	2011	2011	NUM
ct-9661	148	7	;	;	PUNCT
ct-9661	148	8	p.	p.	NOUN
ct-9661	148	9	16	16	NUM
ct-9661	148	10	-	-	SYM
ct-9661	148	11	18	18	NUM
ct-9661	148	12	.	.	PUNCT
ct-9661	148	13	33	33	NUM
ct-9661	148	14	.	.	PUNCT
ct-9661	149	1	gurtovenko	gurtovenko	PROPN
ct-9661	149	2	aa	aa	PROPN
ct-9661	149	3	,	,	PUNCT
ct-9661	149	4	anwar	anwar	PROPN
ct-9661	149	5	j	j	PROPN
ct-9661	149	6	:	:	PUNCT
ct-9661	149	7	modulating	modulate	VERB
ct-9661	149	8	the	the	DET
ct-9661	149	9	structure	structure	NOUN
ct-9661	149	10	and	and	CCONJ
ct-9661	149	11	properties	property	NOUN
ct-9661	149	12	of	of	ADP
ct-9661	149	13	cell	cell	NOUN
ct-9661	149	14	membranes	membrane	NOUN
ct-9661	149	15	:	:	PUNCT
ct-9661	149	16	the	the	DET
ct-9661	149	17	molecular	molecular	ADJ
ct-9661	149	18	mechanism	mechanism	NOUN
ct-9661	149	19	of	of	ADP
ct-9661	149	20	action	action	NOUN
ct-9661	149	21	of	of	ADP
ct-9661	149	22	dimethyl	dimethyl	NOUN
ct-9661	149	23	sulfoxide	sulfoxide	NOUN
ct-9661	149	24	.	.	PUNCT
ct-9661	150	1	j	j	PROPN
ct-9661	150	2	phys	phy	NOUN
ct-9661	150	3	chem	chem	NOUN
ct-9661	150	4	b	b	NOUN
ct-9661	150	5	2007;111:10453	2007;111:10453	NUM
ct-9661	150	6	-	-	SYM
ct-9661	150	7	10460	10460	NUM
ct-9661	150	8	.	.	PUNCT
ct-9661	151	1	34	34	NUM
ct-9661	151	2	.	.	PUNCT
ct-9661	152	1	yahya	yahya	PROPN
ct-9661	152	2	mf	mf	VERB
ct-9661	152	3	,	,	PUNCT
ct-9661	152	4	alias	alias	PROPN
ct-9661	152	5	z	z	PROPN
ct-9661	152	6	,	,	PUNCT
ct-9661	152	7	karsani	karsani	PROPN
ct-9661	152	8	sa	sa	PROPN
ct-9661	152	9	:	:	PUNCT
ct-9661	152	10	antibiofilm	antibiofilm	NOUN
ct-9661	152	11	activity	activity	NOUN
ct-9661	152	12	and	and	CCONJ
ct-9661	152	13	mode	mode	NOUN
ct-9661	152	14	of	of	ADP
ct-9661	152	15	action	action	NOUN
ct-9661	152	16	of	of	ADP
ct-9661	152	17	dmso	dmso	NOUN
ct-9661	152	18	alone	alone	ADJ
ct-9661	152	19	and	and	CCONJ
ct-9661	152	20	its	its	PRON
ct-9661	152	21	combination	combination	NOUN
ct-9661	152	22	with	with	ADP
ct-9661	152	23	afatinib	afatinib	NOUN
ct-9661	152	24	against	against	ADP
ct-9661	152	25	gramnegative	gramnegative	ADJ
ct-9661	152	26	pathogens	pathogen	NOUN
ct-9661	152	27	.	.	PUNCT
ct-9661	153	1	folia	folia	PROPN
ct-9661	153	2	microbiol	microbiol	PROPN
ct-9661	153	3	2018;63:23	2018;63:23	NUM
ct-9661	153	4	-	-	SYM
ct-9661	153	5	30	30	NUM
ct-9661	153	6	.	.	PUNCT
ct-9661	153	7	35	35	NUM
ct-9661	153	8	.	.	X
ct-9661	154	1	ley	ley	PROPN
ct-9661	154	2	wb	wb	PROPN
ct-9661	154	3	,	,	PUNCT
ct-9661	154	4	bowen	bowen	PROPN
ct-9661	154	5	jm	jm	PROPN
ct-9661	154	6	,	,	PUNCT
ct-9661	154	7	sponenberg	sponenberg	PROPN
ct-9661	154	8	dp	dp	PROPN
ct-9661	154	9	,	,	PUNCT
ct-9661	154	10	et	et	PROPN
ct-9661	154	11	al	al	PROPN
ct-9661	154	12	:	:	PUNCT
ct-9661	154	13	dimethyl	dimethyl	NOUN
ct-9661	154	14	sulfoxide	sulfoxide	NOUN
ct-9661	154	15	intrauterine	intrauterine	NOUN
ct-9661	154	16	therapy	therapy	NOUN
ct-9661	154	17	in	in	ADP
ct-9661	154	18	the	the	DET
ct-9661	154	19	mare	mare	NOUN
ct-9661	154	20	:	:	PUNCT
ct-9661	154	21	effects	effect	NOUN
ct-9661	154	22	upon	upon	SCONJ
ct-9661	154	23	endometrial	endometrial	ADJ
ct-9661	154	24	histological	histological	ADJ
ct-9661	154	25	features	feature	NOUN
ct-9661	154	26	and	and	CCONJ
ct-9661	154	27	biopsy	biopsy	VERB
ct-9661	154	28	classification	classification	NOUN
ct-9661	154	29	.	.	PUNCT
ct-9661	155	1	theriogenology	theriogenology	NOUN
ct-9661	155	2	1989;32:263	1989;32:263	NUM
ct-9661	155	3	-	-	SYM
ct-9661	155	4	276	276	NUM
ct-9661	155	5	.	.	PUNCT
ct-9661	155	6	36	36	NUM
ct-9661	155	7	.	.	PUNCT
ct-9661	156	1	berkelman	berkelman	PROPN
ct-9661	156	2	rl	rl	PROPN
ct-9661	156	3	,	,	PUNCT
ct-9661	156	4	holland	holland	PROPN
ct-9661	156	5	bw	bw	PROPN
ct-9661	156	6	,	,	PUNCT
ct-9661	156	7	anderson	anderson	PROPN
ct-9661	156	8	rl	rl	PROPN
ct-9661	156	9	:	:	PUNCT
ct-9661	156	10	increased	increase	VERB
ct-9661	156	11	bactericidal	bactericidal	ADJ
ct-9661	156	12	activity	activity	NOUN
ct-9661	156	13	of	of	ADP
ct-9661	156	14	dilute	dilute	ADJ
ct-9661	156	15	preparations	preparation	NOUN
ct-9661	156	16	of	of	ADP
ct-9661	156	17	povidone	povidone	NOUN
ct-9661	156	18	-	-	PUNCT
ct-9661	156	19	iodine	iodine	NOUN
ct-9661	156	20	solutions	solution	NOUN
ct-9661	156	21	.	.	PUNCT
ct-9661	157	1	j	j	PROPN
ct-9661	157	2	clin	clin	PROPN
ct-9661	157	3	microbiol	microbiol	PROPN
ct-9661	157	4	1982;15:635	1982;15:635	PROPN
ct-9661	157	5	-	-	PUNCT
ct-9661	157	6	639	639	NUM
ct-9661	157	7	.	.	PUNCT
ct-9661	158	1	37	37	NUM
ct-9661	158	2	.	.	PUNCT
ct-9661	159	1	olsen	olsen	PROPN
ct-9661	159	2	lm	lm	PROPN
ct-9661	159	3	,	,	PUNCT
ct-9661	159	4	al	al	PROPN
ct-9661	159	5	-	-	PUNCT
ct-9661	159	6	bagdadi	bagdadi	PROPN
ct-9661	159	7	fk	fk	PROPN
ct-9661	159	8	,	,	PUNCT
ct-9661	159	9	richardson	richardson	PROPN
ct-9661	159	10	gf	gf	PROPN
ct-9661	159	11	,	,	PUNCT
ct-9661	159	12	et	et	PROPN
ct-9661	159	13	al	al	PROPN
ct-9661	159	14	:	:	PUNCT
ct-9661	159	15	a	a	DET
ct-9661	159	16	histological	histological	ADJ
ct-9661	159	17	study	study	NOUN
ct-9661	159	18	of	of	ADP
ct-9661	159	19	the	the	DET
ct-9661	159	20	effect	effect	NOUN
ct-9661	159	21	of	of	ADP
ct-9661	159	22	saline	saline	NOUN
ct-9661	159	23	and	and	CCONJ
ct-9661	159	24	povidone	povidone	NOUN
ct-9661	159	25	-	-	PUNCT
ct-9661	159	26	iodine	iodine	NOUN
ct-9661	159	27	infusions	infusion	NOUN
ct-9661	159	28	on	on	ADP
ct-9661	159	29	the	the	DET
ct-9661	159	30	equine	equine	NOUN
ct-9661	159	31	endometrium	endometrium	NOUN
ct-9661	159	32	.	.	PUNCT
ct-9661	160	1	theriogenology	theriogenology	NOUN
ct-9661	160	2	1992;37:1311	1992;37:1311	NUM
ct-9661	160	3	-	-	PUNCT
ct-9661	160	4	1325	1325	NUM
ct-9661	160	5	.	.	PUNCT
ct-9661	161	1	38	38	NUM
ct-9661	161	2	.	.	PUNCT
ct-9661	162	1	gores	gore	NOUN
ct-9661	162	2	-	-	PUNCT
ct-9661	162	3	lindholm	lindholm	PROPN
ct-9661	162	4	ar	ar	PROPN
ct-9661	162	5	,	,	PUNCT
ct-9661	162	6	leblanc	leblanc	PROPN
ct-9661	162	7	mm	mm	PROPN
ct-9661	162	8	,	,	PUNCT
ct-9661	162	9	causey	causey	PROPN
ct-9661	162	10	r	r	PROPN
ct-9661	162	11	,	,	PUNCT
ct-9661	162	12	et	et	PROPN
ct-9661	162	13	al	al	PROPN
ct-9661	162	14	:	:	PUNCT
ct-9661	162	15	relationships	relationship	NOUN
ct-9661	162	16	between	between	ADP
ct-9661	162	17	intrauterine	intrauterine	ADJ
ct-9661	162	18	infusion	infusion	NOUN
ct-9661	162	19	of	of	ADP
ct-9661	162	20	n	n	CCONJ
ct-9661	162	21	-	-	PUNCT
ct-9661	162	22	acetylcysteine	acetylcysteine	NOUN
ct-9661	162	23	,	,	PUNCT
ct-9661	162	24	equine	equine	ADJ
ct-9661	162	25	endometrial	endometrial	ADJ
ct-9661	162	26	pathology	pathology	NOUN
ct-9661	162	27	,	,	PUNCT
ct-9661	162	28	neutrophil	neutrophil	ADJ
ct-9661	162	29	function	function	NOUN
ct-9661	162	30	,	,	PUNCT
ct-9661	162	31	post	post	ADJ
ct-9661	162	32	-	-	ADJ
ct-9661	162	33	breeding	breeding	ADJ
ct-9661	162	34	therapy	therapy	NOUN
ct-9661	162	35	,	,	PUNCT
ct-9661	162	36	and	and	CCONJ
ct-9661	162	37	reproductive	reproductive	ADJ
ct-9661	162	38	performance	performance	NOUN
ct-9661	162	39	.	.	PUNCT
ct-9661	163	1	theriogenology	theriogenology	NOUN
ct-9661	163	2	2013;80:218	2013;80:218	NUM
ct-9661	163	3	-	-	SYM
ct-9661	163	4	227	227	NUM
ct-9661	163	5	.	.	NOUN
ct-9661	163	6	39	39	NUM
ct-9661	163	7	.	.	PUNCT
ct-9661	164	1	melkus	melku	NOUN
ct-9661	164	2	e	e	NOUN
ct-9661	164	3	,	,	PUNCT
ct-9661	164	4	witte	witte	PROPN
ct-9661	164	5	t	t	PROPN
ct-9661	164	6	,	,	PUNCT
ct-9661	164	7	walter	walter	PROPN
ct-9661	164	8	i	i	PROPN
ct-9661	164	9	,	,	PUNCT
ct-9661	164	10	et	et	PROPN
ct-9661	164	11	al	al	PROPN
ct-9661	164	12	:	:	PUNCT
ct-9661	164	13	investigations	investigation	NOUN
ct-9661	164	14	on	on	ADP
ct-9661	164	15	the	the	DET
ct-9661	164	16	endometrial	endometrial	ADJ
ct-9661	164	17	response	response	NOUN
ct-9661	164	18	to	to	ADP
ct-9661	164	19	intrauterine	intrauterine	ADJ
ct-9661	164	20	administration	administration	NOUN
ct-9661	164	21	of	of	ADP
ct-9661	164	22	n‐acetylcysteine	n‐acetylcysteine	PUNCT
ct-9661	164	23	in	in	ADP
ct-9661	164	24	oestrous	oestrous	ADJ
ct-9661	164	25	mares	mare	NOUN
ct-9661	164	26	.	.	PUNCT
ct-9661	165	1	reprod	reprod	PROPN
ct-9661	165	2	domest	domest	PROPN
ct-9661	165	3	anim	anim	NOUN
ct-9661	165	4	2013;48:591	2013;48:591	PROPN
ct-9661	165	5	-	-	SYM
ct-9661	165	6	597	597	NUM
ct-9661	165	7	.	.	NUM
ct-9661	165	8	40	40	NUM
ct-9661	165	9	.	.	PUNCT
ct-9661	166	1	petersen	petersen	PROPN
ct-9661	166	2	mr	mr	PROPN
ct-9661	166	3	,	,	PUNCT
ct-9661	166	4	skive	skive	ADJ
ct-9661	166	5	b	b	NOUN
ct-9661	166	6	,	,	PUNCT
ct-9661	166	7	christoffersen	christoffersen	NOUN
ct-9661	166	8	m	m	PROPN
ct-9661	166	9	,	,	PUNCT
ct-9661	166	10	et	et	PROPN
ct-9661	166	11	al	al	PROPN
ct-9661	166	12	:	:	PUNCT
ct-9661	166	13	activation	activation	NOUN
ct-9661	166	14	of	of	ADP
ct-9661	166	15	persistent	persistent	ADJ
ct-9661	166	16	streptococcus	streptococcus	NOUN
ct-9661	166	17	equi	equi	NOUN
ct-9661	166	18	subspecies	subspecie	NOUN
ct-9661	166	19	zooepidemicus	zooepidemicus	VERB
ct-9661	166	20	in	in	ADP
ct-9661	166	21	mares	mare	NOUN
ct-9661	166	22	with	with	ADP
ct-9661	166	23	subclinical	subclinical	ADJ
ct-9661	166	24	endometritis	endometritis	NOUN
ct-9661	166	25	.	.	PUNCT
ct-9661	167	1	vet	vet	NOUN
ct-9661	167	2	microbiol	microbiol	NOUN
ct-9661	167	3	2015;179:119	2015;179:119	NUM
ct-9661	167	4	-	-	SYM
ct-9661	167	5	125	125	NUM
ct-9661	167	6	.	.	PUNCT
ct-9661	167	7	41	41	NUM
ct-9661	167	8	.	.	PUNCT
ct-9661	168	1	coyle	coyle	PROPN
ct-9661	168	2	j	j	PROPN
ct-9661	168	3	,	,	PUNCT
ct-9661	168	4	ferrer	ferrer	PROPN
ct-9661	168	5	m	m	PROPN
ct-9661	168	6	,	,	PUNCT
ct-9661	168	7	fishman	fishman	PROPN
ct-9661	168	8	h	h	PROPN
ct-9661	168	9	,	,	PUNCT
ct-9661	168	10	et	et	PROPN
ct-9661	168	11	al	al	PROPN
ct-9661	168	12	:	:	PUNCT
ct-9661	168	13	side	side	NOUN
ct-9661	168	14	effects	effect	NOUN
ct-9661	168	15	and	and	CCONJ
ct-9661	168	16	occupational	occupational	ADJ
ct-9661	168	17	risks	risk	NOUN
ct-9661	168	18	of	of	ADP
ct-9661	168	19	using	use	VERB
ct-9661	168	20	intrauterine	intrauterine	ADJ
ct-9661	168	21	kerosene	kerosene	NOUN
ct-9661	168	22	in	in	ADP
ct-9661	168	23	a	a	DET
ct-9661	168	24	mare	mare	NOUN
ct-9661	168	25	.	.	PUNCT
ct-9661	169	1	clinical	clinical	ADJ
ct-9661	169	2	theriogenology	theriogenology	NOUN
ct-9661	169	3	2017;9:97	2017;9:97	PROPN
ct-9661	169	4	-	-	PUNCT
ct-9661	169	5	104	104	NUM
ct-9661	169	6	.	.	PUNCT
ct-9661	170	1	42	42	NUM
ct-9661	170	2	.	.	PUNCT
ct-9661	171	1	ferris	ferris	PROPN
ct-9661	171	2	ra	ra	PROPN
ct-9661	171	3	,	,	PUNCT
ct-9661	171	4	mccue	mccue	PROPN
ct-9661	171	5	pm	pm	PROPN
ct-9661	171	6	,	,	PUNCT
ct-9661	171	7	borlee	borlee	PROPN
ct-9661	171	8	gi	gi	PROPN
ct-9661	171	9	,	,	PUNCT
ct-9661	171	10	et	et	PROPN
ct-9661	171	11	al	al	PROPN
ct-9661	171	12	:	:	PUNCT
ct-9661	171	13	model	model	NOUN
ct-9661	171	14	of	of	ADP
ct-9661	171	15	chronic	chronic	ADJ
ct-9661	171	16	equine	equine	NOUN
ct-9661	171	17	endometritis	endometritis	NOUN
ct-9661	171	18	involving	involve	VERB
ct-9661	171	19	a	a	DET
ct-9661	171	20	pseudomonas	pseudomona	NOUN
ct-9661	171	21	aeruginosa	aeruginosa	NOUN
ct-9661	171	22	biofilm	biofilm	NOUN
ct-9661	171	23	.	.	PUNCT
ct-9661	172	1	infect	infect	VERB
ct-9661	172	2	immun	immun	PROPN
ct-9661	172	3	2017;85:1	2017;85:1	PROPN
ct-9661	172	4	-	-	SYM
ct-9661	172	5	14	14	NUM
ct-9661	172	6	.	.	PUNCT
ct-9661	173	1	43	43	NUM
ct-9661	173	2	.	.	PUNCT
ct-9661	174	1	papa	papa	PROPN
ct-9661	174	2	fo	fo	PROPN
ct-9661	174	3	,	,	PUNCT
ct-9661	174	4	dell’aqua	dell’aqua	PROPN
ct-9661	174	5	jaj	jaj	PROPN
ct-9661	174	6	,	,	PUNCT
ct-9661	174	7	alvarenga	alvarenga	PROPN
ct-9661	174	8	ma	ma	PROPN
ct-9661	174	9	,	,	PUNCT
ct-9661	174	10	et	et	PROPN
ct-9661	174	11	al	al	PROPN
ct-9661	174	12	:	:	PUNCT
ct-9661	174	13	use	use	NOUN
ct-9661	174	14	of	of	ADP
ct-9661	174	15	corticosteroid	corticosteroid	ADJ
ct-9661	174	16	therapy	therapy	NOUN
ct-9661	174	17	on	on	ADP
ct-9661	174	18	the	the	DET
ct-9661	174	19	modulation	modulation	NOUN
ct-9661	174	20	of	of	ADP
ct-9661	174	21	uterine	uterine	ADJ
ct-9661	174	22	inflammatory	inflammatory	ADJ
ct-9661	174	23	response	response	NOUN
ct-9661	174	24	in	in	ADP
ct-9661	174	25	mares	mare	NOUN
ct-9661	174	26	after	after	ADP
ct-9661	174	27	artificial	artificial	ADJ
ct-9661	174	28	insemination	insemination	NOUN
ct-9661	174	29	with	with	ADP
ct-9661	174	30	frozen	frozen	ADJ
ct-9661	174	31	semen	semen	NOUN
ct-9661	174	32	.	.	PUNCT
ct-9661	175	1	pferdeheilkunde	pferdeheilkunde	PROPN
ct-9661	175	2	2008;24:79	2008;24:79	NUM
ct-9661	175	3	-	-	SYM
ct-9661	175	4	82	82	NUM
ct-9661	175	5	.	.	PUNCT
ct-9661	175	6	44	44	NUM
ct-9661	175	7	.	.	PUNCT
ct-9661	176	1	bucca	bucca	PROPN
ct-9661	176	2	s	s	PROPN
ct-9661	176	3	,	,	PUNCT
ct-9661	176	4	carli	carli	PROPN
ct-9661	176	5	a	a	NOUN
ct-9661	176	6	,	,	PUNCT
ct-9661	176	7	buckley	buckley	PROPN
ct-9661	176	8	t	t	PROPN
ct-9661	176	9	,	,	PUNCT
ct-9661	176	10	et	et	PROPN
ct-9661	176	11	al	al	PROPN
ct-9661	176	12	:	:	PUNCT
ct-9661	176	13	the	the	DET
ct-9661	176	14	use	use	NOUN
ct-9661	176	15	of	of	ADP
ct-9661	176	16	dexamethasone	dexamethasone	NOUN
ct-9661	176	17	administered	administer	VERB
ct-9661	176	18	to	to	ADP
ct-9661	176	19	mares	mare	NOUN
ct-9661	176	20	at	at	ADP
ct-9661	176	21	breeding	breeding	NOUN
ct-9661	176	22	time	time	NOUN
ct-9661	176	23	in	in	ADP
ct-9661	176	24	the	the	DET
ct-9661	176	25	modulation	modulation	NOUN
ct-9661	176	26	of	of	ADP
ct-9661	176	27	persistent	persistent	ADJ
ct-9661	176	28	mating	mating	NOUN
ct-9661	176	29	induced	induce	VERB
ct-9661	176	30	endometritis	endometritis	NOUN
ct-9661	176	31	.	.	PUNCT
ct-9661	177	1	theriogenology	theriogenology	NOUN
ct-9661	177	2	2008;70:1093	2008;70:1093	NUM
ct-9661	177	3	-	-	SYM
ct-9661	177	4	1100	1100	NUM
ct-9661	177	5	.	.	PUNCT
ct-9661	178	1	45	45	NUM
ct-9661	178	2	.	.	PUNCT
ct-9661	178	3	christoffersen	christoffersen	PROPN
ct-9661	178	4	m	m	PROPN
ct-9661	178	5	,	,	PUNCT
ct-9661	178	6	woodward	woodward	PROPN
ct-9661	178	7	em	em	PRON
ct-9661	178	8	,	,	PUNCT
ct-9661	178	9	bojesen	bojesen	PROPN
ct-9661	178	10	am	am	PROPN
ct-9661	178	11	,	,	PUNCT
ct-9661	178	12	et	et	PROPN
ct-9661	178	13	al	al	PROPN
ct-9661	178	14	:	:	PUNCT
ct-9661	178	15	effect	effect	NOUN
ct-9661	178	16	of	of	ADP
ct-9661	178	17	immunomodulatory	immunomodulatory	ADJ
ct-9661	178	18	therapy	therapy	NOUN
ct-9661	178	19	on	on	ADP
ct-9661	178	20	the	the	DET
ct-9661	178	21	endometrial	endometrial	ADJ
ct-9661	178	22	inflammatory	inflammatory	ADJ
ct-9661	178	23	response	response	NOUN
ct-9661	178	24	to	to	AUX
ct-9661	178	25	induced	induce	VERB
ct-9661	178	26	infectious	infectious	ADJ
ct-9661	178	27	endometritis	endometritis	NOUN
ct-9661	178	28	in	in	ADP
ct-9661	178	29	susceptible	susceptible	ADJ
ct-9661	178	30	mares	mare	NOUN
ct-9661	178	31	.	.	PUNCT
ct-9661	179	1	theriogenology	theriogenology	NOUN
ct-9661	179	2	2012;78:991	2012;78:991	NUM
ct-9661	179	3	-	-	SYM
ct-9661	179	4	1004	1004	NUM
ct-9661	179	5	.	.	PUNCT
ct-9661	180	1	46	46	NUM
ct-9661	180	2	.	.	PUNCT
ct-9661	181	1	ferris	ferris	PROPN
ct-9661	181	2	ra	ra	PROPN
ct-9661	181	3	,	,	PUNCT
ct-9661	181	4	mccue	mccue	PROPN
ct-9661	181	5	pm	pm	PROPN
ct-9661	181	6	:	:	PUNCT
ct-9661	181	7	the	the	DET
ct-9661	181	8	effects	effect	NOUN
ct-9661	181	9	of	of	ADP
ct-9661	181	10	dexamethasone	dexamethasone	NOUN
ct-9661	181	11	and	and	CCONJ
ct-9661	181	12	prednisolone	prednisolone	PROPN
ct-9661	181	13	on	on	ADP
ct-9661	181	14	pituitary	pituitary	ADJ
ct-9661	181	15	and	and	CCONJ
ct-9661	181	16	ovarian	ovarian	ADJ
ct-9661	181	17	function	function	NOUN
ct-9661	181	18	in	in	ADP
ct-9661	181	19	the	the	DET
ct-9661	181	20	mare	mare	NOUN
ct-9661	181	21	.	.	PUNCT
ct-9661	182	1	equine	equine	PROPN
ct-9661	182	2	vet	vet	PROPN
ct-9661	182	3	j	j	PROPN
ct-9661	182	4	2010;42:438	2010;42:438	NOUN
ct-9661	182	5	-	-	NUM
ct-9661	182	6	443	443	NUM
ct-9661	182	7	.	.	PUNCT
ct-9661	182	8	47	47	NUM
ct-9661	182	9	.	.	PUNCT
ct-9661	183	1	cuervo	cuervo	PROPN
ct-9661	183	2	-	-	PUNCT
ct-9661	183	3	arango	arango	PROPN
ct-9661	183	4	j	j	PROPN
ct-9661	183	5	,	,	PUNCT
ct-9661	183	6	domingo	domingo	PROPN
ct-9661	183	7	-	-	PUNCT
ct-9661	183	8	ortiz	ortiz	PROPN
ct-9661	183	9	r	r	NOUN
ct-9661	183	10	:	:	PUNCT
ct-9661	183	11	systemic	systemic	ADJ
ct-9661	183	12	treatment	treatment	NOUN
ct-9661	183	13	with	with	ADP
ct-9661	183	14	high	high	ADJ
ct-9661	183	15	dose	dose	NOUN
ct-9661	183	16	of	of	ADP
ct-9661	183	17	flunixin	flunixin	NOUN
ct-9661	183	18	-	-	PUNCT
ct-9661	183	19	meglumine	meglumine	NOUN
ct-9661	183	20	is	be	AUX
ct-9661	183	21	able	able	ADJ
ct-9661	183	22	to	to	PART
ct-9661	183	23	block	block	VERB
ct-9661	183	24	ovulation	ovulation	NOUN
ct-9661	183	25	in	in	ADP
ct-9661	183	26	mares	mare	NOUN
ct-9661	183	27	by	by	ADP
ct-9661	183	28	inducing	induce	VERB
ct-9661	183	29	hemorrhage	hemorrhage	NOUN
ct-9661	183	30	and	and	CCONJ
ct-9661	183	31	luteinisation	luteinisation	NOUN
ct-9661	183	32	of	of	ADP
ct-9661	183	33	follicles	follicle	NOUN
ct-9661	183	34	.	.	PUNCT
ct-9661	184	1	theriogenology	theriogenology	NOUN
ct-9661	184	2	2011;75:707	2011;75:707	NUM
ct-9661	184	3	-	-	PUNCT
ct-9661	184	4	714	714	NUM
ct-9661	184	5	.	.	PUNCT
ct-9661	184	6	48	48	NUM
ct-9661	184	7	.	.	PUNCT
ct-9661	185	1	lima	lima	PROPN
ct-9661	185	2	ag	ag	PROPN
ct-9661	185	3	,	,	PUNCT
ct-9661	185	4	costa	costa	PROPN
ct-9661	185	5	lc	lc	PROPN
ct-9661	185	6	,	,	PUNCT
ct-9661	185	7	alvarenga	alvarenga	PROPN
ct-9661	185	8	ma	ma	PROPN
ct-9661	185	9	,	,	PUNCT
ct-9661	185	10	et	et	PROPN
ct-9661	185	11	al	al	PROPN
ct-9661	185	12	:	:	PUNCT
ct-9661	185	13	does	do	AUX
ct-9661	185	14	clinical	clinical	ADJ
ct-9661	185	15	treatment	treatment	NOUN
ct-9661	185	16	with	with	ADP
ct-9661	185	17	phenylbutazone	phenylbutazone	NOUN
ct-9661	185	18	and	and	CCONJ
ct-9661	185	19	meloxicam	meloxicam	NOUN
ct-9661	185	20	in	in	ADP
ct-9661	185	21	the	the	DET
ct-9661	185	22	pre‐ovulatory	pre‐ovulatory	NOUN
ct-9661	185	23	period	period	NOUN
ct-9661	185	24	influence	influence	VERB
ct-9661	185	25	the	the	DET
ct-9661	185	26	ovulation	ovulation	NOUN
ct-9661	185	27	rate	rate	NOUN
ct-9661	185	28	in	in	ADP
ct-9661	185	29	mares	mare	NOUN
ct-9661	185	30	?	?	PUNCT
ct-9661	186	1	reprod	reprod	PROPN
ct-9661	186	2	domest	domest	PROPN
ct-9661	186	3	anim	anim	NOUN
ct-9661	186	4	2015;50:771	2015;50:771	NOUN
ct-9661	186	5	-	-	SYM
ct-9661	186	6	775	775	NUM
ct-9661	186	7	.	.	PUNCT
ct-9661	187	1	49	49	NUM
ct-9661	187	2	.	.	PUNCT
ct-9661	188	1	donnelly	donnelly	PROPN
ct-9661	188	2	cg	cg	PROPN
ct-9661	188	3	,	,	PUNCT
ct-9661	188	4	sones	sones	PROPN
ct-9661	188	5	jl	jl	PROPN
ct-9661	188	6	,	,	PUNCT
ct-9661	188	7	dockweiler	dockweiler	PROPN
ct-9661	188	8	jc	jc	PROPN
ct-9661	188	9	,	,	PUNCT
ct-9661	188	10	et	et	PROPN
ct-9661	188	11	al	al	PROPN
ct-9661	188	12	:	:	PUNCT
ct-9661	188	13	effects	effect	NOUN
ct-9661	188	14	of	of	ADP
ct-9661	188	15	flunixin	flunixin	NOUN
ct-9661	188	16	meglumine	meglumine	NOUN
ct-9661	188	17	on	on	ADP
ct-9661	188	18	postponement	postponement	NOUN
ct-9661	188	19	of	of	ADP
ct-9661	188	20	ovulation	ovulation	NOUN
ct-9661	188	21	in	in	ADP
ct-9661	188	22	mares	mare	NOUN
ct-9661	188	23	.	.	PUNCT
ct-9661	189	1	am	be	AUX
ct-9661	189	2	j	j	PROPN
ct-9661	189	3	vet	vet	NOUN
ct-9661	189	4	res	re	NOUN
ct-9661	189	5	2019;80:306	2019;80:306	PROPN
ct-9661	189	6	-	-	PUNCT
ct-9661	189	7	310	310	NUM
ct-9661	189	8	.	.	NOUN
ct-9661	190	1	50	50	NUM
ct-9661	190	2	.	.	PUNCT
ct-9661	190	3	brickner	brickner	PROPN
ct-9661	190	4	km	km	PROPN
ct-9661	190	5	,	,	PUNCT
ct-9661	190	6	ferris	ferris	PROPN
ct-9661	190	7	ra	ra	PROPN
ct-9661	190	8	,	,	PUNCT
ct-9661	190	9	trundell	trundell	PROPN
ct-9661	190	10	da	da	PROPN
ct-9661	190	11	,	,	PUNCT
ct-9661	190	12	et	et	PROPN
ct-9661	190	13	al	al	PROPN
ct-9661	190	14	:	:	PUNCT
ct-9661	190	15	effect	effect	NOUN
ct-9661	190	16	of	of	ADP
ct-9661	190	17	chronic	chronic	ADJ
ct-9661	190	18	nsaid	nsaid	PROPN
ct-9661	190	19	administration	administration	PROPN
ct-9661	190	20	on	on	ADP
ct-9661	190	21	ovulation	ovulation	NOUN
ct-9661	190	22	in	in	ADP
ct-9661	190	23	mares	mare	NOUN
ct-9661	190	24	.	.	PUNCT
ct-9661	191	1	clinical	clinical	ADJ
ct-9661	191	2	theriogenology	theriogenology	NOUN
ct-9661	191	3	2017;9:456	2017;9:456	NOUN
ct-9661	191	4	.	.	PUNCT
ct-9661	192	1	51	51	NUM
ct-9661	192	2	.	.	PUNCT
ct-9661	193	1	friso	friso	PROPN
ct-9661	193	2	am	be	AUX
ct-9661	193	3	,	,	PUNCT
ct-9661	193	4	segabinazzi	segabinazzi	NOUN
ct-9661	193	5	lg	lg	NOUN
ct-9661	193	6	,	,	PUNCT
ct-9661	193	7	cyrino	cyrino	PROPN
ct-9661	193	8	m	m	PROPN
ct-9661	193	9	,	,	PUNCT
ct-9661	193	10	et	et	PROPN
ct-9661	193	11	al	al	PROPN
ct-9661	193	12	:	:	PUNCT
ct-9661	193	13	periovulatory	periovulatory	PROPN
ct-9661	193	14	administration	administration	NOUN
ct-9661	193	15	of	of	ADP
ct-9661	193	16	firocoxib	firocoxib	PROPN
ct-9661	193	17	did	do	AUX
ct-9661	193	18	not	not	PART
ct-9661	193	19	alter	alter	VERB
ct-9661	193	20	ovulation	ovulation	NOUN
ct-9661	193	21	rates	rate	NOUN
ct-9661	193	22	and	and	CCONJ
ct-9661	193	23	mitigated	mitigate	VERB
ct-9661	193	24	post	post	ADJ
ct-9661	193	25	-	-	ADJ
ct-9661	193	26	breeding	breeding	ADJ
ct-9661	193	27	inflammatory	inflammatory	ADJ
ct-9661	193	28	response	response	NOUN
ct-9661	193	29	in	in	ADP
ct-9661	193	30	mares	mare	NOUN
ct-9661	193	31	.	.	PUNCT
ct-9661	194	1	theriogenology	theriogenology	NOUN
ct-9661	194	2	2019;138:24	2019;138:24	NUM
ct-9661	194	3	-	-	SYM
ct-9661	194	4	30	30	NUM
ct-9661	194	5	.	.	PUNCT
ct-9661	194	6	52	52	NUM
ct-9661	194	7	.	.	PUNCT
ct-9661	195	1	rojer	rojer	NOUN
ct-9661	195	2	h	h	PROPN
ct-9661	195	3	,	,	PUNCT
ct-9661	195	4	aurich	aurich	PROPN
ct-9661	195	5	c	c	NOUN
ct-9661	195	6	:	:	PUNCT
ct-9661	195	7	treatment	treatment	NOUN
ct-9661	195	8	of	of	ADP
ct-9661	195	9	persistent	persistent	ADJ
ct-9661	195	10	mating‐induced	mating‐induce	VERB
ct-9661	195	11	endometritis	endometritis	NOUN
ct-9661	195	12	in	in	ADP
ct-9661	195	13	mares	mare	NOUN
ct-9661	195	14	with	with	ADP
ct-9661	195	15	the	the	DET
ct-9661	195	16	non‐steroid	non‐steroid	ADJ
ct-9661	195	17	anti‐inflammatory	anti‐inflammatory	NOUN
ct-9661	195	18	drug	drug	NOUN
ct-9661	195	19	vedaprofen	vedaprofen	NOUN
ct-9661	195	20	.	.	PUNCT
ct-9661	196	1	reprod	reprod	PROPN
ct-9661	196	2	domest	domest	PROPN
ct-9661	196	3	anim	anim	NOUN
ct-9661	196	4	2010;45	2010;45	NUM
ct-9661	196	5	:	:	PUNCT
ct-9661	196	6	e458	e458	NUM
ct-9661	196	7	-	-	SYM
ct-9661	196	8	460	460	NUM
ct-9661	196	9	.	.	PUNCT
ct-9661	197	1	53	53	NUM
ct-9661	197	2	.	.	PUNCT
ct-9661	198	1	danielli	danielli	PROPN
ct-9661	198	2	jfl	jfl	PROPN
ct-9661	198	3	:	:	PUNCT
ct-9661	198	4	capillary	capillary	ADJ
ct-9661	198	5	permeability	permeability	NOUN
ct-9661	198	6	and	and	CCONJ
ct-9661	198	7	oedema	oedema	NOUN
ct-9661	198	8	in	in	ADP
ct-9661	198	9	the	the	DET
ct-9661	198	10	perfused	perfuse	VERB
ct-9661	198	11	frog	frog	NOUN
ct-9661	198	12	.	.	PUNCT
ct-9661	199	1	j	j	PROPN
ct-9661	199	2	physiol	physiol	PROPN
ct-9661	199	3	1940;98:109	1940;98:109	PROPN
ct-9661	199	4	-	-	PUNCT
ct-9661	199	5	129	129	NUM
ct-9661	199	6	.	.	PUNCT
ct-9661	200	1	54	54	NUM
ct-9661	200	2	.	.	PUNCT
ct-9661	201	1	reghini	reghini	PROPN
ct-9661	201	2	mf	mf	PROPN
ct-9661	201	3	,	,	PUNCT
ct-9661	201	4	neto	neto	NOUN
ct-9661	201	5	cr	cr	PROPN
ct-9661	201	6	,	,	PUNCT
ct-9661	201	7	segabinazzi	segabinazzi	NOUN
ct-9661	201	8	lg	lg	NOUN
ct-9661	201	9	,	,	PUNCT
ct-9661	201	10	et	et	PROPN
ct-9661	201	11	al	al	PROPN
ct-9661	201	12	:	:	PUNCT
ct-9661	201	13	inflammatory	inflammatory	ADJ
ct-9661	201	14	response	response	NOUN
ct-9661	201	15	in	in	ADP
ct-9661	201	16	chronic	chronic	ADJ
ct-9661	201	17	degenerative	degenerative	ADJ
ct-9661	201	18	endometritis	endometritis	PROPN
ct-9661	201	19	mares	mare	NOUN
ct-9661	201	20	treated	treat	VERB
ct-9661	201	21	with	with	ADP
ct-9661	201	22	platelet	platelet	ADJ
ct-9661	201	23	-	-	PUNCT
ct-9661	201	24	rich	rich	ADJ
ct-9661	201	25	plasma	plasma	NOUN
ct-9661	201	26	.	.	PUNCT
ct-9661	202	1	theriogenology	theriogenology	NOUN
ct-9661	202	2	2016;86:516	2016;86:516	NUM
ct-9661	202	3	-	-	SYM
ct-9661	202	4	522	522	NUM
ct-9661	202	5	.	.	PUNCT
ct-9661	202	6	55	55	NUM
ct-9661	202	7	.	.	PUNCT
ct-9661	203	1	metcalf	metcalf	PROPN
ct-9661	203	2	es	es	PROPN
ct-9661	203	3	:	:	PUNCT
ct-9661	203	4	the	the	DET
ct-9661	203	5	effect	effect	NOUN
ct-9661	203	6	of	of	ADP
ct-9661	203	7	platelet	platelet	ADJ
ct-9661	203	8	-	-	PUNCT
ct-9661	203	9	rich	rich	ADJ
ct-9661	203	10	plasma	plasma	NOUN
ct-9661	203	11	(	(	PUNCT
ct-9661	203	12	prp	prp	PROPN
ct-9661	203	13	)	)	PUNCT
ct-9661	203	14	on	on	ADP
ct-9661	203	15	intraluminal	intraluminal	ADJ
ct-9661	203	16	fluid	fluid	NOUN
ct-9661	203	17	and	and	CCONJ
ct-9661	203	18	pregnancy	pregnancy	NOUN
ct-9661	203	19	rates	rate	NOUN
ct-9661	203	20	in	in	ADP
ct-9661	203	21	mares	mare	NOUN
ct-9661	203	22	susceptible	susceptible	ADJ
ct-9661	203	23	to	to	ADP
ct-9661	203	24	persistent	persistent	ADJ
ct-9661	203	25	mating	mating	NOUN
ct-9661	203	26	-	-	PUNCT
ct-9661	203	27	induced	induce	VERB
ct-9661	203	28	endometritis	endometritis	NOUN
ct-9661	203	29	(	(	PUNCT
ct-9661	203	30	pmie	pmie	PROPN
ct-9661	203	31	)	)	PUNCT
ct-9661	203	32	.	.	PUNCT
ct-9661	204	1	j	j	PROPN
ct-9661	204	2	equine	equine	PROPN
ct-9661	204	3	vet	vet	NOUN
ct-9661	204	4	sci	sci	PROPN
ct-9661	204	5	2014;1:128	2014;1:128	NUM
ct-9661	204	6	.	.	PUNCT
ct-9661	205	1	56	56	NUM
ct-9661	205	2	.	.	NOUN
ct-9661	205	3	rohrbach	rohrbach	PROPN
ct-9661	205	4	bw	bw	PROPN
ct-9661	205	5	,	,	PUNCT
ct-9661	205	6	sheerin	sheerin	NOUN
ct-9661	205	7	pc	pc	NOUN
ct-9661	205	8	,	,	PUNCT
ct-9661	205	9	cantrell	cantrell	PROPN
ct-9661	205	10	ck	ck	PROPN
ct-9661	205	11	,	,	PUNCT
ct-9661	205	12	et	et	PROPN
ct-9661	205	13	al	al	PROPN
ct-9661	205	14	:	:	PUNCT
ct-9661	205	15	effect	effect	NOUN
ct-9661	205	16	of	of	ADP
ct-9661	205	17	adjunctive	adjunctive	ADJ
ct-9661	205	18	treatment	treatment	NOUN
ct-9661	205	19	with	with	ADP
ct-9661	205	20	intravenously	intravenously	ADV
ct-9661	205	21	administered	administer	VERB
ct-9661	205	22	propionibacterium	propionibacterium	NOUN
ct-9661	205	23	acnes	acne	NOUN
ct-9661	205	24	on	on	ADP
ct-9661	205	25	reproductive	reproductive	ADJ
ct-9661	205	26	performance	performance	NOUN
ct-9661	205	27	in	in	ADP
ct-9661	205	28	mares	mare	NOUN
ct-9661	205	29	with	with	ADP
ct-9661	205	30	persistent	persistent	ADJ
ct-9661	205	31	endometritis	endometritis	NOUN
ct-9661	205	32	.	.	PUNCT
ct-9661	206	1	j	j	PROPN
ct-9661	206	2	am	be	AUX
ct-9661	206	3	vet	vet	NOUN
ct-9661	206	4	med	med	ADJ
ct-9661	206	5	assoc	assoc	PROPN
ct-9661	206	6	2007;231:107	2007;231:107	PROPN
ct-9661	206	7	-	-	SYM
ct-9661	206	8	113	113	NUM
ct-9661	206	9	.	.	PUNCT
ct-9661	207	1	57	57	NUM
ct-9661	207	2	.	.	PUNCT
ct-9661	208	1	zingher	zingher	NOUN
ct-9661	208	2	ac	ac	PROPN
ct-9661	208	3	:	:	PUNCT
ct-9661	208	4	effects	effect	NOUN
ct-9661	208	5	of	of	ADP
ct-9661	208	6	immunostimulation	immunostimulation	NOUN
ct-9661	208	7	with	with	ADP
ct-9661	208	8	propionibacterium	propionibacterium	NOUN
ct-9661	208	9	acnes	acne	NOUN
ct-9661	208	10	(	(	PUNCT
ct-9661	208	11	eqstim	eqstim	NOUN
ct-9661	208	12	®	®	NOUN
ct-9661	208	13	)	)	PUNCT
ct-9661	208	14	in	in	ADP
ct-9661	208	15	mares	mare	NOUN
ct-9661	208	16	cytologically	cytologically	ADV
ct-9661	208	17	positive	positive	ADJ
ct-9661	208	18	for	for	ADP
ct-9661	208	19	endometritis	endometritis	NOUN
ct-9661	208	20	.	.	PUNCT
ct-9661	209	1	j	j	PROPN
ct-9661	209	2	equine	equine	PROPN
ct-9661	209	3	vet	vet	NOUN
ct-9661	209	4	sci	sci	PROPN
ct-9661	209	5	1996;16:100	1996;16:100	PROPN
ct-9661	209	6	-	-	SYM
ct-9661	209	7	103	103	NUM
ct-9661	209	8	.	.	PUNCT
ct-9661	210	1	58	58	NUM
ct-9661	210	2	.	.	PUNCT
ct-9661	211	1	woodward	woodward	PROPN
ct-9661	211	2	em	em	PRON
ct-9661	211	3	,	,	PUNCT
ct-9661	211	4	metcalf	metcalf	PROPN
ct-9661	211	5	es	es	NOUN
ct-9661	211	6	,	,	PUNCT
ct-9661	211	7	scoggin	scoggin	NOUN
ct-9661	211	8	ke	ke	PROPN
ct-9661	211	9	,	,	PUNCT
ct-9661	211	10	et	et	PROPN
ct-9661	211	11	al	al	PROPN
ct-9661	211	12	:	:	PUNCT
ct-9661	211	13	the	the	DET
ct-9661	211	14	effect	effect	NOUN
ct-9661	211	15	of	of	ADP
ct-9661	211	16	immune	immune	ADJ
ct-9661	211	17	modulators	modulator	NOUN
ct-9661	211	18	on	on	ADP
ct-9661	211	19	endometrial	endometrial	ADJ
ct-9661	211	20	cytokine	cytokine	NOUN
ct-9661	211	21	expression	expression	NOUN
ct-9661	211	22	in	in	ADP
ct-9661	211	23	mares	mare	NOUN
ct-9661	211	24	susceptible	susceptible	ADJ
ct-9661	211	25	to	to	ADP
ct-9661	211	26	persistent	persistent	ADJ
ct-9661	211	27	breeding	breeding	NOUN
ct-9661	211	28	induced	induce	VERB
ct-9661	211	29	endometritis	endometritis	NOUN
ct-9661	211	30	.	.	PUNCT
ct-9661	212	1	clinical	clinical	ADJ
ct-9661	212	2	theriogenology	theriogenology	NOUN
ct-9661	212	3	2013;5:364	2013;5:364	NUM
ct-9661	212	4	.	.	PUNCT
ct-9661	213	1	59	59	NUM
ct-9661	213	2	.	.	PUNCT
ct-9661	214	1	molina	molina	PROPN
ct-9661	214	2	nm	nm	PROPN
ct-9661	214	3	,	,	PUNCT
ct-9661	214	4	sola	sola	PROPN
ct-9661	214	5	-	-	PUNCT
ct-9661	214	6	leyva	leyva	PROPN
ct-9661	214	7	a	a	PRON
ct-9661	214	8	,	,	PUNCT
ct-9661	214	9	saez	saez	PROPN
ct-9661	214	10	-	-	PUNCT
ct-9661	214	11	lara	lara	PROPN
ct-9661	214	12	mj	mj	PROPN
ct-9661	214	13	,	,	PUNCT
ct-9661	214	14	et	et	PROPN
ct-9661	214	15	al	al	PROPN
ct-9661	214	16	:	:	PUNCT
ct-9661	214	17	now	now	ADV
ct-9661	214	18	opportunities	opportunity	NOUN
ct-9661	214	19	for	for	ADP
ct-9661	214	20	endometrial	endometrial	ADJ
ct-9661	214	21	health	health	NOUN
ct-9661	214	22	by	by	ADP
ct-9661	214	23	modifying	modify	VERB
ct-9661	214	24	uterine	uterine	ADJ
ct-9661	214	25	microbial	microbial	ADJ
ct-9661	214	26	composition	composition	NOUN
ct-9661	214	27	:	:	PUNCT
ct-9661	214	28	present	present	ADJ
ct-9661	214	29	or	or	CCONJ
ct-9661	214	30	future	future	ADJ
ct-9661	214	31	?	?	PUNCT
ct-9661	215	1	biomolecules	biomolecule	NOUN
ct-9661	215	2	2020;10:1	2020;10:1	NUM
ct-9661	215	3	-	-	SYM
ct-9661	215	4	21	21	NUM
ct-9661	215	5	.	.	PUNCT
ct-9661	216	1	clinical	clinical	ADJ
ct-9661	216	2	theriogenology	theriogenology	NOUN
ct-9661	216	3	2021	2021	NUM
ct-9661	216	4	;	;	PUNCT
ct-9661	216	5	13	13	NUM
ct-9661	216	6	:	:	SYM
ct-9661	216	7	264	264	NUM
ct-9661	216	8	nonantibiotic	nonantibiotic	ADJ
ct-9661	216	9	therapies	therapy	NOUN
ct-9661	216	10	for	for	ADP
ct-9661	216	11	endometritis	endometritis	NOUN
ct-9661	216	12	:	:	PUNCT
ct-9661	216	13	what	what	PRON
ct-9661	216	14	,	,	PUNCT
ct-9661	216	15	when	when	SCONJ
ct-9661	216	16	,	,	PUNCT
ct-9661	216	17	and	and	CCONJ
ct-9661	217	1	why	why	SCONJ